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ABSTRACT 
Aflatoxin BI (AFB I), a potent hepatotoxic and hepatocarcinogenic mycotoxin synthesised by 
toxigenic fungi (Aspergillus flavus and Aspergillus parasiticus), is a common contaminant of 
many cereal commodities consequently posing a major threat to human and animal health. 
Sutherlandia frutescens (SF), a traditional medicinal plant endemic to Southern Africa, is 
commonly used by many cultures as a tonic for various health-related conditions. Incidentally, 
the present study aimed at investigating the potential hepatoprotective capacity of SF and L-
canavanine (L-can, a major constituent of SF) against AFBI-induced cytotoxicity in human 
Hep02 cells and used a standard treatment procedure of 24 h. Cell viability was evaluated 
using the methyl thiazol tetrazolium (MIT) assay, which effectively demonstrated the ability 
of SF, when administered individually and in combination with AFB I, to be significantly 
cytotoxic to Hep02 cells in a dose-dependant manner. Reactive oxygen species (ROS) and 
consequent peroxidative damage caused by AFBI are considered to be the main mechanisms 
leading to hepatotoxicity and was confirmed by the thiobarbituric acid reactive substances 
(TBARS) assay which revealed that AFB I mediated a significant increase in lipid peroxidation. 
Additionally, comet assay analysis demonstrated the most pronounced effect to be observed 
following administration of AFB I. In contrast, AFBI-mediated genotoxicity was significantly 
reduced by SF and L-can. Such amelioration can be attributed to the marked increases in 
glutathione (OSH) levels observed after the co-administration of SF and L-can with AFB I. 
Cytoprotection by SF and L-can against AFB I-induced toxicity was further substantiated by 
the significant increases in heat shock protein 70 expression. Moreover, when SF and L-can 
were co-administered along with AFB I, analysis by flow cytometry revealed that AFB I-
induced increases in apoptosis and necrosis were reduced. The findings of this study propose 
that SF and L-can may be selectively effective in alleviating AFBI-induced cytotoxicity and 
lends pharmacological credibility to the suggested ethnomedical uses of SF. However, the 
exact mechanism of action and the extracts efficacy in humans requires further authentication. 
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According to Paracelsus, a significant figure in the history of science and medicine during the 
late Middle Ages, "All substances are poisons; there is none which is not a poison. The right 
dose differentiates a poison from a remedy" (Langman and Kapur, 2006). 
The traditional definition of toxicology is "the science of poisons" (Langman and Kapur, 
2006), however toxicology, like medicine, is both a science and an art (Roberfroid, 1995). The 
science of toxicology involves studying the properties of chemicals and their effects on living 
organisms, whereas the art of toxicology is the predictive phase of the discipline aimed at 
assessing the potential adverse effects of chemicals in order to help preserve and protect human 
health (Roberfroid, 1995). 
The history of toxicology has been interesting and varied, but never dull. The discipline dates 
to earliest man, who used animal venoms and plant extracts for hunting, waging war and 
assassinations, and has evolved rapidly during the past century. In addition, the modern era of 
toxicology continues to develop and expand by assimilating knowledge and techniques from 
most branches of the basic sciences, such as biology, chemistry, physics and mathematics. This 
complex mixture has resulted in an exciting, innovative and diversified field that is serving 
science and the community at large. Few disciplines can point to both basic sciences and direct 
application at the same time. Toxicology, the study of adverse effects of xenobiotics on living 
organisms, is unique in this regard (Amdur et al. , 1991). 
A well established branch of the multidisciplinary field of toxicology is environmental 
toxicology, which is concerned primarily with the harmful effects of chemicals that are 
encountered incidentally because they are in the atmosphere, in the food chain, or present in 
occupational or recreational environments (Langman and Kapur, 2006). 
Environmental toxicology encompasses the diverse and powerful biological effects of the 
mycotoxins (Steyn, 1995), a varied group of species-specific secondary metabolites produced 
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by toxigenic fungi (Amdur et al., 1991). It has been well established that mycotoxins adversely 
affect human or animal health and are found mainly in post-harvest crops such as cereal grains 
or forages (Hussein and Brasel, 2(01). 
Among the various mycotoxins, the aflatoxins have been the subject of the most extensive 
research (Amdur et al., 1991). Aflatoxin B1, synthesised by strains of Aspergillus flavus and 
Aspergillus parasiticus, is the most toxic member of the group and is usually present in the 
highest concentration under natural conditions (Meerdink, 2002). It is an extremely 
biologically reactive compound, altering a number of biochemical systems (Amdur et al., 
1991). Although the liver is clearly the principal target organ for AFB 1, the lung, kidney and 
colon have also been implicated as potential targets following dietary and inhalational 
exposure (Wang and Groopman, 1999; Bedard and Massey, 2(06). In addition, it is the most 
carcinogenic of the aflatoxins with the International Agency for Research on Cancer reporting 
that there is sufficient evidence to classify AFBI as a Group I carcinogen (Bedard and Massey, 
2(06). For these reasons, AFBI poses a major threat to human and animal health, and 
determination of its biological mechanism of action has understandably been the focus of much 
research (Coulombe, 1993). 
Plants have played an important role in the treatment of various human ailments and, indeed, 
most new clinical applications of plant secondary metabolites and their derivatives over the last 
half century have been applied towards combating human disease (Balunas and Kinghorn, 
2(05). Herbal medicines represent a major component of this revolution (Fernandes et al., 
2(04). Unfortunately, there is a great deal of confusion about their identification, effectivity, 
therapeutic doses, toxicity, standardisation and regulation (Chattopadhyay, 2(03). 
One of the best known mUlti-purpose medicinal plants in Southern Africa, SF, is used for a 
wide range of indications, including cancer, viral diseases and inflammatory conditions 
(Fernandes et al., 2(04). 
With the interest that has been generated by the general public, university researchers and 
multinationals across the globe into ethnobotany, there is now more than ever a golden 
opportunity to continue making a worthwhile contribution to healthcare. 
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1.2 Objectives 
Based on the many controversial claims of SF, this study analysed the therapeutic potential of 
an SF aqueous extract against AFB I-induced cytotoxicity in cultured HepG2 cells. 
The objectives of this study were to investigate: 
• The cytotoxicity of SF, when administered individually and in combination with AFB I, 
on HepG2 cells 
• The influence of SF, L-can and AFB I, when administered individually and in 
combination, on cellular redox state, genome integrity, protein integrity and apoptosis 





LITERA TURE REVIEW 
Fungi synthesise a wide range of secondary metabolites, many of which have been linked with 
the precipitation of adverse health effects in both animals and humans. These ubiquitous 
compounds have been allocated the term mycotoxins (D' Mello and MacDonald, 1997). 
Mycotoxins encompass a large and structurally diverse group of toxins (Neal, 1995). It has 
been determined that approximately 25% of the worlds food supply is contaminated by 
mycotoxins annually (Coulombe, 1993). Cereal plants may become contaminated by 
mycotoxins due to fungi growing either as pathogens on plants or saprophytically on stored 
plants (Handl and Richard, 2007). Temperature extremes, humidity, drought, excessive 
moisture in the field and in storage, variations in harvesting practices, and insect infestation are 
some of the major environmental factors that contribute to the severity of mycotoxin 
contamination (Coulombe, 1993). 
The deleterious effects imposed by mycotoxins are referred to as mycotoxicoses (Handl and 
Richard, 2007). Even though evidence of mycotoxicoses can be traced back to ancient times, 
the momentum for mycotoxin research was not provided until 1960, when the so called 
'Turkey-X' disease caused 100000 turkey poults to die from an acute necrosis of the liver and 
hyperplasia of the bile duct following the consumption of groundnuts contaminated with 
Aspergillus flavus. As a result of this event subsequent research eventually led to the isolation 
and identification of the aflatoxins (D'Mello and MacDonald, 1997). Stimulated by the 
discovery of the aflatoxins, the search for mycotoxins in food has led to the identification of 
over 100 toxigenic fungi and more than 300 mycotoxins (Wang and Groopman, 1999). 
2.1.2 Aflatoxins and aflatoxicosis 
The aflatoxins, of which there are five (Bl , B2, 0 1, O2 and M) of concern as natural 
contaminants in food, are mycotoxins produced by a closely related group of aspergilli; A. 
flavus, A. parasiticus and A. nomius (Moss, 2002). 
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Diseases caused due to aflatoxin consumption are collectively termed aflatoxicosis. It has been 
reported that acute aflatoxicosis results in direct liver damage and subsequent illness or death 
whereas chronic aflatoxicosis results in immunosuppression, cancer, and other slow 
pathological conditions (Ubagai et al. , 2008). 
The foremost concern regarding the aflatoxins encompasses their carcinogenic properties 
(Kuilman et al., 2000). Aflatoxin Bl is the most prevalent and carcinogenic of the aflatoxins, 
and the International Agency for Research on Cancer has classified AFB 1 as a Group I 
carcinogen (an agent that is carcinogenic to humans) (Madhusudhanan et al., 2004). 
In all animal species examined to date, including man, the liver frequently demonstrates to be 
the primary target organ for AFBI (Neal, 1995), with low levels of chronic exposure resulting 
in neoplasia, primarily liver cancer (Wang and Groopman, 1999). Primary liver cancer ranks 
fifth in frequency among all malignancies in the world and is the third most common cause of 
cancer mortality. Hepatocellular carcinoma accounts for approximately 90% of primary liver 
cancers (EI-Serag and Rudolph, 2007) with the great majority of liver cancer occurring in 
either eastern Asia or sub-Saharan Africa (McGlynn and London, 2005). 
For these reasons, mycotoxins pose a major threat to public and animal health, and 
determination of the biological mechanism of action of mycotoxins has understandably been 
the focus of much research. 
2.2 Cellular Metabolism 
2.2.1 Activation 
Aflatoxin Bl is a low molecular weight, lipophilic molecule that is efficiently absorbed after 
ingestion of AFBJ-contaminated food. The toxin itself is not carcinogenic, but is metabolised 
within the body to produce an ultimate carcinogenic metabolite (McLean and Dutton, 1995). 
There is an abundance of evidence which reports that many mycotoxins require metabolic 
activation in order to induce a toxic response (Neal, 1995) and although early investigations 
were concerned with the possibility that AFBJ is a direct-acting carcinogen, subsequent 
investigations clearly demonstrate that biotransformation mediates a key role in the disposition, 
toxicity and carcinogenicity of AFBJ (Guengerich et al. , 1998). 
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The mechanism of AFBI hepatocarcinogenesis is specifically related to activation by the 
hepatic cytochrome P 450-dependent polysubstrate monooxygenase enzyme superfamily 
(CYP450) after transport of the toxin across the plasma membrane (Awney et al., 2(02). The 
CYP450 isoenzymes involved in both epoxidation and hydroxylation of AFB\ are mainly 
CYP lA2 and CYP3A4 (Lee et al., 2005). In humans, CYP3A4 appears to be the dominant 
CYP450 involved in the biotransformation of AFB\ (Guengerich et al., 1998). 
Aflatoxin B\ is bioactivated by epoxidation of the terminal furan ring double bond, resulting in 
the generation of the AFB\-8,9-epoxide, a stereoisomer which can exist in both an exo (AFB\-
exo-8,9-epoxide) and an endo (AFBI-endo-8,9-epoxide) conformation (Bedard and Massey, 
2006; Figure 2.1). 
Binding to 
DNA 
P45Y AFB1 ~50 
AFB1 exo-epoxlde 
/ 









Figure 2.1 Glutathione S-transferase-catalysed conjugation of aflatoxin 81 exo- and 
endo-epoxide with glutathione (Stewart et ai., 1996). 
The microsomal monooxygenase system is also responsible for converting AFB \ into polar 
metabolites such as AFM\, AFP\ and AFQ\, all three of which can be efficiently eliminated by 
hepatocytes. The toxin may alternatively be converted (reversibly) by an NADPH-reductase to 
aflatoxicol, which may thus serve as a reservoir for AFB\ (McLean and Dutton, 1995). 
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2.2.2 Detoxification 
The activating enzymes are not the only determinants of sensitivity to AFBJ-induced toxicity 
(Stewart et al., 1996). Activities of detoxifying enzymes are also decisive, and glutathione S-
transferase (GST)-catalysed conjugation of GSH to the generated AFB\-8,9-epoxides is in fact 
presumed to play the most important role in preventing epoxide binding to target 
macromolecules (Lori co et ai., 2002; Figure 2.1). The GST's, which comprise a gene 
superfamily, are a group of microsomal and cytosolic enzymes that catalyse the conjugation of 
reduced GSH to a range of electrophilic compounds. This reaction constitutes the initial step of 
the mercapturic acid pathway, a process which facilitates the excretion of many xenobiotics. 
Because conjugation of the electrophilic AFBJ-8,9-epoxide with GSH is an alternative fate to 
binding to nucleophilic centres in cellular macromolecules, GST's playa key role in the 
protection of tissues from AFB\-induced toxicity (Stewart et al. , 1996). 
The AFBJ-8,9-epoxides might also be detoxified by UDP-glucuronyl-transferase, 
sulphotransferases (Coulombe, 1993) and possibly by the epoxide hydrolase systems as well 
(McLean and Dutton, 1995). 
The removal of AFB\ metabolites (AFB1-GSH and glucuronide conjugates) from the liver is 
mediated via biliary excretion (Towner et al. , 2(02). In fact, the elimination of GSH conjugates 
is a decisive step of the detoxification process, because their accumulation can lead to 
inhibition of GST's which may then have deleterious consequences with respect to cellular 
function and viability (Lorico et al. , 2(02). Once released in the bile however, these conjugates 
may be hydrolysed by intestinal microflora which facilitates the release of AFBJ for 
enterohepatic circulation and reabsorption. Most of the other aflatoxins form glucuronide or 
sulphate conjugates and are excreted in the urine (McLean and Dutton, 1995). Therefore, the 
ultimate toxicity of AFB J depends on the enzymes that bioactivate it to the AFB J-8,9-epoxides 
and on the enzymes that detoxify AFBJ and/or the AFBl-8,9-epoxides (Stewart et ai., 1996). 
The extent of GSH conjugation of AFB 1 is a major factor in variations in risk of different 
animal species to AFB1-induced toxicity (Coulombe, 1993). Esaki and Kumagai (2002) 
showed that GST activity is low in the rat, quail and turkey, all of which are susceptible 
species, but high in resistant species such as the hamster, mouse, guinea-pig and mastomys. 
Thus, GST-catalysed detoxification, rather than microsomal activation, is the critical 
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determinant of species susceptibility to the deleterious effects of AFBI (Stewart et al., 1996). 
However, Hayes et al. (1991) suggests that the potential mechanisms associated with resistance 
to AFBI toxicity includes not only high detoxification activity but also low capacity to form 
AFB 1-8,9-epoxides as well as increased AFB 1 efflux from cells and high DNA repair capacity. 
2.2.3 Interaction with biomolecules 
2.2.3.1 Nucleic acids 
Nucleophilic hetero-atoms (nitrogen and oxygen) in the organic bases of nucleic acids are 
susceptible to electrophilic attack by metabolites of mycotoxins subsequently resulting in the 
formation of covalent adducts. Any alterations in nucleic acid (DNA and RNA) structure 
mediated by these adducts may lead to impaired DNA and RNA template activity thus 
promoting the inhibition of DNA, RNA and protein synthesis (McLean and Dutton, 1995). 
2.2.3.1.1 Aflatoxin BI-DNA adduct formation 
For reasons that remain elusive, the AFB 1-endo-8,9-epoxide is reported to be more stable than 
the exo-isomer. However, the reactivity of the exo-isomer with DNA is at least 1 OOO-foid 
greater than the endo-isomer. It is suggested that the most reasonable explanation for such 
differences in biological activity is because the intercalation of the furanocoumarin entity 
between DNA bases seems to favourably position the exo-isomer for SN2 attack by the 
nitrogen number seven (N7) atom of guanine (Gua) residues (Guengerich, 2003). It has also 
been reported that nucleophilic attack by N7 of Gua is possibly blocked by the oxirane ring of 
the endo-isomer upon its intercalation into DNA (Bedard and Massey, 2006). 
During the intercalation of the exo-isomer into DNA, a peripheral proton field is created and 
imposes proximity effects (Guengerich et al. , 1998) which facilitate the generation of trans-
8,9-dihydro-8-(N7 -guanyl)-9-hydroxyaflatoxin Bl (AFB1-N
7 -Gua, Figure 2.2), the primary 
AFBI-DNA adduct (Bedard and Massey, 2006). The imidazole ring of AFBI-N7-Gua bears a 
positive charge making the adduct fairly labile and allowing for it to undergo one of the 
following three reactions (Figure 2.2): (1) release of AFB l-8,9-dihydrodiol, restoring guanylic 
sites in DNA; (2) depurination, leading to the formation of an apurinic (AP) site in DNA; and 
(3) base-catalysed hydrolysis during which the imidazole ring opens, forming a stable AFB 1_ 
formamidopyrimidine adduct (AFBI-FAPY) (Smela et al., 2001; Bedard and Massey, 2006). 
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Figure 2.2 Aflatoxin BI-DNA adduct formation (Bedard and Massey, 2006). 
The AFBI-8,9-dihydrodiol undergoes a base-catalysed, ringopening rearrangement to form a 
dialdehyde (Guengerich et al., 1998). It is reported that the dihydrodiol and dialdehyde are not 
genotoxic (Guengerich, 2(03). The other two lesions formed by AFB 1, the AP site and AFB 1-
FAPY, have not been studied in sufficient detail to conclude definitively whether or not they 
contribute significantly to AFB 1-induced toxicology (Smela et al., 2(01). 
The mutational asymmetry observed for AFBI-N7-Gua is consistent with structural models 
indicating that the AFB 1 moiety of the AFB 1-N 7 -Gua adduct is covalently intercalated on the 5' 
face of the Gua residue. It is thus suggested that this adduct specifically induces the genetic 
requirements for mutagenesis. Aflatoxin B1-DNA adducts possess the capacity of forming 
repair-resistant adducts or may induce error-prone DNA repair resulting in single-strand 
breaks, frame shift mutations or base pair substitutions. Mispairing of adducts could induce 
both transversion and transition mutations (Wang and Groopman, 1999). 
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The most commonly observed mutation induced by chemically reactive forms of AFB I, for 
example AFB I-8,9-exo-epoxide, is a GC to TA transversion which occurs in the third position 
of codon 249 of the p53 gene (Gerbes and Caselmann, 1993). The biochemical consequence of 
this mutation is an arginine to serine alteration in the p53 protein. This mutation appears to be 
unique to AFBI-induced liver tumours, as tumours presumably induced by other factors fail to 
consistently show this genetic change. The resulting mutation prevails in hepatocellular 
carcinomas of people that consume AFBI-contaminated food (Smela et ai., 2(01). 
2.2.3.2 Proteins 
Aflatoxin BI reacts with various liver proteins particularly albumin, to form a stable adduct 
(Amaya-Farfan, 1999). In fact, the AFBI-albumin adduct is correlated with levels of the AFB I-
DNA adduct in the liver and is used to examine exposure (Wild et at., 1996). Proteins that bind 
AFB I reversibly may thus serve as reservoirs of the toxin, prolonging toxin exposure, or they 
may serve as carriers in the transport of reactive metabolites (McLean and Dutton, 1995). 
It is proposed that AFBlo on entering the cell, is translocated in a non-covalently bound form 
(by cellular proteins) to microsomes for activation by microsomal enzymes (McLean and 
Dutton, 1995). 
Chih et ai. (1993) investigated the formation of AFBI-protein complexes. It was reported that 
several cellular proteins (pyruvate kinase>albumin>carbonic anhydrase>RNase>histones) bind 
to AFB I. It has also been reported that AFBI binds to nuclear proteins (free nuclear 
proteins>histones>chromatin-bound non-histone proteins) (Yu et ai., 1988). 
The formation of AFB I-DNA adducts is implicated in AFB I-induced carcinogenesis; however 
the mechanism by which AFBI or its derivatives are translocated to the nucleus remains 
elusive. Evidence suggests that AFBI and/or its metabolites become cytoplasmically bound to 
molecules destined for the nucleus. In this regard, Chih et ai. (1993) showed that a toxin-
protein complex is translocated to the nucleus. It is thus possible that AFB I translocates the 
nuclear pore as a ligand-bound complex by binding non-covalently to proteins destined for the 
nucleus, for example histones, thus facilitating its uptake, activation and subsequent damage to 
DNA. 
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It is suggested that the structure and activity of proteins may be detrimentally altered by non-
specific-irreversible covalent (conformational change resulting in denaturation or blocking of 
binding sites) and specific-reversible non-covalent (competitive binding) binding with the 
toxin (McLean and Dutton, 1995). Enzyme inactivation is a further consequence of toxin 
binding (Amaya-Farfan, 1999). 
Besides AFB \ itself or the generated exo-isomer interacting with proteins, the dialdehyde 
generated from the AFB\-8,9-dihydrodiol is capable of condensing with primary amino acid 
groups, such as lysine, and other cellular constituents, forming Schiff bases (Guengerich et aI., 
1998) thus also contributing to alterations in protein/enzyme structure and function. 
2.2.3.3 EtTects on the mitochondrion 
Liver mitochondrial injury is indeed one of the dominant features of AFB \ toxicity. 
The cytochrome complexes represent the major redox components of the mitochondrial 
respiratory chain (Sajan et aI., 1995). Doherty and Campbell (1973) reported that the major site 
of electron transport inhibition by AFB \ was between cytochromes b and c 1. It was also 
determined that AFB\ (2.5-4.8 x 104 M) mediated up to 44% inhibition of electron transport in 
an actively respiring rat liver mitochondrial preparation. 
Pai et al. (1975) investigated the effects of AFB\ (1 x 104 M) on rat liver mitochondrial 
function and also reported that AFB \ inhibited electron transport between cytochromes b and 
C1· It was further demonstrated that AFB\ (1 x lO-6M.) uncoupled oxidative phosphorylation. 
In other studies, Obidoa and Obonoa (1981) reported a concentration-dependent inhibition of 
rat liver mitochondrial succinate dehydrogenase and ATPase by AFB\, whereas Sajan et al. 
(1995) reported 31%, 36% and 41% decreases in cytochrome oxidase, succinoxidase and 
succinate dehydrogenase activity respectively, after analysing liver mitochondria of AFB\-
treated (7mglkg body weight, i.p) rats. Additionally, Obidoa (1986) further demonstrated the 
capacity of AFB \ to inhibit cytochrome oxidase activity in isolated rat liver mitochondria. 
Mitochondrial DNA encodes several major enzyme complexes involved in oxidative 
phosphorylation (Schatz and Manson, 1974). It is suggested that mitochondrial DNA, which is 
less protected by associated histones than nuclear DNA, is a major target for carcinogen 
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binding. It was shown that the extent of AFBI adduct formation with mitochondrial DNA was 
several-fold more than that with nuclear DNA (Niranjan et ai., 1981). Because mitochondria 
lack excision repair mechanisms and protective histones, the AFBI-DNA adducts formed 
contribute to defective synthesis of respiratory enzymes. Adduct formation of AFBI with 
mitochondrial proteins may also modify respiratory enzymes (Sajan et ai., 1995). 
Mitochondrial membranes are rich in phospholipids. Thus, lipophilic carcinogens such as 
AFBI can readily interact with the phospholipid bilayer and cause changes in mitochondrial 
membrane fluidity (Sajan et ai., 1995). In addition, AFBI treatment generates ROS which are 
known to damage membranes by lipid peroxidation (Shen et ai., 1994). The mitochondrial 
membrane may therefore be affected by lipid peroxidation induced by AFBI and this too can 
impair associated functions. 
2.3 Effects on Macromolecular Biosynthesis 
_ Inhibition of macromolecular biosynthesis is a major metabolic effect of AFBI (McLean and 
Dutton, 1995). This action has been equated with its ability to bind to DNA and thus affect 
RNA transcription and translation as well as polyribosome profiles and protein synthesis, a 
consequence of which is cell death (Scaife, 1971). 
2.3.1 DNA 
One of the initial measurable effects of AFBI on cells and tissues is the inhibition of DNA 
synthesis. This may occur after the covalent binding of AFBI to DNA and/or proteins, leading 
to modification of the DNA template and/or inactivation of certain enzymes in DNA synthesis. 
It has also been shown that covalent binding of AFB I to membrane proteins may reduce the 
uptake of thymidine and other precursor nucleotides which are necessary for DNA synthesis 
(McLean and Dutton, 1995). 
Iwaki et al. (1990) reported a 30% inhibition of DNA synthesis in human hepatic cells exposed 
to AFBI (1f.tglml). Further analysis revealed that AFBI-associated cellular components were 
mainly DNA, RNA, and proteins. 
In a similar study, Meneghini and Schumacher (1977) demonstrated inhibition of DNA 
synthesis when African green monkey cells were incubated for 3 h with AFBI (O.lf.tglml). On 
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the basis of pulse labelled DNA analysis, the authors concluded that AFBI blocked initiation of 
DNA replication rather than elongation. 
2.3.2 RNA 
It has been established that AFB], when administered in vivo or activated in vitro, inhibits rat 
liver nuclear and nucleolar RNA synthesis (Yu et aI., 1988). According to Roy (1968), a 
metabolite of AFB I rather than the toxin itself inhibits DNA-dependent RNA synthesis. 
Wagner and Drews (1965) investigated the effects of a single dose of AFBI (1.25mglkg body 
weight, Lp) on the metabolism of rat liver nuclear RNA. The authors observed a 50% decrease 
in the incorporation of labelled RNA precursors into nuclear RNA. It was further shown that 
AFBI impaired the formation of the 35S ribosomal precursor RNA and the 28S RNA. 
Floyd et al. (1968) demonstrated the inhibition of nucleolar RNA synthesis by AFBl, whereas 
studies by Wagner and Unterreiner (1982) revealed 91%, 77% and 75% inhibition of total 
RNA synthesis, tRNA synthesis and protein synthesis respectively, by AFB 1• 
Aflatoxin Bl has also been shown to inhibit UTP incorporation into RNA (Clifford et aI., 1976) 
as well as to mediate the inhibition of nucleoplasmic RNA polymerase (Prasanna et al., 1978). 
The effects of AFBI on hepatocyte RNA synthesis was investigated by Ch'ih et al. (1983). It 
was reported that AFBI (50!-,M) inhibited macromolecular synthesis by greater than 70% after 
a 3 h incubation whereas at lower concentrations (0.05-1O!-,M), dose-and time-dependent 
decreases in cell viability and, RNA and protein synthesis were observed. 
2.3.3 Protein 
The inhibition of protein synthesis by AFBI may arise directly via inactivation of biosynthetic 
enzymes or indirectly via an alteration of DNA template activity, inhibition of RNA synthesis 
or translation, and/or interference with amino acid transport (McLean and Dutton, 1995). 
It is currently admitted that AFBI impairs protein synthesis in the liver, an effect that is 
expected to occur as a consequence of altered transcription (Sarasin and Moulr, 1973). Rao 
(1971) determined that liver protein synthesis of Macaco irus was inhibited by 50% when 
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these monkeys were administered single oral doses of AFBI (2mglkg) for 3 h. Concomitant 
with this change was an extensive disaggregation of polyribosomes. 
In another study, Sidransky et ai. (1977) demonstrated the disaggregation of free and 
membrane-bound polyribosomes accompanied by inhibition of protein synthesis in rat liver 
after the administration of AFBI (6mglkg body weight, Lp). 
John and Miller (1969) utilised isolated perfused male Sprague-Dawley rat liver to study the 
influence of AFBI on the net synthesis of the plasma proteins albumin, fibrinogen, (ll-acid 
glycoprotein and (l2-(acute phase) globulin. A dose-dependant (125-1 ()()()!lg) inhibition of 
protein synthesis was observed 4 h after perfusion. 
Sarasin and Moulr (1973) investigated the early effects of AFBI administration on protein 
synthesis in rat liver. After a single injection (lmglkg body weight, Lp) inhibition of protein 
synthesis by AFBI progressively increased to a level of approximately 85%. In addition, 
disaggregation of polysomes began 4 h after AFBI administration then progressively increased, 
reaching a maximum of approximately 60%. The authors concluded that a direct action of the 
toxin on the translational process might account for the early inhibition of protein synthesis. 
On the basis of e4C]-leucine incorporation with the postmitochondrial supernatant, Wagner 
and Unterreiner (1981) demonstrated an 80% inhibition of polypeptide synthesis when rats 
were treated with AFBI (3mglkg body weight, Lp) for 24 h. In addition, overall protein 
synthesis was inhibited by 67%. The authors also observed a 20% inhibition in leucine-specific 
arninoacyl-tRNA synthesis accompanied by an inhibition of arninoacyl-tRNA synthetase 
activity. It was concluded that inhibition of protein synthesis by AFB I is in part due to 
decreased arninoacyl-tRNA levels caused by inhibited arninoacyl-tRNA synthetases. 
2.4. Specific Effects 
2.4.1 Oxidative damage 
The intracellular generation of ROS and its impairment to cellular components such as 
enzymes, membrane lipids, proteins and nucleic acids have been implicated in the cytotoxicity 
and carcinogenicity of certain chemical carcinogens (Shen et al., 1995). Oxidative damage 
caused by AFBI may be one of the underlining mechanisms for AFBI-induced cell injury and 
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DNA damage (Shen et al., 1994). In fact, Souza et al. (1999) reported that oxidative stress is 
the principle manifestation of AFBJ-induced toxicity. 
Although the mechanism underlying AFBJ hepatotoxicity has not been fully elucidated, it is 
suggested that toxicity may ensue through the generation of intracellular ROS during the 
metabolic processing of AFB J by CYP 450 in the liver (Preetha et al., 2006). Lipid peroxidation 
is one of the main manifestations of oxidative stress and has been demonstrated to mediate a 
key role in the toxicity and carcinogenesis of many carcinogens (Shen et al., 1994). Many 
studies have reported the induction of lipid peroxidation by AFB J both in vivo and in vitro 
(Shen et al. , 1994; Shen et ai. , 1995, Madhusudhanan et ai. 2004; Meki et al., 2004; Lee et al., 
2005; Jodynis-Liebert et al. , 2006; Preetha et al., 2006). Thus ROS induction is regarded to 
playa key role in the toxicity and carcinogenicity of AFB J. 
2.4.2 Repair of Aflatoxin BI-induced DNA damage 
Evolution has allowed for the generation of an intricate network of highly conserved DNA 
repair systems to maintain genetic integrity. One of these systems is nucleotide excision repair 
(NER), a DNA damage removal mechanism that affords protection to the genome. The NER is 
divided into two subpathways; global genome repair (GGR) and transcription coupled repair 
(TCR). In GGR, the entire genome is screened for DNA lesions and is suggested to be 
transcription-independent. With TCR however, lesions that arrest RNA polymerase on the 
transcribed strand of active genes are investigated in particular. It is suggested that AFB J-
induced DNA damage is repaired by NER in mammalian systems and that NER is an important 
mechanism for enzymatic repair of AFBJ-DNA adducts (Bedard and Massey, 2006). 
Thus, susceptibility and resistance to the toxic and carcinogenic effects of AFB J may depend 
on several factors; bio-activating and detoxifying CYP450, GST activity, effective cellular 
removal of AFBJ detoxification products, the ability for excision of AFBJ adducts from DNA 
as well as repair of AFBJ-induced DNA damage. 
The perceived importance of the aflatoxins, in particular AFBJ, is reflected in the pace of 
research leading to their identification, full chemical characterisation and elucidation of 
imposed adverse health effects. 
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2.5 Sutherlandia frutescens 
Evidence suggests that approximately 80% of Africans depend upon ethnomedicine for their 
access to daily healthcare (Ojewole, 2008). Thus, it is not the case that traditional medicine 
offers an alternative for African people but rather that it is in fact their only source of treatment 
(Hartnett et aI., 2005). 
Almost 50% of all current pharmaceuticals are derived from plants (Mills et aI., 2005 a). 
Southern Africa has a rich diversity of medicinal plants with an estimated 3 000 that are 
regularly used (van Wyk, 2008). One of the best known multi-purpose medicinal plants that are 
used for various preparations is SF, a flowering shrub of the pea family (Fabaceae) (Sia, 2004). 
Decoctions of SF have been used for a variety of medicinal purposes for many years. It is 
widely believed that the Khoi and Nama people were the flrst to use it against fevers as well as 
for the cleansing of open wounds (Chadwick et aI., 2007). It is known to be used by cultural 
groups for a variety of other ailments which include indigestion, oesophagitis, peptic ulcers, 
dysentery, cancer, diabetes, colds, asthma, kidney and liver conditions, rheumatism, urinary 
tract infections and stress (van Wyk, 2008). The known side-effects of SF include mild 
diarrhoea, mild diuresis, and dizziness (Mills et ai., 2oo5a). 
There exists a long history of seemingly safe usage of SF (Mills et ai., 2005a). Plants that are 
used in traditional medicine are assumed safe, due to their long-term use and are considered to 
have insigniflcant side effects because they are 'natural'. However, this may not necessarily be 
true and is somewhat circumstantial since it is important to determine the toxicology of plant 
extracts, especially those that are used frequently over long periods (Reid et aI., 2006). 
2.5.1 Toxicity 
A toxicology screening in a primate model utilised dosages of SF up to 9 times greater than 
recommended with no noted clinical, haematological or physiological toxicity (Mills et ai., 
2oo5a). Additionally, a recent clinical trial reported safety of SF leaf powder by concluding 
that consumption of a daily dose of 800mg for 3 months was tolerated by healthy human 
volunteers in the absence of signiflcant adverse events (Ojewole, 2008). For these reasons it is 
possible that SF is now available in a tablet form with a recommended dosage of 600mg daily. 
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2.5.2 Chemistry 
Chemical compounds which have been isolated from SF include pinitol, secondary plant 
metabolites such as saponins, flavonoids, free amino acids such as gamma-amino-butyric-acid 
(GAB A) and L-can (van Wyk, 2008), arginine, asparagine, alanine, proline, leucine, 
phenylalanine and tryptophan (Tai et al., 2004) as well as a series of other components 
including methyl parabens, propyl parabens, hexadecanoic acid, gamma sitosterol, sigmast-4-
en-3-one, and several long-chain alcohols typically found in plants (Sia, 2004). 
When SF leaves were analysed, high levels of the free amino acids asparagine (up to 
35.0mglg), proline (up to 7.5mglg) and arginine (up to 6.7mglg) were detected. In addition, it 
was determined that up to 14mglg of pinitol was present in the leaves of SF (van Wyk and 
Albrecht, 2008). 
Pinitol was described as being active against acute oedema in rat models as well as mediating a 
reduction of pro-inflammatory cytokines, such as tumour necrosis factor-a (TNF-a) and 
interleukin-l~ (IL-l~) (Sia, 2004). More importantly, pinitol is a known anti-diabetic agent. It 
is thought to exert an insulin-like effect, thereby lowering blood sugar levels and increasing the 
bioavailability of glucose for cellular metabolism (van Wyk and Albrecht, 2008). 
There is approximately O.4mglg of GABA in SF tablets (Tai et al., 2004). This inhibitory 
neurotransmitter mediates its primary effects outside the central nervous system (van Wyk, 
2008). In this regard, its potential activity against anxiety and stress has been reported (Sia, 
2004). It was also shown to inhibit tumour cell migration (van Wyk and Albrecht, 2008). 
The seeds of Fabaceae contain non-protein amino acids, the most prominent being L-can. 
However, L-can is also found within the leaves of SF which contain approximately 14.5mglg 
of the compound (van Wyk and Albrecht, 2008). Other evidence demonstrated that there is 
3mglg of L-can present in SF tablets (Tai et al. , 2004). L-canavanine is a potent L-arginine (L-
arg) analogue and possesses antimetabolic activities and properties as a result. It also displays 




The incidence of type II diabetes is increasing worldwide. It has been demonstrated that SF is a 
potential hypoglycaemic mediator for the treatment of type II diabetes (Chadwick et ai., 2(07). 
After crushed SF leaves in drinking water were administered to Wistar rats fed a high fat diet, 
Chadwick et al. (2007) determined that the plant extract normalised insulin levels and glucose 
uptake in peripheral tissues (muscle and fat), suppressed intestinal glucose uptake and 
mediated glucose clearance with no noted weight gain. The authors concluded that SF is an 
efficient hypoglycaemic mediator compared to metformin for example, which is a drug that is 
commonly utilised for the treatment of type II diabetes. 
Ojewole (2004) investigated the hypoglycaemic effects of the plants shoot aqueous extract 
when administered to streptozotocin (STZ)-induced diabetic rats. It was shown that SF (50-
800mg/kg, i.p) caused significant (p<0.05-0.001) hypoglycaemia in these animals. It was 
determined that the maximum reduction of blood glucose levels by SF in normoglycaemic rats 
was 25.43% and the hypoglycaemic effect was even higher in STZ-treated rats. 
Other studies reported that pinitol, when administered to hypoinsulinaemic STZ-induced 
diabetic mice, was capable of reducing blood sugar levels in these animals (Sia et ai., 2004). 
2.5.3.2 HIV 
It has been reported by doctors and health care workers that HIV -infected people who 
consumed SF displayed improved appetite and weight gain, improved CD4+ counts, decreased 
viral loads as well as general mood improvements (Harnett et al., 2(05). 
With regard to HIV treatment in Africa specifically, patients often opt for traditional healing 
systems as a means of primary care. This is possibly associated with the difficulties in 
accessing antiretroviral treatment. What is known for sure is that the use of traditional 
medicines by Africans living with HIV is widespread (Mills et al. , 2005a). 
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2.5.3.3 Antioxidant properties 
Reactive oxygen species, such as hydrogen peroxide (H20 2) and superoxide (02-) contribute to 
the pathogenesis of many inflammatory conditions. In this regard, anti-inflammatory properties 
of herbal medications are possibly due to their antioxidant activities (Fernandes et ai., 2(04). 
Fernandes et ai. (2004) used luminol and lucigenin enhanced chemiluminescence to investigate 
the H20 2 and O2- scavenging properties of an SF water extract in neutrophils. It was reported 
that SF possessed H20 2 and O2- scavenging activities at concentrations as low as lO!!glml. 
By utilising a 70% ethanolic extract Tai et ai. (2004) demonstrated the hydroxyl radical (·OH) 
scavenging activity of SF. It was estimated by the authors that 0.5!!1 of the SF ethanolic extract 
possessed ·OH scavenging activity equivalent to lO!!M of Trolox, a chemical with potent 
antioxidant activity. 
2.5.3.4 Anticonvulsant properties 
Ojewole (2008) investigated the anticonvulsant properties of an SF aqueous extract against 
pentylenetetrazole, picrotoxin and bicuculline-induced seizures in BaihlC mice. It was 
determined that the extract (50-400mglkg, i.p) significantly (p<0.05-0.001) delayed the onset 
of and antagonised only pentylenetetrazole-induced seizures. 
2.5.3.5 Anti-inflammatory properties 
Upregulation of cyclooxygenase (COX)-2 frequently occurs in various malignancies. The 
enzyme is normally involved in prostagland!n (PG) biosynthesis and inflammation. Plant 
extracts have inhibited COX-2 induction both in vitro and in vivo (Kundu et aI., 2(05). In this 
regard, Kundu et al. (2005) investigated the effect of an SF methanolic extract on the 
expression of COX-2 in mouse skin stimulated with the tumour promoter 12-0-
tetradecanoylphorbol-13-acetate. In was determined that SF suppressed COX-2 expression by 
26% and 48% at doses of l00mg and 200mg respectively. 
2.5.3.6 Stress 
A study by Prevoo et ai. (2008) illustrated the attenuation of adrenal CYP 450 enzymes, CYP 17 
and CYP21, by an aqueous extract of SF. The authors suggested that SF was able to affect the 
catalytic activity of these enzymes, which are normally involved in the biosynthesis of steroid 
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hormones, due to observed reductions in glucocorticoid levels. These findings provide 
preliminary scientific appraisal for the stress relieving properties of SF. 
2.5.3.7 Antimutagenic, antimetabolic and pro-apoptotic properties 
It has been determined that most cancer chemotherapeutic agents severely affect the host's 
normal cells. As a consequence, the employment of natural products has now been considered 
as an alternative in the control of cancer (Steenkamp and Gouws, 2(06). 
Using the Ames test, Reid et al. (2006) demonstrated that SF possesses antimutagenic activity. 
Dichloromethane extracts comprising both leaf and stem material of SF were utilised and it 
was concluded that the extract has chemopreventative potential. In a more recent study, Ntuli 
et ai. (2007) used the Salmonella mutagenicity assay and also demonstrated antimutagenic 
properties of SF by using ethylacetate and 50% aqueous methanolic extracts of the plant. 
A study by Steenkamp and Gouws (2006) showed that an aqueous leaf extract of SF (50""glml) 
induced growth inhibition of both the human prostate cancer cell line, DU-145 as well as the 
human breast carcinoma cell line, MCF-7. 
Stander et ai. (2007) investigated the influence of a crude SF ethanolic extract on MCF-7 cells. 
Compared to the control, the SF-treated cells displayed morphological hallmarks of apoptosis 
including cytoplasmic shrinking, membrane blebbing and the presence of apoptotic bodies. In 
addition, cDNA micro array analysis revealed a total of 345 genes to be statistically 
significantly (p<0.05) differentially expressed. Amongst these genes were the TNF superfamily 
members (DR4 and DR5) as well as other genes which play important roles in apoptosis, 
growth inhibition and Nuclear Factor-KB (NF-KB) signalling. 
Signal transducer and activator of transcription 1 (STATl) regulates p53 stability by inhibiting 
the Mouse double minute 2 (Mdm2) gene, a major factor that controls p53 degradation. PIAS 1 
protein interacts with STATl to reduce its activity. PIASl gene expression was downregulated 
in SF-treated (50""glml) MCF-7 cells (Stander et al. , 2007). This effect of SF signifies a 
possible mechanism for its pro-apoptotic/anticancer properties. 
By utilising ethanolic extracts of SF, Tai et al. (2004) showed differential in vitro anti-
proliferative properties of this herbal medication by demonstrating a concentration-dependent 
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inhibition of growth of various human cell lines including the leukaemia lurkat cell line, MCF-
7 and the promyelocyte cell line, HL60. 
Chinkwo (2005) examined the apoptotic properties of a crude aqueous SF whole plant extract 
on Caski cells (cervical carcinoma), CHO cells (Chinese Hamster Ovary) and the Jurkat T 
lymphoma cell line. Caski and CHO cells were treated with 3.5mglml SF for 8 and 24 h. 
Morphologically, cell death was evidenced in Caski and CHO cells by cell shrinkage and 
disintegration as well as a reduction in cell number. The author suggested that there were 
constituents in the extract that induced the observed morphological changes and cell death. 
During apoptosis there results an externalisation of a phospholipid, phosphatidylserine (PS), in 
the plasma membrane of the associated cell. Chinkwo (2005) utilised the apoPercentage™ 
assay and efficiently demonstrated this process in SF-treated CHO cells. In addition, the author 
used the crossmon trichrome stain and showed that chromatin condensation, a morphological 
feature of apoptotic cells, was induced in CHO cells exposed to the plant extract. 
When lurkat T cells were incubated with SF (3.5mglml) for 6 h and analysed by flow 
cytometry (Annexin-V staining), the resulting histogram illustrated that more than 84% of the 
cells were apoptotic Chinkwo (2005). 
Medicinal plants have become popular as an alternate healthcare source because of several 
claimed advantages such as fewer side-effects, better patient compliance, relatively low cost, 
high accessibility as well as high acceptability due to their long history of use (Brown et al., 
2008). Sutherlandiafrutescens (known in isiZulu as 'unwele', in English as 'cancerbush' and 
in Afrikaans as 'kankerbos ') is a popular medicinal plant and has a long history of 
ethnomedical usage by a variety of African cultures (Ojewole, 2008). Recent evidence has 
displayed a range of pharmacological properties that lends credence in providing convincing 
support for the array of traditional uses that have been claimed and documented for so long. 
Although the exact mechanisms of action mediated by the various extracts derived from SF are 
currently unknown, existing evidence documents that the medicinal plant is indeed effective in 
inhibiting inflammation as well as possesses anti-oxidant, hypoglycaemic and, antimutagenic 
and antiproliferative properties in both in vitro and in vivo experimental systems. However, the 
true benefits of this plant need to be scientifically evaluated in a clinical setting. 
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2.6 L-canavanine 
2.6.1 Natural sources and functions of L-canavanine 
L-Canavanine was first identified in 1929 when it was isolated from seeds of Canavalia 
ensiformis (jack bean) (Ding et al., 1999). It is found in leguminous plants, particularly 
members of the Lotaideae family, a subdivision of Leguminosae (Bence and Crooks, 2(03). 
L-canavanine has two functions in the plant. It is well suited to store nitrogen in plant seeds 
due to its high nitrogen content (31.8%). It therefore serves as an efficient nitrogen storing 
compound and is thus fundamental to the plant's chemical defence system (Rosenthal, 1977). 
Another very important function afforded by L-can in plants is its protective property against 
insects and other herbivores. It has been shown to deleteriously affect the growth and 
development of organisms that consume plants containing the compound. When the tobacco 
hom worm Manduca sexta ingested L-can, the resulting effects included stunted development 
and growth attenuation of this plant-eating insect (Rosenthal, 1988). This property of L-can 
provides a formidable chemical barrier against predation by nonadapted species and 
consequently presents a measure of defence for the plant against certain insects and herbivores. 
2.6.2 Physicochemical properties of L-canavanine 
L-Canavanine is a o-oxa-analogue of L-arg. The oxyguanidino group of L-can is structurally 
and electronically different from the guanidino group of L-arg (Figure 2.3). The electron 
density of the guanidino group is diminished due to the destabilising effect of the oxygen atom 
(Bence and Crooks, 2(03). As a result, the guanidino group of L-arg has a pKa value of 12.48 
compared to 7.05 for the oxyguanidino group of L-can (Swaffar et at., 1994). 
J~~ .;1Iti 
/ .. o,~- ~~ 
L-ARGININE 
Figure 2.3 L-canavanine and L-arginine (Rosenthal, 1997). 
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When compared to L-arg, it has been established that L-can is less basic, slightly longer and 
exists mostly in the amino, rather than imino tautomeric form. These differences may be faint 
but they indeed have an evident effect on the differing physiological actions of L-can and L-
argo L-arginine for example, is a very important amino acid that is necessary for normal growth 
and development of cells (Bence and Crooks, 2003). L-canavanine on the other hand is 
cytotoxic and holds promise as a novel antimetabolite (Swaffar et aI., 1994). 
2.6.3 Mechanism of action of L-canavanine 
Aminoacyl-tRNA synthetases are enzymes that are central to the maintenance of protein 
synthesis. These enzymes mediate the aminoacylation of their cognate tRNA to a specific 
amino acid. Aminoacyl-tRNA synthetases identify structural features of their associated tRNA 
and subsequently catalyse the esterification of their complementary amino acid to the 
associated tRNA thereby forming an aminoacyl-tRNA. The aminoacyl-tRNA activates the 
carboxylic acid of the amino acid in order to promote peptide bond formation and also provides 
a mechanism which allows for correct positioning as well as proper incorporation of the amino 
acid in a growing peptide chain (Bence and Crooks, 2003). 
Arginyl-tRNA synthetase is a unique aminoacyl-tRNA synthetase in that it functions to load its 
complementary amino acid, L-arg, to arginyl-tRNA (Bence and Crooks, 2003). Some of the 
antimetabolic properties of L-can are presumed to be based on the inability of arginyl-tRNA 
synthetase to efficiently distinguish L-can from L-arg (Rosenthal and Dahlman, 1991b). 
During the synthesis of native proteins, the positively charged L-arg residues form ionic pairs 
with negatively charged amino acid residues. These interactions are critical in sustaining 
structural integrity and thus function of the associated protein. The substitution of an L-arg 
residue in a protein with L-can may considerably affect important interactions that function to 
institute the tertiary and quaternary structure of the protein (Rosenthal et aI., 1989). The 
resulting erroneous integration of L-can into proteins instead of L-arg leads to an induction of 
structural changes that ultimately alter protein function. At the same time, L-can further 
induces overall protein synthesis thereby accelerating the formation of aberrant proteins. This 
process forms the basis of L-can' s antimetabolic activity (Rosenthal and Dahlman, 1991 b). 
L-canavanine may be a substrate or inhibitor of other L-arg utilising enzymes and/or pathways. 
Two such pathways are the polyamine and the nitric oxide synthase (NOS) pathways. 
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It is known that within mammalian cells the arginases mediate the divalent cation-dependent 
hydrolysis of L-arg to facilitate the synthesis of the nonprotein amino acid L-ornithine, which 
is the biosynthetic precursor of the polyamines (Ash, 2(04). 
Nitric oxide synthase however, utilises L-arg for the biosynthesis of nitric oxide (NO) and L-
citrulline. The NOS reaction occurs in two steps, each requiring molecular oxygen (02) and 
reduced NADPH as co-substrates (Luzzi and MarIetta, 2(05). Luzzi and MarIetta (2005) have 
shown that L-can is an inhibitor of NOS. It was established that L-can functions as a substrate 
for the NOS reaction since it was shown to be converted to L-homoserine by the enzyme. 
2.6.3.1 L-canavanine is loaded to arginyl-tRNA 
Using yeast, Allende and Allende (1964) were the first to demonstrate that L-can was loaded to 
arginyl-tRNA. Once L-can is loaded to arginyl-tRNA, its integration into the growing 
polypeptide chain is thereafter mandatory, the consequence of which is the formation of L-can-
containing, structurally aberrant proteins (Rosenthal, 1977). 
Other experiments demonstrated that L-can binds to arginyl-tRNA synthetase in a manner 
analogous to that of L-arg since both compounds bind to the active site of the enzyme in a 
virtually identical manner (Bence and Crooks, 2003). 
2.6.3.2 L-canavanine is incorporated into proteins in place of L-arginine 
Studies have provided evidence that L-can can be loaded to arginyl-tRNA as well as be 
subsequently integrated into a growing peptide chain. 
Evidence which established that L-can is incorporated into proteins was provided by Redman 
et al. (1983). Albumin was isolated after HepG2 cells were incubated with L-can and it was 
determined that the albumin synthesised by L-can-treated cells displayed lower electrophoretic 
mobility compared to the albumin obtained from the control cells. 
Other studies demonstrated the incorporation of L-can into proteins after E. coli K12 cells were 
exposed to L-e
4
C]-can. Antibodies specific to alkaline phosphatase were utilised and e4C]-
labelled protein was isolated. The protein was thereafter analysed and compared to native 
protein, which contained 20-22 L-arg residues. Analysis of L-canavanyl proteins revealed that 
as many as 19 L-arg residues were replaced with L-can (Bence and Crooks, 2(03). 
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Trypsin readily hydrolysed the native prohormones of glucagon, insulin, and somatostatin in 
anglerfish islets cells. In contrast, these prohormones resisted tryptic hydrolysis when cells 
were incubated with L-can. Trypsin normally cleaves the peptide chain at L-arg residues. The 
author suggested that the inability of the prohormones to be cleaved by trypsin was due to L-
can incorporation in place of L-arg (Noe, 1981). 
In addition, Rosenthal and Dahlman (1991a) determined that L-can replaced approximately 
one out of every three L-arg residues in the haemolymph of newly emerged Manduca sexta 
larvae following administration of L-guanidinooxy_14C]-can. 
2.6.3.3 Incorporation of L-canavanine results in altered protein conformation 
Vitellogenin, synthesised by the female locust (Locusta migratoria migratoriodes), is utilised 
in the synthesis of an essential protein called vitellin. L-canavanine was incorporated into 
vitellogenin in place of L-arg after exposure of the locust to L-can. It was established that 18 of 
the 200 L-arg residues in vitellogenin were substituted with L-can and that the incorporation of 
L-can into vitellogenin induced a three dimensional conformation of L-canavanyl-vitellogenin 
that was significantly different compared to that of native vitellogenin (Rosenthal et ai., 1989). 
2.6.3.4 Incorporation of L-canavanine alters protein function 
In response to a bacterial infection, lysozyme, a hydrolytic enzyme, is induced in insects and it 
functions to protect the organism by mediating lysis of the bacterial cell wall. Rosenthal and 
Dahlman (1991b) demonstrated that lysozyme function was adversely affected due to 
incorporation of L-can into its structure in place of L-arg. Manduca sexta were exposed to L-
can and thereafter stimulated to produce lysozyme. It was established that L-can had 
substituted 21 % of the L-arg in the induced lysozyme. Consequently, it was determined that L-
can substitution resulted in a 49.5% loss of lysozyme activity. 
Thomas and Rosenthal (1987) investigated the toxicity of L-can in Sprague-Dawley rats. The 
most significant changes noted after a single dose of L-can (2.0glkg, s.c) were severe 
attenuations of serum aspartate (asp) and alanine aminotransferase activity. 
Conformational and electronic changes are induced in proteins when L-can is incorporated into 
a nascent peptide chain in place of L-arg. A consequence of such substitution is the induction 
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of functional changes in the L-can-containing proteins. The above-mentioned effects represent 
the biochemical basis for the antimetabolic properties of L-can. 
2.6.4 Anticancer properties of L-canavanine 
Both in vitro and in vivo studies have displayed anticancer properties of L-can. 
Berjis and Green (1986) investigated the toxicity of L-can in the normal canine kidney 
epithelial cell line, Madin-Darby canine kidney (MDCK) as well as its chemically transformed 
derivative MDCK-T\. The normal cell line exhibited minimal cell death; however after 4 days 
of exposure to L-can more than 90% of the transformed cell line was killed. 
Another study showed that L-can was cytotoxic to the human uterine sarcoma cell lines MES-
SA (parental) and Dx-5 (MDR +), and to the human leukaemia cells lines K562 (parental) and 
K562-R7 (MDR +). Significant (p<0.05) cytotoxicity was observed in all cell lines after 72 h 
of exposure to concentrations greater than ImM L-can (Worthen et al., 1998). 
In a more recent study, it was established that L-can mediated growth inhibition of the human 
lung adenocarcinoma cell line, A549, by arresting the cell cycle at the 0\ phase (Ding et al., 
1999). 
L-canavanine was also cytotoxic to other human cancer cell lines including the bladder cancer 
cell line HTB9, and the cervical cancer cell line, HeLa. Exposure of each cell line to 3mM L-
can for 48 h resulted in greater than 75% cell death (Bence and Crooks, 2003). 
It has been established that L-can was cytotoxic not only to MIA PaCa-2 cells (Swaffar et al. , 
1994), but also to other human pancreatic cancer cell lines such as PANC-l, CFPAC-l, Capan-
1 and BxPC-3. After 72 h of exposure to 3mM L-can, cell cycle analysis revealed that the 
percentage of cells in the 02/M phase increased 4-fold in MIA PaCa-2 cells and 6-fold in 
PANC-l cells (Bence et al. , 2003). 
L-Canavanine does not only mediate cytotoxicity when evaluated in vitro, but also possesses 
the capacity to mediate shrinkage of tumour growth in vivo. 
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Thomas et al. (1980) instituted a study to assess the potential value of L-can as an anticancer 
agent. Tumours were induced in Fischer rats after a single injection (s.c) of a 10% tumour cell 
suspension (w/v). A 22% reduction in tumour volume was noted in animals receiving L-can 
(3.0glkg) daily for 5 days. In addition, a 60% reduction in tumour volume was eminent in the 
3.0glkg-daily-for-9-day's treatment group. This study demonstrated the capacity of L-can to 
mediate significant growth inhibition of solid tumours in rats. 
In a similar investigation, mice carrying an H5V tumour were used and a significant (p<0.05) 
reduction in tumour volume was noted when these animals were treated with L-can (30mglkg, 
i.p) (Bence and Crooks, 2003). 
In addition to the toxicity induced by L-can itself, L-canaline (L-2-amino-[4-aminooxy] 
butanoic acid), a metabolite of L-can metabolism (Rosenth~l, 1981) may also contribute to L-
can cytotoxicity. 
2.6.5 Mechanisms of L-canaline toxicity 
L-canavanine is cleaved hydrolytically by arginase to yield L-canaline and urea. L-
canavanine's structural analogy to L-arg corresponds exactly to the relationship of L-canaline 
to L-ornithine (Rosenthal, 1981). Rosenthal (1981) demonstrated that the possible basis of L-
canaline's antimetabolic properties result from its ability to bind with pyridoxal phosphate, 
rendering the B6 moiety of enzymes such as L-tyrosine decarboxylase employing this cofactor 
inactive. It was shown that L-canaline reacts with the aldehydic carbon atom of the pyridoxal 
phosphate moiety of B6-containing enzymes which leads to the blocking of the reactive 0)-NH2 
group. A Schiffs base linkage is thus formed and a concomitant loss in catalytic activity 
results. 
In addition, a 27 % decrease in brain glutamic acid levels was noted when Rosenthal (1997) 
treated male Sprague-Dawley rats with lOO!!g of L-canaline. 
It has also been reported that stable oximes are formed following the rapid reaction of L-
canaline with glyoxylate and other 2-oxo acids, thereby indicating L-canaline's ability to 
scavenge 2-oxo-containing metabolites such as pyruvate and enabling it to mediate its anti-
metabolic effects via depletion of tricarboxylic acid (TCA) cycle reserves (Rosenthal, 1981). 
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2.7 Apoptosis 
Programmed cell death, also referred to as apoptosis, is an important physiological process that 
plays a crucial role in regulating the number of cells during the process of development and 
even throughout an organisms life, by mediating the removal of cells at the appropriate time 
(Zimmermann et al., 2001). Cell death occurs in response to an array of stimuli and during the 
process of apoptosis it occurs in a strictly controlled, regulated manner (Dash, 2005). 
During apoptosis, it is apparent that organelle integrity is maintained and that little external 
leakage of the contents of the apoptotic cell can be detected. As a consequence of such strict 
regulation, apoptotic cells do not mediate an inflammatory response (Slater et al., 1995), 
making apoptosis distinct from another type of cell death called necrosis. During necrosis, the 
cell swells, its mitochondria dilate, organelles dissolve and the plasma membrane ruptures, 
releasing cytoplasmic material, often leading to an inflammatory response and potentially, to 
adverse health effects (Desagher and Martinou, 2000). In addition, necrosis appears to be an 
unregulated, passive process that is triggered by nonphysiological stimuli and unlike apoptosis 
it does not require energy or the synthesis of nucleic acids and proteins (Kim et al., 200 1). 
It has been postulated that the dysregulation of the apoptotic process tends to play an integral 
role in the pathogenesis of a variety of human diseases and pathological conditions (Kaufmann . 
and Hengartner, 2001). Cancer for example, is a disease characterised by little or no apoptosis 
due to mutations that are present which reduces the susceptibility of cells to apoptosis. 
Whereas cancer is a disease during which too little apoptosis occurs, there are other diseases 
where too much apoptosis is presumed to be the problem. In this regard, apoptosis is thought to 
account for most of the cell death as well as the progressive loss of neurons in 
neurodegenerative diseases such as Alzheimer' s or Parkinson's disease (Dash, 2005). Other 
diseases associated with apoptosis include rheumatoid arthritis, acute neurological injuries, and 
cardiovascular diseases as well as AIDS. Therefore, the precise understanding and knowledge 
of the exact mechanisms involved in the process of apoptosis may prove important in the 
design of new therapeutic strategies (Zimmerman et al., 2001). 
During the early stages of apoptosis a family of proteins induces the cleavage of important 
cellular substrates required for normal function. These substrates include structural proteins in 
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the cytoskeleton as well as other degradative enzymes such as DNases, which cleave DNA in 
the nucleus (Dash, 2005). 
Recently, rapid progress has been made in providing evidence for identifying the molecules 
that are responsible for the regulation and execution of apoptosis (Song and Steller, 1999). The 
proteolytic cleavages that occur during apoptosis are mediated by caspases - aspartate-directed 
cysteine proteases that selectively mediate the cleavage of more than 100 substrates when 
mammalian cells are subject to apoptosis (Kaufmann and Hengartner, 2001). 
The biochemical features which have been documented to be associated with apoptosis include 
internucleosomal cleavage of DNA which leads to an oligonucleosomal "ladder" and PS 
translocation (Zimmermann et al. , 2001). 
The consequence of such biochemical changes as well as the cleavage of susceptible substrates 
is the appearance of morphological changes in the cell (Dash, 2005). Morphological features 
that are used to define apoptotic cells include blebbing of the cell membrane, condensation of 
chromatin (due to breakdown of chromatin and nuclear structural proteins), nuclear 
fragmentation, loss of adhesion and rounding (in adherent cells), and cell shrinkage (due to 
cleavage of lamins and actin filaments) (Zimmermann et al., 2001). Small membrane enclosed 
vesicles called apoptotic bodies may also be observed (Desagher and Martinou, 2000). 
Apoptosis is thus a critical process that provides a safe and efficient way to continuously 
turnover cells in any tissue as well as provides an organism with the ability to remove specific 
or even surplus cells during developmental processes (Slater et al., 1995). 
2.7.1 Mechanisms of apoptosis 
There exist many mechanisms by which apoptosis can be induced and the sensitivity of cells to 
apoptotic stimuli may vary depending on various factors. In some cases apoptotic stimuli may 
comprise an extrinsic signal involving the ligation of cell surface receptors called death 
receptors (DRs) which generally occurs in damaged or virus infected cells (Dash, 2005). In 
other cases, apoptosis may be induced by intrinsic signals that arise following cellular stress, 
which include exposure to radiation or chemicals, growth factor deprivation, oxidative stress 
and physical damage especially to DNA and cell membranes (Fraser et ai., 1996; Dash, 2005). 
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2.7.1.1 Extrinsic cell death signalling 
Death receptors are cell surface receptors that mediate the transmission of apoptotic signals 
initiated by specific ligands. They playa crucial role in apoptosis by functioning to activate an 
immediate caspase cascade following ligand binding. Induction of apoptosis via this 
mechanism is very rapid (Dash, 2005). 
Cell surface DRs belong to the TNF receptor (TNFR) superfamily. The best-characterised 
family members include Fas (CD95) and TNFRI. Additional members of the TNFR 
superfamily include DR3 (Apo3), DR4, DRS (Apo2) and DR6 (Ashe and Berry, 2003). 
Death receptors are type I transmembrane proteins, a common feature of which is the presence 
of extracellular cysteine-rich domains which are involved in receptor-ligand interactions, and 
intracellular death domains (DDs), which function to bind to homologous domains on 












Tumour necrosis factor-a signalling (Dash, 2005). 
It has been documented that the ligand for these receptors is a trimer (Dash, 2005). Binding of 
extracellular ligands, such as Fas (a glycosylated cell surface molecule found abundantly in 
liver) to its cognate receptor is thus presumed to induce trimerisation of the receptor (Song and 
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Steller, 1999). After trimerisation and subsequent activation of DRs, other DD-containing 
proteins are recruited and serve as adaptor molecules in the signal transduction cascade (Ashe 
and Berry, 2003). An example is the association of the adaptor molecule FADD (Fas-
associated death domain) to Fas (Kaufmann and Hengartner, 2001). FADD itself has a DD, and 
binds to Fas via DD-DD interactions (Zimmermann et al. , 2001). In addition to its DD, FADD 
also possesses a death effector domain (DED) which mediates its association with other DED 
containing proteins such as pro-caspases 8 (Ashe and Berry, 2003; Figure 2.4 and Figure 2.5). 
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Figure 2.5 Multiple pathways of caspase activation (Kaufmann and Hengartner, 2001). 
Pro-caspase 8 (FLICE - Fas activated protein like IL-l p converting enzyme) is thus able to 
associate with FADD via its own DED. The complex of proteins - Fas, FADD and pro-caspase 
8 - is also known as the death inducing signalling complex (DISC) (Dash, 2005). The 
activation of procaspase-8 follows an "induced proximity" model (Chowdhury et al. , 2008). In 
this model, formation of the DISC after recruitment of procaspase-8 molecules to the Fas-
FADD complex, juxtaposes multiple procaspase-8 zymogens, an event that mediates the 
autoproteolytic liberation of active caspase-8 into the cytosol (Kaufmann and Hengartner, 
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2(01). Caspase-8 can then cleave downstream caspases such as caspase-3. Caspase-8 also 
cleaves a pro-apoptotic member of the Bcl-2 family, Bid, to truncated Bid (tBid) (Song and 
Steller, 1999). Truncated Bid is involved in the release of the mitochondrial proapoptotic 
factors: cytochrome c, Smac (second mitochondrial activator of caspases)/Diablo, AIF 
(apoptosis inducing factor) and endonuclease G (Ashe and Berry, 2(03). 
Despite the commonality of DISC association, DR-initiated signalling diverges in different 
cells. There are two types of cells using distinct Fas signalling pathways that have been 
identified (Ashe and Berry, 2(03). In 'type I' cells, following DR ligation results the vigorous 
activation of caspase-8 and subsequently caspase-3. In all other cells ('type II'), caspase-8 
activation is generally insufficient to mediate caspase-3 activation. Instead, caspase-8 cleaves 
the cytoplasmic protein Bid (Kaufmann and Hengartner, 2(01). Thus, the extrinsic apoptotic 
pathway recruits an intrinsic apoptotic pathway (Ashe and Berry, 2(03). 
It is presumed that other DRs also activate caspase-8 through the same induced proximity 
mechanism (Kaufmann and Hengartner, 2(01). It is likely that DR4 and DR5 signals similarly 
to Fas (Dash, 2(05). 
Signalling via TNFR1 however, is more complex than that occurring through the 
aforementioned receptors because of the requirement for another adapter protein known as 
TNFR-1-associated DD (TRADD). TRADD binds the ligated TNFR1 via DD-DD interactions 
(Zimmermann et ai., 2001; Figure 2.4). It is then able to recruit FADD to the complex, 
resulting in pro-caspase-8 recruitment and activation (Fraser et aI., 19.96). Additionally, 
TNFR1 is able to mediate apoptosis by recruitment of another adapter molecule called RAIDD 
[RIP (receptor-interacting protein)-associated ICH-1 / CED-3 homologous protein with a death 
domain]. RAIDD associates with RIP via DD-DD interactions and contains a CARD (caspase 
recruitment domain) through which it can interact with and activate pro-caspase-2. Active 
caspase-2 functions similarly to caspase-8 and also cleaves Bid to tBid (Ashe and Berry, 2003). 
In addition to the pathway mediated by Fas, an alternate, FADD-independent pathway exists. 
Daxx, an alternate Fas-binding protein, binds specifically to the Fas DD and mediates the 
activation of the Jun NH2-terminal kinase (JNK) pathway. Daxx may thus function as a link 
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between Fas and apoptosis signal-regulating kinase-l (ASKl), a mitogen activated protein 
(MAP) kinase kinase kinase that is also able to activate apoptosis (Ashe and Berry, 2(03). 
2.7.1.2 Intrinsic cell death signalling 
Mitochondria play an indispensable role in apoptosis (Zimmermann et ai., 2001). Various 
types of apoptotic stimuli, such as cytotoxic stress, oxidative stress, heat shock and DNA 
damage lead to the release of cytochrome c from the intermembrane space of the 
mitochondrion into the cytoplasm. A consequence of mitochondrial release of cytochrome c is 
the activation of the downstream execution phase of apoptosis (Chowdhury et al., 2008). This 
phase of apoptosis is referred to as the intrinsic or mitochondrial pathway of apoptosis and is 
mediated by members of the Bcl-2 family of proteins (Aravind et aI., 1999), originally 
discovered as a proto-oncogene in follicular B-celllymphoma (Zimmermann et al., 2001). It 
has been demonstrated that many of these proteins are associated with the outer mitochondrial 
membrane (Aravind et al., 1999). 
The precise mechanism by which the Bcl-2 family regulates apoptosis remains controversial 
(Song and Steller, 1999). Some of these proteins are anti-apoptotic, while others are pro-
apoptotic (Dash, 2005). They have been well characterised and their classification is based on 
the presence or absence of Bcl-2 homology (BH) domains of which there are four that exist 
(BHI-BH4) (Ashe and Berry, 2(03). The anti-apoptotic members such as Bcl-2, Bcl-xL, Bcl-
w, Mcl-l, AI, NR-13, and Boo, contain at least BHl and BH2 (those most similar to Bcl-2 
contain all four BH domains) (Zimmermann et al., 2(01). Two subfamilies of proapoptotic 
Bcl-2 family memb~rs have been identified; the bax family (Bax, Bok, and Bak), containing 
BHl, BH2, and BH3, and the BH3-only family [Bid, Bim, Bik, Bad, Bmf, Hrk, PUMA (p53-
upregulated modulator of apoptosis) and Noxa] (Ashe and Berry, 2(03). 
Under normal cellular conditions, cytochrome c remains isolated in the inner mitochondrial 
membrane by being loosely (via ionic interactions) or tightly (via through hydrophobic 
interactions) bound to cardiolipin (Pretet, 2(02). The precise mechanisms by which it is 
released from the mitochondrion are not clearly understood (Pretet, 2002), however, after its 
release, caspases are activated by a high molecular mass cytoplasmic complex referred to as 
the apoptosome and the cell is subsequently subject to undergo apoptosis (Zimmermann et aI., 
2001; Chowdhury et aI., 2008). 
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It has been documented that after cellular damage or stress, Bax (generated due to activation of 
p53 during DNA damage-induced apoptosis) and Bak (generated by ionising radiation), which 
normally reside in the cytoplasm, translocate to the outer mitochondrial membrane. Here, they 
undergo a conformational change thereby allowing tBid to facilitate their insertion into the 
mitochondrial membrane (Kaufmann and Hengartner, 2001). It has been shown that Bax and 
other Bcl-2 proteins have structural similarities with pore-forming proteins. It was therefore 
suggested that Bax forms a transmembrane pore across the outer mitochondrial membrane, 
leading to the loss of membrane potential and efflux of pro-apoptotic factors (Dash, 2005) 
including cytochrome c, Smac, AIF and endonuclease G (Hofseth et ai., 2004) . 
On the contrary, anti-apoptotic Bcl-2 family members such as Bcl-2 itself, function at least in 
part, by selectively binding to the 'active' Bax, thereby preventing its insertion into the outer 
mitochondrial membrane (Kaufmann and Hengartner, 2001). 
When cytochrome c is released from the mitochondrion into the cytosol, it interacts with 
apoptotic protease-activating factor-l (Apaf-l) and ATP (Adrain and Martin, 2001; Figure 
2.5). Apaf-l has a CARD, which facilitates its interaction with pro-caspase-9. In the presence 
of cytochrome c and A TP, Apaf-l undergoes a conformational change that exposes its CARD, 
thus inducing the recruitment of pro-caspase-9 (via CARD-CARD interactions). A 
consequence of such interactions is the generation of the cytochrome c-Apaf-l-procaspase-9 
'apoptosome' and subsequent caspase-9 activation (Adams and Cory, 2002). Caspase-9 can 
then directly activate caspase-3 and 7, resulting in the orderly death of the cell via strictly 
regulated proteolytic processing of various downstream targets (Ashe and Berry, 2003). 
It has recently been discovered that a protein with the dual name SmaclDiablo which is 
released from the mitochondria along with cytochrome c during apoptosis (Adrain and Martin, 
2001), binds to domains within the inhibitor of apoptosis proteins (lAPs) to remove their 
inhibitory effect on caspase activity, thus promoting apoptosis (Ashe and Berry, 2003). 
Another mitochondrial factor released together with cytochrome c and implicated in apoptosis 
is AIF, a flavoprotein that, once released from the mitochondrion, translocates to the nucleus 
(Ashe and Berry, 2003). In the nucleus, AIF induces DNA fragmentation and chromatin 
condensation, two key morphological features of apoptosis (Kaufmann and Hengartner, 2001). 
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Mitochondria also release endonuclease G, which is implicated in apoptotic DNA degradation 
(Kaufmann and Hengartner, 2001). 
Thus, the sensitivity of cells to apoptotic stimuli depends on the balance of pro- and anti-
apoptotic Bcl-2 proteins (Dash, 2005) and the exit from the mitochondrion indicates a new 
conflicting role for cytochrome c as a life-taker compared to its normal life-sustaining role in 
the electron transport chain (ETC) (Adrain and Martin, 2001). 
2.7.2 Caspases 
The aspartate-specific cysteine protease (caspase) cascade is now envisaged to be the key 
pathway by which apoptotic cell death is orchestrated (Zimmermann et ai., 2001). An 
efficiently functional, well regulated apoptotic program requires multiple caspases and the 
contribution of the various caspases to the different phases of apoptosis is very critical 
(Algeciras-Schimnich et ai., 2002). 
Caspases are similar in amino acid sequence, structure, and substrate specificity and are among 
the most specific proteases, having an unusual and absolute requirement for cleavage of their 
targets after asp residues. Consequently, due to the presence of asp in caspases themselves, 
these proteases are able to auto-activate or to be activated by other caspases as part of an 
amplification cascade (Zimmermann et ai., 2001). 
Caspases are present within the cell as inactive latent pro-forms (zymogens) (Song and Steller, 
1999) and contain three domains; an N-terminal prodomain, a large subunit containing the 
active site cysteine and a C-terminal small subunit (Zimmermann et ai., 2001). 
Based on the structure of the prodomain and their functions, the caspases consist of 15 
mammalian members, categorised into 3 subclasses. Those that contain large prodomains 
(caspase-l, 4, 5, 12, 13 and 14) playa role in cytokine maturation and inflammatory responses, 
and are referred to as inflammatory caspases (group-I). The second group of caspases have 
long prodomains containing either DED domains (caspase-8 and to) or a CARD (caspase-2 
and 9) and are called initiator of apoptosis caspases. Caspases that contain short prodomains 
(Group ill) are called executioner caspases (caspase-3, 6, and 7) (Chowdhury et ai., 2008). 
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During caspase activation, which generally follows the induction of apoptosis through extrinsic 
or intrinsic death mechanisms, pro-caspases are cleaved at asp residues which facilitate the 
removal of the inhibitory pro-domain and ·consequently generate two distinct subunits (Song 
and Steller, 1999; Figure 2.5). These subunits are able to assemble into active proteases which 
then initiate apoptosis (Chowdhury et ai. , 2008). Activation of the executioner caspases is 
often referred to as the apoptotic commitment point (Ashe and Berry, 2003). 
Via adaptor molecules, DRs recruit initiator caspases-2, 8 or 10 whereas intrinsic death signals 
result in the activation of caspase-9 (Ashe and Berry, 2003; Figure 2.5). These caspases can 
then activate other caspases eventually promoting the activation of the executioner caspases, 
which are responsible for the cleavage of key cellular proteins that leads to the typical 
morphological changes observed in cells undergoing apoptosis (Dash, 2005). 
Caspases bind to their substrates via interactions of the active site cleft with amino acids in the 
cleavage site. Substrates of caspases are categorised as nuclear proteins (lamin A and B, 
chromosome scaffold binding proteins, ribonucleoprotein-associated proteins), DNA 
metabolism and repair proteins (DNA-replication proteins, RNA-polymerase), protein kinases, 
signal transduction pathway proteins (Phospholipases), cytoplasmic proteins (gelsolin, actin, 
adherens), cell cycle and cell proliferative proteins (p21, p27, pRB) and other apoptosis related 
proteins (Chowdhury et ai., 2008). 
The caspase that is ultimately responsible for majority of the apoptotic effects is the most 
prevalent caspase, caspase-3. It is however supported by caspase-6 and 7. These three effector 
caspases initiate the apoptotic phenotype by facilitating cleavage and/or degradation of several 
critical cellular substrates. An example is DNA fragmentation mediated by the action of 
caspase-3 on a complex of caspase-activated deoxyribonuclease (CAD) and iCAD, its 
inhibitor. Under non-apoptotic circumstances CAD is present in an inactive complex with 
iCAD (Zimmermann et al., 2001). During apoptosis however, active caspase-9 damages 
nuclear pores, allowing nuclear entry of caspase-3 which in turns cleaves iCAD, thus liberating 
CAD and allowing apoptotic DNA fragmentation and chromatin digestion (Kaufmann and 
Hengartner, 2001). In addition, it is believed that membrane blebbing observed during 
apoptosis occurs due to the cleavage of gelsolin and fodrin, a consequence of which is the 
dissociation of the plasma membrane from the cytoskeleton (Zimmermann et al. , 2001). 
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Caspase activity is inhibited by different groups of natural inhibitors (Aravind et ai. , 1999). 
Many proteins that prevent cell death via caspase activation have been identified. The most 
well known are the lAPs, which bind to and inhibit active caspase-3, 7 and 9 (Chowdhury et 
al., 2(08) or stimulate proteasomal degradation of caspase-3 and 7 (LeBlanc, 2(03). 
The action of caspases may also be regulated at other levels including blockade of caspase 
activation at the DISC (Chowdhury et ai., 2(08). A molecule referred to as cFLIP (FLICE 
inhibitory protein) is able to block Fas-mediated apoptosis (Zimmermann et ai., 2(01). It is an 
inactive caspase homologue, whose catalytic site is damaged thus enabling it to serve as a 
dominant negative modulator of caspase activity. It inhibits the activation of procaspase-8 at 
the DISC by blocking and thus preventing its processing (Chowdhury et al., 2(08). It is 
recruited to the ligated Fas signalling complex, but cannot convey the death signal required to 
initiate apoptosis (Zimmermann et al., 2001). 
Apoptosis is thus a complex process involving many protein families, subcellular 
compartments, and signal transduction cascades and, cell type and mode of apoptotic induction 
are critical factors with respect to which apoptotic pathway is recruited. 
2.7.3 The role of p53 in apoptosis 
The gene that encodes p53 is a well-defined tumour suppressor gene (Chen, 1999). Tumour 
suppressor protein p53 is frequently referred to as the 'guardian of the genome' or the 'cellular 
gatekeeper' (Brooks and Gu, 2(03). At the biological level, p53 has been implicated as a key 
mediator of the cellular response to DNA damage (Haffner and Oren, 1995). One well defined 
role of p53 is to survey cellular stress and induce apoptosis, if necessary (Hofseth et al., 2004). 
However, the mechanism of p53-mediated apoptosis in response to cellular stresses such as 
DNA damage remains poorly understood (Moll and Zaika, 2(01). 
Mouse double minute 2, an E3 ligase in an ubiquitinase pathway, which binds to p53 and 
promotes its polyubiquitination and degradation by proteasomes, normally maintains p53 at 
low levels within the cell (Brooks and Gu, 2003). p53 and Mdm2 are phosphoproteins, both of 
which contain several phosphorylation sites (Kubbutat and Vousden, 1998). 
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DNA damage results in the formation of DNA chain breaks and changes in chromatin structure 
that activate chromatin-bound protein kinases such as ATM (ataxia telangiectasia mutated 
protein) and ATR (ATM related) which then phosphorylate p53 (Hickman et ai., 2(02). 
Another protein kinase, double-stranded DNA-dependent protein kinase (DNA-PK), is 
activated by double-stranded DNA breaks and also phosphorylates p53 (Kubbutat and 
Vousden, 1998). Phosphorylation of p53 results in a reduction of p53-Mdm2 binding (Lohrum 
and Vousden, 2000; Figure 2.6). Acetylation of p53 also contributes to preventing the binding 
of Mdm2 to p53 and enzymes such as CB P/p300 , a protein possessing histone acetyl 
transferase (HAT) activity, mediates the acetylation of p53 (Brooks and Gu, 2(03). 
Additionally, internal aberrations such as the deregulation of cellular oncogenes may lead to 
p53 stabilisation. Overexpression of some oncogenes induces expression of 14/19ARF which 

















Regulation of p53 stability and function in response to genotoxic stress 
(Kubbutat and Vousden, 1998). 
It is possible that phosphorylation, acetylation and binding of 14/19ARF to Mdm2, contribute 
to the resistance of p53 to Mdm2-mediated degradation and a subsequent increase in the levels 
and activity of p53 (Lohrum and Vousden, 2(00). 
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After p53 activation, it accumulates in the nucleus where it binds to specific DNA sequences 
and induces transcription (Komarova and Gudkov, 1998). Transcriptional activation and 
transcriptional repression are the best described biochemical functions ascribed to p53 and are 
important for apoptosis induction (Yu and Zhang, 2005). Apoptosis-associated genes that are 
upregulated in response to p53 activation include Bax (Bensaad and Vousden, 2007), Fas, 
Apaf-l (Ashe and Berry, 2003), DR4, DR5 (Yu and Zhang, 2005), Bid (Hofseth et al., 2004), 
PUMA and Noxa (Hickman et al., 2002). In contrast, apoptosis-associated genes postulated to 
be suppressed by p53 include Bcl-2, Bcl-xL (Yu and Zhang, 2005) and cFLIP (Ashe and 
Berry, 2003). 
p53 also promotes apoptosis via transcription-independent mechanisms. It forms complexes 
with anti-apoptotic Bcl-2 proteins via its DNA-binding domain (Zeimet, 2003), promotes the 
activation of Bax and mediates the cell surface redistribution of Fas (Ashe and Berry, 2003). 
p53 possesses the capacity of adjusting the biological response to the nature of the activating 
signal. In particular, it can stimulate apoptosis when cells are confronted with severe, 
irreparable damage, whilst mediating growth arrest when cellular damage is minimal, thus 
enabling the cell to repair the damage and resume normal life and function (Shmueli and Oren, 
2007). The induction ofthe cyclin-dependent kinase inhibitor p21 (wafl/cipl) is an example of 
a principal effector of growth arrest (Kubbutat and Vousden, 1998). 
2.7.4 The modulation of apoptosis by different heat shock gene products 
As a consequence of being alive, cells of all organisms constantly endure a multitude of 
"damages" induced by internal as well as external factors. As a result, living systems have 
evolved many strategies to facilitate repair of the damage and/or eliminate the damaged 
components (Arya et al., 2007). 
Damage to cells can elicit two opposing responses; apoptosis, and the heat shock response 
(HSR), which prevents damage and/or mediates a recovery process to maintain cell survival. 
Interactions between these pathways are critical in determining the fate of a cell (Beere, 2004). 
The HSR is a carefully coordinated series of biochemical and genetic events often involving 
rapid induction of heat shock protein (Hsp) gene expression in response to stress (Powers and 
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Workman, 2007). Heat shock proteins were first discovered in 1962 as a set of highly 
conserved proteins whose expression was induced by various stresses (Garrido et ai. , 2001). 
These proteins can be induced by many stresses including those imposed by heat shock, 
chemotherapeutic agents, ultraviolet (UV) irradiation, TNF (Beere, 2004), amino acid 
analogues, infection, inhibitors of energy metabolism, heavy metals (Li et ai., 2000), ischemia 
(Sharp et ai., 1999) and oxidative stress (Kim et ai. , 2005). 
The Hsp's are highly conserved and are abundant in nearly all subcellular compartments 
(Santoro, 2000). They are classified into distinct families on the basis of their molecular 
weights, functions and amino acid seq~ences (Arya et ai. , 2007). There are many members of 
the Hsp family, the most important of which are Hsp70 and Hsp90 (Sharp et ai., 1999). 
In physiological conditions some of the Hsp's function as intracellular molecular chaperones 
(Pockley, 2003). The term chaperone is assigned to a protein that selectively recognises and 
binds to the exposed hydrophobic surfaces of a non-native protein in a noncovalent interaction 
in order to inhibit irreversible aggregation (Slavotinek and Biesecker, 2001). 
Some of the important house-keeping functions of molecular chaperones include: (1) import of 
proteins into cellular compartments; (2) folding of proteins in the cytosol, mitochondria and 
endoplasmic reticulum (ER); (3) refolding of misfolded proteins; (4) prevention of protein 
aggregation; (5); degradation of unstable proteins (6) dissolution of protein complexes; and (7) 
control of regulatory proteins (Garrido et ai. , 2001). 
Besides their function in regulating cellular homeostasis as molecular chaperones, another 
interesting example of the integrative roles of Hsp's is their involvement in the apoptotic 
pathways and subsequent promotion of cell survival (Arya et ai. , 2007). 
The accumulation of denatured/abnormally folded proteins as a consequence of cellular stress 
results in the formation of aggregates that perturbs normal cellular function and prompts cell 
death (Parcellier et ai., 2003). Such denatured proteins initiate the HSR by binding to Hsp90, 
resulting in the dissociation of Hsp90 from certain heat-shock factor (Hst) proteins (Figure 
2.7). Under normal conditions, Hsp90 binds to and suppresses the Hsfs. The dissociation of 
Hsp90 from Hsf s results in the phosphorylation of Hsf s by protein kinase C (PKC) for 
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example, a consequence of which is Hsf activation. The activated Hsf's then form trimers 
which bind to the promoter region of the Hsp70 gene and stimulate transcription. This leads to 
a substantial increase in Hsp70 mRNA and protein levels within the stressed cells. Following 
its synthesis, Hsp70 binds to denatured proteins in an attempt to restore the tertiary structure 
and enzymatic activity of the affected proteins in a cycle that is driven by ATP hydrolysis. 
Denatured proteins are therefore able to serve as a stimulus for the induction of the expression 
of Hsp70, and Hsp70 can in tum restore protein structure and function (Sharp et al., 1999). 
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Figure 2.7 The mechanism of heat shock protein 70 production (Sharp et al., 1999). 
2.7.4.1 Heat shock protein 70 
Heat shock protein 70 is an A TP-dependant inducible Hsp (Sharp et al., 1999) that interacts 
with almost all newly synthesised, unfolded proteins (Powers and Workman, 2007). 
The following describes the role of Hsp70 in apoptosis: 
• It interacts directly with the CARD of Apaf-l, either preventing its oligomerisation 
(LeBlanc, 2003) or maintaining the oligomer in a conformation incompatible with pro-
caspase-9 recruitment thus preventing apoptosome formation (Beere, 2(04). 
• It associates with the N-terminal region of AIF via its peptide domain thereby 
preventing the nuclear import of AIF after its release from mitochondria (Beere, 2(04). 
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• Hsp70 can inhibit JNK mediated cell death by suppressing JNK phosphorylation either 
directly and/or through direct inhibition of ASK1 (Arya et ai. , 2007). JNK 
phosphorylates c-Myc and p53 both of which mediate mitochondrial release of 
cytochrome c. JNK is also implicated in the release of Smac from mitochondria. The 
ability of Hsp70 to disrupt JNK signalling could thus impact on many pathways in the 
apoptotic process and possibly represents the underlying mechanism of Hsp70-
mediated suppression of cytochrome c release (Beere, 2004). 
• It has also been shown to directly associate with p53 and c-myc (Parcellier et ai., 2003). 
• Hsp70 prevents Bax from undergoing a conformational change and translocation to the 
mitochondria (Powers and Workman, 2007). 
• It binds to and inhibits caspase-3 activity (Sreedhar and Csermely, 2004). 
. • The integrity of the lysosomal membrane is maintained by Hsp70, thereby preventing 
the release of hydrolases such as cathepsin into the cytosol and subsequently impeding 
a lysosome-mediated caspase independent cell death pathway (Arya et ai., 2007). 
• It suppresses TNF-induced apoptosis in many cell types (Beere, 2004). 
• It prevents the cleavage and activation of Bid (Beere, 2004). 
• Bag-1 is a co-chaperone identified as an anti-apoptotic protein because of its ability to 
bind Bcl-2. It also binds to and sequesters FADD (Sreedhar and Csermely, 2004). 
Hsp70 binds to and modulates the function of Bag-l (Sharp et ai., 1999). 
2.7.4.2 Heat shock protein 90 
Heat shock protein 90 is also an A TP-dependant chaperone which is quite abundant and 
constitutes approximately 1-2% of total cellular protein. Its chaperone functions involve 
ensuring the correct conformation, activity, intracellular localisation and proteolytic turnover 
of proteins involved in cell growth, differentiation and survival (Powers and Workman, 2007). 
Like Hsp70, it inhibits apoptosis by directly binding to Apaf-1 and preventing the formation of 
the apoptosome (Sreedhar and Csermely, 2004). 
Apoptotic-inducing signals are intimately coupled to cell-survival signals. One pathway that 
promotes cell survival utilises a serine/threonine kinase, Akt, which is activated via 
phosphoinositide 3 kinase, by an array of growth factors (Arya et al. , 2007). Phosphorylation 
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stabilises Akt, which activates NF-lCB, but can also induce phosphorylation of Bad, resulting in 
the dissociation of Bad from Bcl-xL (Beere, 2004). Phosphorylated Bad can then be 
sequestered by the 14-3-3 protein in the cytosol. Consequently, translocation of Bad to 
mitochondria and subsequent downstream apoptotic events are not triggered (Sreedhar and 
Csermely, 2004). 
Although TNF is a potent inducer of cell death, it can also contribute to cell survival via NF-
lCB. This serves as an important link in many biological processes including stress responses, 
cell growth or death (Arya et al., 2007). 
Under normal physiological conditions, NF-lCB is bound and sequestered in the cytosol by its 
inhibitor IlCB. Upon exposure to stimuli, such as TNF, IlCB is subsequently degraded. This 
promotes the release of NF-lCB, which can translocate to the nucleus and initiate the 
transcription of cell survival genes. Phosphorylation and subsequent inactivation of IlCB is 
facilitated by a protein kinase complex termed IlCB kinase (IKK). TNF mediates the activation 
of IKK via its association with signal transducing molecules like RIP (Arya et at., 2007). 
Hsp90 interacts with and is essential for the stability of RIP (Parcellier et al., 2003). It also 
directly interacts with and maintains the activity of Akt by inhibiting its dephosphorylation 
(Beere, 2004). In addition, Hsp90 and its co-chaperone Cdc37 assist in the formation of active 
IKK or Akt complexes. All of these effects of Hsp90 mediate the disassociation of NF-lCB from 
its inhibitor and promotes cell survival (Arya et at., 2007). 
Besides its direct role of promoting cell survival, the Hsp90-Akt complex can also indirectly 
promote cell survival by inhibition of JNK-mediated cell death through phosphorylation and 
subsequent inactivation of ASK1 (Arya et al., 2007). 
At any point in time, a living cell is a multi-tasking system in which a multitude of signals are 
processed; however the responses to anyone or more of these activities have to be integrative. 
Due to the nature of their functions, Hsp's appear to be significant co-ordinators of cellular 
signals and responses (Arya et al., 2007). Thus, their involvement in a multitude of 
intracellular actions places them as central coordinators in determining the fate of a cell. 
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Chapter 3 
CELL CULTURE AND CYTOTOXICITY 
3.1 Introduction 
The culture of cells and tissues is now a frequently utilised technique in a variety of disciplines 
from the basic sciences of cell and molecular biology to the rapidly evolving field of 
biotechnology (Freshney, 1992). 
The interest in cellular in vitro models is due to the fact that they represent the elementary 
living unit and, at least theoretically, cells from any species and tissue can be cultivated, 
including those of human origin. Moreover, this type of experimentation bypasses most of the 
ethical problems associated with human experimentation, involves a reduction of animal 
studies that are often in the public protest limelight, and also reduces the financial costs 
incurred by animal studies (Clynes, 1998). 
The list of different cell types which can now be grown in culture is extensive (Freshney, 1992) 
presumably because in vitro culture facilitates a controlled and manipulated environment, in 
which the biochemical mechanisms of toxicity can be more specifically analysed. 
3.2 The cell and its environment 
It is presumed that the best environment for growing cells in vitro is one providing as closely 
as possible the conditions they experience in vivo. The essential requirements for an optimum 
cell culture environment are temperature and pH, gas phases, a suitable substrate and media 
containing the necessary nutrients (Freshney, 1992). 
3.2.1 Temperature and pH 
The optimal temperature for cell culture depends on the body temperature of the organism 
from which the specific cell type was obtained. Thus, the temperature required for optimal 
growth of most human cell lines is 37°C which is accomplished in vitro by the use of a 
humidified carbon dioxide (C02) incubator. 
Ideally, pH should be near 7.4 at the initiation of a culture and not fall below a value of 7.0. 
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3.2.2 Gas phases 
The most important gases required in vitro are O2 and CO2. It is necessary to supply O2 to the 
medium throughout the life of the culture and this is accomplished by maintaining 02 tension 
at atmospheric pressure. The rule is that the bicarbonate and C02 tension must be in 
equilibrium. Hepes is a satisfactory buffer able to perform this function by maintaining the 
correct pH without the requirement of an enriched atmosphere (Freshney, 1992). 
3.2.3 Substrate 
Some cultures can be propagated in suspension, but most are propagated as a monolayer, 
anchored to a substrate. Polystyrene which has been treated to make it wettable and give it a 
net negative charge is now utilised almost universally as a substrate. Single use polystyrene 
flasks provide a simple and reproducible environment for cultured cells because they can be 
sealed, do not need a humid CO2 incubator and provide better protection against contamination 
(Freshney, 1992). 
3.2.4 Medium 
The culture medium is by far the most important single factor in culturing cells. The 
extracellular medium must meet the essential requirements (nutritional, hormonal and stromal 
factors) for survival and growth (Freshney, 1992). 
A complete culture medium (CCM) contains Eagle's minimum essential medium (EMEM; 
Appendix 1), foetal calf serum (FCS), L-glutamine as well as antibiotics and antifungal agents. 
Eagle's minimum essential medium is a commercially prepared growth medium that contains 
essential amino acids, vitamins and salts. 
Foetal calf serum is a complex mixture of various small and large biomolecules with different, 
physiologically balanced growth promoting and growth inhibiting properties. Some of the 
major functions of FCS is to provide the following: basic nutrients, in solution and bound to 
proteins; hormones and growth factors for stimulating growth and specialised functions; 
attachment and spreading factors; binding proteins (albumin and transferrin) carrying 
hormones, vitamins, minerals and lipids; protection factors against mechanical damage; 
protease inhibitors as well as contribution to buffering (Freshney, 1992). 
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A given concentration of nutrients can only support a certain number of cells. One of the 
nutrients most likely to be exhausted first is L-glutamine, partly due to it spontaneously 
cyclising to pyrrolidine carboxylic acid and also because it can be enzymatically converted by 
serum and cellular enzymes to glutamic acid, leucine and isoleucine (Freshney, 1992). For 
these reasons, media is usually supplemented with a further 1 % of L-glutamine. 
In an attempt to counteract microbial and fungal contamination, media is also supplemented 
with Penstrep-Fungizone, a cocktail of antibiotics and antifungal agents. It contains Penstrep, a 
mixture of the antibiotics penicillin and streptomycin, and Fungizone, an antifungal agent. 
3.3 The HepG2 cell line 
The liver is the most important drug metabolising organ in mammals. Liver cell lines, which 
have retained the activities of drug metabolising enzymes involved in the activation and 
detoxification of carcinogens, reflect the cytotoxic effects of such substances better than stable 
mammalian cell lines, which are currently used in routine testing and require the addition of 
exogenous activation homogenates (Majer et ai., 2004). 
One of the most promising lines is the human HepG2 cell line which was originally isolated in 
1979 from a primary hepatoblastoma of an 11-year-old Argentinean boy (Uhl et ai., 2000). 
These cells have an epithelial like morphology which resembles liver parenchymal cells and 
they synthesise and secrete many of the plasma proteins characteristic for normal human liver 
cells (Knasmuller et ai., 1998). They have retained many of the functions of normal liver cells 
and express different inducible xenobiotic metabolising enzymes (phase I and phase IT 
biotransformation enzymes) that play key roles in the activation and detoxification of DNA 
reactive carcinogens (Belloir et ai., 2006). 
Isoenzymes of several CYP450 families (including CYP3A4) which are responsible for the 
activation of diverse promutagens are present in HepG2 cells. Apart from the CYP450 isozymes, 
several other oxidoreductases involved in either electron transfer processes to CYP450 isozymes 
or in the activation of ROS are also expressed by HepG2 cells. In addition, they have no 
known point mutations in tumour suppressor genes, p53 and pRb (Knasmuller et ai., 1998). 
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In all animal species examined to date, including man, the liver frequently demonstrates to be 
the primary target organ for AFBI (Neal, 1995). It is for this and the abovementioned reasons 
that a liver cell line, specifically the HepG2 cell line, was selected for this study. 
3.4 Cytotoxicity testing 
The broad aim of in vitro toxicity testing is to screen compounds in order to elucidate their 
general toxicity. Cell culture systems have different areas of application in toxicology 
according to the aim of the study, which can either be to investigate a particular mechanism or 
to screen chemicals (Clynes, 1998). 
In vitro toxicity testing is based on a few assumptions which include: a) a variety of 
pathologies are related to a small number of crucial events at a cellular level, especially where 
acute toxicity is concerned; b) several elements of the organisms complexity may be mimicked 
in vitro; and c) the exposure conditions may be efficiently reproduced in vitro (Clynes, 1998). 
The assay most commonly utilised to measure cytotoxicity in vitro involves the use of a 
tetrazolium salt, methyl thiazol tetrazolium or MTT [3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide] (Freshney, 1992). This technique is particularly useful for cells which are 
metabolically active but not proliferatiI).g and is based on the capacity of mitochondrial 
dehydrogenase enzymes (succinate dehydrogenase) to reduce the yellow, water-soluble salt 
into a purple insoluble formazan product. The insoluble crystals may then be dissolved in 
dimethyl sulfoxide (DMSO) and the absorbance can be read with a spectrophotometer 
(560nm). The amount of · formazan produced is directly proportional to cell number thus 
allowing for the determination of cell viability and proliferation by this assay (Clynes, 1998). 
The aim of this chapter was to utilise the MTT assay to determine ICso values after exposure of 
HepG2 cells to various dilutions of an SF water extract, when administered individually and in 
combination with AFB 1• 
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3.5 Materials and Methods 
3.5.1 Ethical approval 
This study was given full ethical approval by the Biomedical Research Ethics Committee 
(Reference No: BE050108). 
3.5.2 Materials 
Aflatoxin BI and L-can were purchased from Sigma (SA). A bottle of SF tablets (60 x 300mg) 
was obtained from Phyto Nova Natural Medicines (SA). Penstrep-Fungizone, EMEM, FCS, 
culture flasks, 96-well plates and sterilin tubes were purchased pre-sterilised from Adcock 
Ingram (SA). Ethanol, phosphate buffered saline (PBS) tablets and DMSO was acquired from 
Merck (SA). 
3.5.3 Methodology 
3.5.3.1 Cell culture environment 
Prior to work being conducted in the tissue culture laboratory, hands were sanitised with 5% 
hibitane (chlorhexidine gluconate), an antiseptic which sterilises and provides moisture, 
reducing the risk of dry skin and loosely adherent micro-organisms serving as a source of 
contamination. Personal protective equipment including sterile gloves and a clean laboratory 
coat were also worn. All cell culture procedures were conducted under a microbiological safety 
cabinet equipped with a UV light and continuous laminar flow. The cabinet was always 
sterilised with 70% ethanol both before and after use. In addition, gloves as well as all 
materials and equipment used during the session were swabbed with 70% ethanol before any 
work commenced. 
3.5.3.2 Preparation of cell culture media and freezing medium 
Cells were maintained in EMEM containing 10% FCS supplemented with 1 % L-glutamine and 
1 % Penstrep-Fungizone. 
Dimethyl sulfoxide was added at a concentration of 10% to CCM. This served as a freezing 
medium for storing cells at -80°C. Dimethyl sulfoxide is a dipolar organic solvent and was 
utilised as a cryoprotective agent because it doesn't crystallise at -80°C, a property which 
enables it to form a protective layer around the cell during cryopreservation and minimise the 
formation of ice crystals. 
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3.5.3.3 Trypsinisation 
Trypsin is a proteolytic enzyme that aids in the digestion of connective tissue of cells and their 
cell membranes. 
Trypsinisation was conducted by initially discarding the spent culture medium from the tissue 
culture flask. Cells were then rinsed with three changes of pre-warmed (37°C) PBS so that the 
residual culture medium and any cellular debris was effectively removed. This process was 
efficiently carried out by briefly shaking the flask containing PBS and thereafter discarding the 
PBS-wash solution. Pre-warmed (37°C) trypsin was thereafter added to the culture flask (just 
enough to submerge the attached cell monolayer). The flask was then sealed and placed in the 
incubator (37°C) for approximately 2 minutes. Following the incubation period, cells were 
visualised using an inverted light microscope (Olympus IXSI; 20x magnification) to observe 
morphological changes of the cells. Cells were considered to be trypsinised if they were 
rounded and if the intercellular processes were no longer visible. 
The trypsin solution was then discarded followed by the addition of pre-warmed (37°C) CCM 
to the culture flask. The FCS in CCM serves as an inhibitor of trypsin thus neutralising the 
residual trypsin in the flask which may otherwise result in damage to cell surface receptors if 
the cells are exposed for too long. The flask was then energetically shaken until the cells were 
in suspension. Cells were then counted and subsequently subcultured or utilised for specific 
assays. 
3.5.3.4 Cell counting by dye exclusion using a haemocytometer 
Trypan blue (0.4%) was utilised in a dye exclusion procedure for cell counting. The principle is 
that non-viable cells readily take up the dye and are visualised as being stained blue whereas 
viable cells are visualised as unstained cells because they are unable to take up the dye. 
Cell numbers were determined using a Neubauer haemocytometer which comprised 2 
chambers, each further consisting of nine Imm squares (Figure 3.1, A-E). Prior to cell 
counting, the haemocytometer was sterilised with 70% ethanol and a coverslip was affixed to 
it. 
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Cells were thereafter brought into suspension by trypsinisation and a cell counting solution 
containing 150!!1 CCM, 50!!1 trypan blue and 50!!1 of the CCM-cell suspension was made up in 
an eppendorf, vortexed and allowed to stand for 5 minutes. The resulting solution provided a 
dilution factor of 1:5. 
With the coverslip in place, 15!!1 of the cell counting solution was then pipetted into each 
chamber of the haemocytometer. The solution was allowed to be drawn out of the pipette and 
into each chamber by capillary action. The haemocytometer was then placed under the 
microscope and bright field settings accompanied by a magnification of 20x were employed for 
cell counting. A separate count of viable and non-viable cells was carried out. Starting with 
chamber 1 of the haemocytometer, all cells present in the Imm corner squares (Figure 3.1, A-
D) as well as the middle square (Figure 3.1, E) were counted. Cells present on the boundary 
lines of these squares were ignored. 
Figure 3.1 Diagram of a haemocytometer (Thomson, 2(08). 
The live cells were then averaged by dividing the total count by five. Dead cells were similarly 
averaged. Both averages were then added to obtain a total cell count for the first chamber. This 
counting procedure was repeated for the second chamber and a final cell count was obtained by 
averaging the total cell count of both chambers. 
The number of cells present within a millilitre (ml) of a particular sample (cells/ml) was then 
calculated by mUltiplying the final cell count by 10 000 and then by 5 (dilution factor). The 
number of cells present within the entire sample was then calculated by mUltiplying the 
cells/ml by the total volume (ml) of sample. 
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3.5.3.5 Preparation of the Sutherlandia frutescens aqueous extract 
Sutherlandia tablets were crushed to a fine powder using a pestle and mortar, and subsequently 
weighed. An SF aqueous extract was thereafter prepared by initially boiling (in a sealed 
beaker) a mixture (1.2g1lOml) of the SF powdered tablets and deioinised water (dH20). After 
30 minutes, the resulting mixture was allowed to cool to room temperature, tr~sferred to 50ml 
sterilin tubes and centrifuged at 1 000 rpm for 5 minutes at 24°C. Thereafter, the supernatants 
were removed, passed through 0.451lm filters into a 250ml bottle and autoc1aved at 115°C for 
30 minutes. The resulting solution served as the crude SF aqueous extract. 
3.5.3.6 Preparation of stock solutions 
It was necessary to determine IC50 values for each compound under investigation prior to 
conducting any assays. Selection of an IC50 for AFBI (lIlM) and L-can (2mM) was based on 
previous studies (UbI et ai., 2000; Majer et al., 2004; McKean et ai. , 2006) and (Swaffar et ai. , 
1994; Ding et al., 1999; Jang et ai., 2002) respectively. 
Aflatoxin BI (lmg) was initially dissolved in ethanol (300Ill) and made up to a final volume of 
lOml in CCM to yield a stock solution with a concentration of 3211lM. For purposes of the 
MIT assay, a 251lM AFBI solution was prepared utilising the 3211lM AFBI stock solution. 
Essentially, cells treated with AFBI were exposed to 0.0092% ethanol. In order to obtain 
consistency of measurement, the control and L-can stock solutions as well as the SF dilutions 
were prepared such that the cells incubated with these samples would also be exposed to the 
same percentage of ethanol. 
A 4mM stock solution (lOml) of L-can was prepared by dissolving 7.05mg L-can in CCM. 
Dilutions (l: 1.5, 1 :3, 1 :4.5 and 1 :6) of SF in CCM were made utilising the SF aqueous extract. 
The MIT stock solution (5mglml) was prepared by adding 1ml of PBS to 5mg MIT and 
vortexing until the salt was completed dissolved. The dye solution was utilised immediately 
after preparation. 
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3.5.3.7 Treatment, isolation and harvesting of HepG2 cells 
HepG2 cells were grown to approximately 80% confluency in a 75cm3 culture flask. Cells were 
rinsed with three changes of pre-warmed (37°C) PBS ~d thereafter harvested by trypsinisation 
and counted. 
3.5.3.8 The methyl thiazol tetrazolium bioassay on cultured HepG2 cells 
The assay was conducted in triplicate for each sample under investigation. 
For the control, SF only and AFB\ only treatments (Figure 3.2), aliquots comprising 125111 of 
the CCM-cell suspension was dispensed into each of the relevant wells of a 96 well rnicrotitre 
plate to give a final cell count of approximately 10 000 cells/well. 
Subsequent to vortexing, 125111 aliquots of the control solution and SF dilutions (1:1.5, 1:3, 
1 :4.5, and 1 :6) were dispensed into each of the relevant wells resulting in a final volume of 
250llllwell. The final dilutions of the SF extract to which the cells were exposed were 1 :3, 1 :6, 
1:9 and 1:12 respectively (Figure 3.2). 
For the AFB\ only treatment, 115111 of CCM was dispensed into the appropriate wells followed 
by the addition of 10111 of AFB\ (25IlM) to give a final volume of 250llllwell. The final 









1 1 3 4 5 6 7 8 9 10 1112 Key 
• • 
• • • • • • • • 
SF only (1:3) 
SF only (1 :6) 
SF only (1 :9) 
SF only (1:12) 
SF (1:3) + AFBI (111M) 
SF (1 :6) + AFBI (111M) 
SF (1 :9) + AFBI o 11M) 
SF 0:125+ AFBI (1IlM) 
AFBI only o 11M) 
Control 
Blank. 
Figure 3.2 Schematic diagram of the treatment of cells for the MTT assay. 
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For the SF-AFBI combination treatment (Figure 3.2), the CCM-cell suspension was adjusted 
such that 115f,.t1 aliquots were added to each of the relevant wells yielding a final cell count of 
approximately 10 000 cells/well. Aliquots comprising 125f,.t1 of the SF samples and 1Of,.t1 of 
AFBI (25f,.tM) were then dispensed into each of the appropriate wells resulting in a final 
volume of 250f,.tllwell. The final dilutions of SF and the final concentration of AFBI to which 
cells were exposed were 1:3, 1:6, 1:9, 1:12 and If,.tM respectively. 
The 96 well plate was then sealed with parafilm, swabbed with 70% ethanol and incubated 
(37°C) for 24 h. Following the incubation period, the supernatant of each well was discarded 
and the cells in each well were resuspended with 100f,.t1 of CCM. A blank control (Figure 3.2) 
containing only CCM (l00f,.t1) was also included in order to correct background absorbance. A 
1Of,.t1 aliquot of the MIT stock solution (5mglml) was then added to each well. The plate was 
subsequently covered with foil and returned to the incubator (37°C). After 4 h of incubation, 
the plate was centrifuged at 1 000 rpm for 5 minutes at 24°C and the supernatant of each well 
was discarded followed by the addition of DMSO (l00f,.t1) into each well. The plate was 
incubated (37°C) once more for an hour, removed from the incubator and allowed to cool to 
room temperature before measuring the optical densities of the samples at 560nm with a 
reference wavelength of 620nm using a Bio-Tek f,.tQuant microplate spectrophotometer. 
3.5.3.9 Data analysis and statistics 
The net MIT -dependant absorbance of each sample was calculated by subtracting the average 
absorbance of the blank from the average absorbance of each sample. Samples were compared 
for differences using one-way ANOVA and the Tukey-Kramer multiple comparisons test 
(Graph Pad InStat Software, version 3.06). A probability value (P) of less than 0.05 (p<0.05) 
was considered as statistically significant (* indicates significant (p<0.05) differences between 
treated and control groups; # indicates significant (p<0.05) differences between SF and SF-
AFB 1; ° indicates significant (p<0.05) differences between AFBI and SF-AFB1). Data are 
represented as % cell viability plus or minus the standard deviations. 
% Cell viability was calculated by utilising the following equation: 
% Cell viability = mean absorbance of treated cells 
mean absorbance of control cells 
x 100 
53 
3.6 Results and Discussion 
The MIT assay is a convenient tool for rapidly assessing metabolism, functional capacity and 
cell viability. It is based on the ability of mitochondria within viable cells to reduce the yellow 
MIT salt to a purple formazan product which can subsequently be quantified 
spectrophotometrically. Due to such reduction, the assay facilitates a quantitative, convenient 
method for evaluating a cell population's response to external factors, whether it is an increase 
in cell viability, no effect, or a decrease in cell viability. 
Aflatoxin B I is the most prevalent and carcinogenic of the aflatoxins, and the toxic effects of 
AFBI have been studied extensively in vitro. In all animal species examined to date, including 
man, the liver is the primary target organ for AFBI toxicity (Neal, 1995). 
Sutherlandia frutescens is a plant that has broad therapeutic potential and more specifically, it 
is perceived by some to have the ability to treat cancer. 
Based on the many controversial claims of the effects of AFBI and SF, the MIT assay was 
utilised in order to investigate the cytotoxic potential of SF when administered individually and 
in combinat~on with AFB 1• 
A typical dose-dependent viability response was observed when cultured HepG2 cells were 
.incubated with increasing dilutions of SF (1:3, 1:6, 1:9, and 1:12) either individually or in 
combination with AFBI (1IlM) for 24 h (Figure 3.3). 
Statistical analysis to examine the effects on cellular reduction of MIT, using one-way 
ANOVA, revealed that cytotoxicity was significant (p<0.001) following all treatments, when 
compared to the control. 
The exposure of cells to SF only for 24 h resulted in cell viability increasing by 17%, 67%, 
80% and 90% with dilutions of 1:3, 1:6, 1:9 and 1:12 respectively (Table 3.1). 
These findings demonstrate that SF inhibits proliferation of the HepG2 carcinoma cell line in a 
dose-dependant manner and correlates with other studies (Tai et al., 2004; Chinkwo, 2005; 
Steenkamp and Gouws, 2006; Stander et al., 2(07). Steenkamp and Gouws (2006) 
demonstrated that a hot water leaf extract of SF inhibited growth of both the prostate cancer 
54 
cell line, DU-145 as well as the breast carcinoma cell line, MCF-7. In addition, Chinkwo 
(2005) found a crude aqueous whole plant extract of SF to induce cytotoxicity in Caski cells, 
CHO cells and the Jurkat T lymphoma cell line. Further to utilising aqueous extracts of the 
plant, other authors (Tai et al., 2004; Stander et al. , 2007) used ethanolic extracts and have 
showed dose-dependent induction of cell death of several cancer cell lines (MCF7, Jurkat T 
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The effect of SF, AFB. and SF-AFB. combination treatments on cell 
viability of the HepG2 cell line. ***p<0.001, 00 °p<0.001, ###p<O.OOl. 
It is unclear how SF might influence mitochondrial activity and metabolism resulting in the 
observed dose-dependant decreases in cellular ability to reduce MIT. Many investigations 
utilising SF have been studied from a chemical point of view. L-canavanine, one of the active 
substances of SF, is known to exhibit tumouricidal and/or cytotoxic activity (Green et al., 
1980; Thomas et al., 1980; Swaffar et al., 1994; Ding et al., 1999). 
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It has been demonstrated that L-can induces the synthesis and subsequent accumulation of 
aberrant proteins due to its erroneous integration into proteins instead of L-arg. It is suggested 








Mean cell viability as a percentage of the control ± SD following exposure 
of HepGz cells to SF only and SF -AFBI combination treatments. 
Cell viability (% ) - SF only Cell viability (%) - SF-AFBI (1J1M) 
17 ± 3.2 15 ± 1.6 
67 ± 6.2 55 ± 2.8 flU 
80 ± 1.9 77 ± 2.6 
90 ± 3.0 88 ± 1.7 
Wilkie (1970) demonstrated the inhibitory effects of L-can on mitochondrial function in 
Saccharomyces cerevisiae, which was detected as inhibition of growth, greatly reduced 
respiratory activity and considerable decreases in the synthesis of cytochromes a and h. 
Moreover, Winston and Bosmann (1971) reported inhibition of both rat liver and brain 
mitochondrial systems by L-can. 
In addition to its inhibitory effects on the mitochondrion, studies have demonstrated that L-can 
induces oxidative stress (Riganti et aI., 2003) and genotoxicity (Schachtele et aI., 1968; Hare, 
1969; Cervera et al., 1983). 
Cell viability may also be influenced by L-canaline due to its ability to form oximes that 
scavenge essential metabolites such as pyruvate and oxaloacetate, thereby depleting TCA cycle 
reserves and interfering with ATP production (Rosenthal, 1997). Significant energy depletion 
will inevitably lead to a loss of cell function and cell death (Amdur et al., 1991). 
Therefore, cytotoxicity by SF may be ascribed to the ability of L-can to influence protein 
structure and function, mitochondrial activity, genomic integrity as well as the redox state of 
cells, the consequence of which may be cell death. However, the bioactivity of SF is possibly 
due to the synergistic effects of the many compounds present in the extract and may not be 
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solely dependent on a single compound, but rather a host of phytocompounds thereby resulting 
in a relatively complex mechanism of action (Stander et ai., 2007). 
After 24 h of incubation, AFBI (1!!M) was shown to be significantly (p<0.001) cytotoxic to 
HepG2 cells (Figure 3.3). Liver mitochondrial injury is one of the dominant features of AFBI 
toxicity. The ability of AFBI to influence mitochondrial function can be attributed to its 
inhibitory effects on the ETC and oxidative phosphorylation (Doherty and Campbell, 1973; Pai 
et ai., 1975). It has been reported that AFBI specifically inhibits succinate dehydrogenase 
(Obidoa and Obonna, 1981; Sajan et ai. , 1995), the same enzyme that reduces MIT. 
In addition to its negative effects on the mitochondrion studies have demonstrated the capacity 
of AFBI to mediate oxidative stress (Shen et ai., 1995; Shen et ai., 1996; Awney et ai., 2002; 
Towner et ai., 2002; Lee et ai., 2005) and genotoxicity (Amstad et ai., 1984; EI-Khatib et ai. , 
1998; O'Brien et ai., 2000; Uhl et ai., 2000; Raj et ai. , 2001; Ehrlicha et ai., 2002; Majer et ai., 
2004), the consequences of which may be cellular lethality. 
Other findings showed that co-administration of SF along with AFB 1 resulted in cell viability 
increasing by 15%, 55%, 77% and 88% with 1:3, 1:6, 1:9, 1:12 SF and AFBI (1!!M) 
respectively (Table 3.1). 
When SF-AFBI and SF only data were compared, it was revealed that cell viability for all the 
combination (SF-AFBt} treatments were lower than the corresponding individual (SF only) 
treatments (Table 3.1). A statistically significant (p<O.ool) difference between SF (1:6) and the 
corresponding SF (1:6)-AFBI treatment was noted (Figure 3.3). 
Data also demonstrated statistically significant (p<O.OOI) differences between AFBI only and 
SF-AFBI, except for when SF (1:12) and AFBI were combined (Figure 3.3). 
Based on these findings, both compounds appear to be working simultaneously when 
administered in combination, however the precise mechanisms by which they act in concert to 
influence cell viability are not fully understood. 
Despite the substantial progress in the development of anticancer therapies, the incidence of 
cancer is still increasing worldwide. One of the most reasonable approaches to reduce the risk 
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of cancer is chemoprevention, a relatively new and promising strategy of cancer prevention. 
Since the majority of cancer chemotherapeutic agents severely affect the host's normal cells, 
utilisation of natural products has now been contemplated of exceptional value in the control of 
cancer. Recently, attention has been focused on the identification of plants such as SF as 
potential sources of chemotherapeutic agents. 
However, little is known regarding the pharmacology of compounds contained in SF extracts, 
thus complicating the correlation between in vitro and in vivo results. To facilitate SF 
effectiveness in vivo, the active substances must be absorbed and presented to the targets at 
concentrations that can exert an effect. The manufacturer of SF recommends a daily dose of 
two tablets (600mg), three times a day for HIV/AIDS patients. However, the dosage for cancer 
treatment remains elusive. Assuming a patient of 60kg has a 36L fluid compartment, each 
tablet contains 3mg of L-can as the active component and SF is consumed with 100% 
absorption, then the plasma concentration of L-can will be approximately O.5!lglml (Tai et al., 
2004). This concentration is much lower than the concentration of L-can found to have 
antiproliferative effects in vitro (2mM = 352!lglml). 
Thus, future research pertaining to the pharmacokinetics of bioactive principles, following the 
ingestion of SF, is crucial to facilitate accurate interpretation of in vitro data and for the 
development of suitable in vivo experiments. Furthermore, it is anticipated that some of the 
compounds in SF, if structurally identified and characterised, may be effective candidates for 
anticancer drug development. 
3.7 Conclusion 
Based on the findings of this assay, it was concluded that the 1:6 dilution for both the 
individual (SF only) and combined (SF-AFBI) treatments would be utilised for all further 
experiments. 
The claim by traditional healers that SF has anticancer properties has been partially validated 
in this study by the MTT assay which revealed an aqueous extract of the plant to possess 
significant cytotoxic activities in vitro on the human hepatocellular carcinoma cell line, HepG
2
• 
Overall, the MTT assay proved to be an efficient colorimetric technique for assessing the 




CELLULAR REDOX STATE 
Aerobic organisms are continually subjected to ROS, derivatives of 02 that are generated as 
products or by-products by a range of enzymatic reactions during various cellular processes 
(Liu et aI., 2(08). Within a normal cell, there always exists an exquisite balance between pro-
and antioxidant pathways (Sreedhar and Csermely, 2(04). When this balance tips toward the 
oxidant side, or when a disruption of redox signalling and control occurs, oxidative stress 
ensues (Liu et aI., 2(08). 
4.2 Reactive oxygen species and oxidative stress 
Reactive oxygen species such as 02-, H202 and ·OH can be generated by a variety of 
mechanisms which include the mitochondrial and microsomal ETC, xanthine oxidase and other 
flavoprotein oxidases, auto-oxidation of hydroquinones, catecholamines, thiols, intracellular 
xenobiotic mechanisms (CYP 450), NADP (H)-oxidase, peroxisome metabolism as well as by 
the auto-oxidation of haemoglobin (Sreedhar and Csermely, 2004). 
A wide array of enzymatic and nonenzymatic antioxidant defences exists in order to avoid 
redox imbalance and oxidative stress. The primary defence system includes superoxide 
dismutase (SOD), glutathione peroxidase (GPX) and catalase (CAT) (Mateas and Sanchez-
Jimeanez, 2000). For example 02- is dismutated by SOD to H20 2, and H20 2 could either be 
converted to water by CAT or GPX (utilises GSH) (Awney et aI., 2002). On the other hand, 
H202, contrary to O2-, is able to cross cell membranes and once inside cells it can participate 
with transition metal ions such as iron (Fe) and copper (Cu) via Fenton chemistry (equation 1). 
·OH + OH- + Fe (III) (1) 
Hydrogen peroxide may subsequently be reduced by electron donors such as NADPH, 
hydroquinone, ascorbic acid or GSH to ·OH, which is widely regarded as the most reactive 
form of ROS as it readily reacts with cellular components to cause oxidative damage such as 
lipid peroxidation and oxidative DNA damage (Shen et ai., 1996; Goetz and Luch, 2008). 
59 
Secondary defence's mainly combat processes elicited by free radicals and the compounds 
comprising this defence system include ascorbic acid (vitamin C), a-tocopherol (vitamin E), 
GSH, p-carotene, vitamin A, NADPH and urate (Mateas and Sanchez-Jimeanez, 2000). 
The term 'oxidative stress' describes the adverse interactions of molecular O2 or of its reactive 
derivatives (ROS) with biomolecules such as DNA, proteins, and lipids, as well as the damage 
initiated via oxidative modification of these cellular molecules which subsequently contributes 
to the pathogenesis of various human diseases (Goetz and Luch, 2(08). 
Subsequent to its production intracellularly, ROS may damage DNA. Reactivity of ROS 
towards DNA induces point mutations, DNA-DNA and DNA-protein crosslinks, sister 
chromatid exchanges (Goetz and Luch, 2(08), base damage, both single- and double-strand 
breaks and often the subsequent production of clastogenic factors (Blount et al., 1989). Site-
specific DNA damage is predominantly induced by ·OH. 8-Hydroxy 20-deoxyguanosine (8-
HO-dG) represents the most extensively studied oxidative DNA modification (Goetz and Luch, 
2(08). 
As much as 1 % of the 02 consumed by the average human cell may be diverted to the 
oxidative modification of proteins. Enzyme inhibition by ROS occurs following oxidation of 
proteinaceous amino acids such as cysteine, methionine, histidine, and tryptophan (Gracy et 
al., 1999). In addition, oxidation of proteins can result in major physical changes in protein 
structure (fragmentation of the backbone or oxidation of the side-chains) leading to unfolding 
and conformational changes which can have consequential effects on biological function. 
Moreover, reactive species including hydroperoxides or peroxides can also be induced 
following the oxidation of proteins thus potentiating oxidative stress (Davies, 2(05). 
Indeed, DNA and proteins are often more significant targets of injury than are lipids, and lipid 
peroxidation often occurs late in the injury process (Halliwell and Chirico, 1993). Lipid 
peroxidation is commonly regarded as a deleterious process, induced by free radicals, leading 
to structural modification of complex lipid-protein assemblies such as biomembranes and 
lipoproteins (Kuhn and Borchert, 2(02). 
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A free radical is defined as any species capable of independent existence and possesses one or 
more unpaired electrons. If two radicals coincide, they can combine their unpaired electrons to 
form a shared electron pair (covalent bond). Most biological molecules are nonradicals. When 
a radical gives one electron to, takes one electron from, or simply adds on to a nonradical, that 
nonradical becomes a radical. Thus, a feature of the reaction of free radicals with nonradicals is 
that they usually proceed as chain reactions and lipid peroxidation is the most studied 
biologically relevant free radical chain reaction (Halliwell and Chirico, 1993). 
Polyunsaturated fatty acids (PUFAs) are particularly susceptible to lipid peroxidation. 
Hydrogen atoms in PUFAs contain a single electron and its removal by a free radical leaves 
behind an unpaired electron on the carbon atom to which it was originally attached. The 
resulting carbon-centred lipid radical thereafter undergoes molecular rearrangement, followed 
by reaction with O2 to generate a peroxyl radical. Peroxyl radicals may then attack membrane 
proteins but are also capable of abstracting hydrogen from adjacent fatty acid side chains thus 
propagating the chain reaction of lipid peroxidation. Hence, a single initiation event can result 
in the conversion of hundreds of fatty acid side chains into lipid hydroperoxides (Halliwell and 
Chirico, 1993). 
4~3 The role of glutathione 
The GSH redox cycle is an important component of the antioxidant machinery in cells (Meki et 
ai., 2004). Glutathione, y-glutamylcysteinylglycine, is the most abundant non-protein thiol, 
being found in the millimolar range in most cells (Dickinson and Forman, 2002). It is 
syntliesised from L-glutamate, L-cysteine and glycine in two consecutive steps, catalysed by y-
glutamyl-cysteine synthase (GCS) and glutathione synthase (Sies, 1999). 
Glutathione is a molecule with many important cellular properties including a) its cysteinyl 
residue provides a nucleophilic thiol important for the detoxification of electrophilic 
metabolites and metabolically produced oxidising agents; b) its net negative charge and overall 
hydrophilicity greatly increases the aqueous solubility of the lipophilic moieties with which it 
becomes conjugated; c) its molecular weight ensures that its adducts are preferentially secreted 
via the biliary system and d) its unique tripeptide structure, including the N-terminal glutamyl 
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residue linked via a y-glutamyl peptide bond, provides for specificity in GSH-enzyme 
interactions (Ketterer et aI., 1983). 
It is able to form conjugates (GSH S-conjugates) with a variety of electrophilic compounds 
nonenzymatically, when the electrophile is very reactive, or more often via the action of GST. 
Conjugation with GSH is an essential aspect of both xenobiotic and normal physiological 
metabolism (Dickinson and Forman, 2002). Within mammals, GSH S-conjugates are 
preferentially secreted by the biliary system but may be further metabolised by hydrolysis and 
N-acetylation, resulting in N-acetylcysteinyl conjugates known as mercapturic acids, which 
may subsequently be excreted in urine (Dickinson and Forman, 2002). 
Glutathione does not react directly with lipid hydroperoxides but its use as a substrate for GPX 
is· recognised for the reduction of H202 (equation 2) and lipid hydroperoxides (equation 3). 
During these reactions GSH is converted to glutathione disulfide (GSSG) and H202 is reduced 
to water or the hydroperoxide is converted to its corresponding alcohol (Dickinson and 
Forman, 2002). 






Glutathione disulfide can then be reduced to GSH by NADPH via the glutathione reductase 
reaction (equation 4) (Dickinson and Forman, 2002). 
GSSG + NADPH + W NADP++2GSH (4) 
The critical role of GSH in protecting cells should be apparent based on the multitude of 
reactions through which it removes potentially harmful molecules from cells (Dickinson and 
Forman, 2002). 
4.4 The GSH-GloTM Glutathione assay 
4.4.1 Principle and applications 
The GSH-GloTM Glutathione assay is a luminescence-based assay for the detection and 
quantification of GSH. Detection of GSH using this assay is based on the result of the 
combination of two chemical reactions (Figure 4.1). 
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The first reaction (GSH-GloTM reaction) involves the generation of luciferin from a 
luminogenic substrate (Luciferin-NT), catalysed by GST in the presence of GSH. The second 
step (Luciferin Detection reaction) is initiated by adding an equal volume of Luciferin 
Detection Reagent which comprises firefly luciferase; an enzyme that is able to interact with 
the luciferin produced in the first reaction and subsequently mediate the generation of a stable 
"glow-type" luminescent signal. This signal is directly proportional to the amount of luciferin 
formed during the GSH-GloTM reaction and is thus proportional to the amount of GSH present 
in the sample (Promega, 2007). The assay is ideal for many applications, including the 
measurement of GSH levels in various cell or tissue extracts as an indicator of cell viability or 
oxidative stress. It can also be used for screening drugs and new chemical entities for their 
capacity to modulate GSH levels in cells, tissues or blood (Promega, 2007). 
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Figure 4.1 The GSH-Glo™ and Luciferin Detection reactions of the GSH-Glo™ 
Glutathione assay (Promega, 2007). 
4.5 The thiobarbituric acid reactive substances assay 
4.5.1 Principle of the assay 
Many assays are available to measure lipid peroxidation. One of the most commonly applied 
assays is the thiobarbituric acid (TBA) test or TBARS assay, which measures malondialdehyde 
(MDA) formed in peroxidising lipid systems (Halliwell and Chirico, 1993). This method is 
based on the condensation of two molecules of TBA with one molecule of MDA to form a pink 
chromogen (TBA pigment; Figure 4.2), the intensity of which is a measure of MDA 
concentration (lipid peroxidation) and can be measured by spectrophotometry at 532nm 
(Fernindez et ai., 1997). 
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The aim of this chapter was to utilise the GSH-GloTM Glutathione assay and the TBARS assay 
to determine the influence of SF, L-can and AFB}, when administered individually and in 
combination, on cellular redox state. 
HSY"Ir°H 
2 H~H + 
OH 
MAl.ONDIALDEHVDE 
TBA TBA PIGMENT 
Figure 4.2 Reaction between thiobarbituric acid and malondialdehyde to form the 
thiobarbituric acid pigment (Fernindez et al., 1997). 
4.6 Materials and methods 
4.6.1 Materials 
The GSH-GloTM Glutathione Assay kit was purchased from Promega. The product components 
include Luciferin-NT, Glutathione S-Transferase, GSH-GloTM Reaction Buffer, Luciferin 
Detection Buffer and the Luciferin Detection Reagent. Phosphoric acid (H3P04), hydrochloric 
acid (HCI), TBA and butanol were acquired from Merck (SA). Butylated hydroxy toluene 
(BHT) was obtained from Sigma (SA). All other reagents and consumables utilised were 
obtained from the sources mentioned previously. 
4.6.2 Methodology 
4.6.2.1 Treatment, isolation and harvesting of HepG2 cells 
HepG2 cells were grown to approximately 80% confluency in 75cm3 culture flasks. Cells were 
rinsed with three changes of pre-warmed (37°C) PBS following the removal of the spent 
culture medium from each flask. An aliquot of 6ml of each sample (Table 4.1) was thereafter 
dispensed into each appropriate flask and all six flasks were sealed and incubated at 37°C. 
Mter a 24 h incubation period, the supernatants from each flask were dispensed into 
appropriately labelled 15ml sterilin tubes and stored at -80°C. Cells were rinsed with three 
changes of pre-warmed (37°C) PBS and thereafter harvested by trypsinisation and counted. 
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4.6.2.2 Preparation of the GSH-GloTM Reagent 2X and Luciferin Detection Reagent 
The GSH-GloTM Reagent 2X was prepared by diluting the Luciferin-NT substrate and 
Glutathione S-Transferase 1:50 in GSH-GloTM Reaction Buffer, whereas the Luciferin 
Detection Reagent was prepared by mixing the Luciferin Detection Buffer with the Luciferin 
Detection Reagent. 
Table 4.1: Preparation of samples 
Volume of sample (fll) 
Final volume Final dilution! 
Sample 
with CCM (ml) concentration of sample 
Control - 12 -
SF 2000 12 1:6 
L-can 6000 (4mM) 12 2mM 
AFBI 37 (321!-tM) 12 IJ1M 
SF+AFBI 2000 + 37 (321!-tM) 12 1:6 + IflM 
L-can + AFBI 6000 (4mM) + 37 (321!-tM) 12 2mM + IJ1M 
4.6.2.3 The GSH-GloTM Glutathione assay on cultured HepGz cells 
This assay was performed in duplicate and conducted under the laminar flow hood. Cell culture 
media contains serum and phenol red which interferes with the GSH-GloTM assay chemistry; 
therefore the cells were assayed in PBS. An aliquot of 50!-t1 containing approximately 10 000 
cells from each treated sample was dispensed into individual wells of a white, opaque 
polystyrene flat-bottomed 96-well luminometer plate. In an attempt to achieve linear assay 
performance, a blank sample (negative control) containing only PBS (50!-tl) was also included 
in order to correct background luminescence. An aliquot of 50!-t1 of the GSH-Glo Reagent 2X 
was then dispensed into each well. The plate was then covered with foil in order to prevent 
direct exposure of the samples to light because the luminescent signal obtained during the 
assay is rapidly degraded in the presence of light. The plate was then placed on an orbital 
shaker at 200 rpm for 3 minutes to facilitate efficient mixing of the contents of each well. After 
a 30 minute incubation period (room temperature), the foil was removed and l00!-t1 of the 
Luciferin Detection Reagent was added to each well. The plate was then covered, briefly 
mixed once again on the orbital shaker and incubated at room temperature for 15 minutes. The 
foil cover was then removed and the plate was placed into the GloMax Multi Detection System 
(Promega), a luminometer which was utilised for the measurement of signals generated during 
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the assay. The instrument had preinstalled software for various luminometry-based assays and 
the GSH-Glo assay software was selected. 
4.6.2.4 The thiobarbituric acid reactive substances assay on cultured HepG2 cells 
Approximately 2 x 106 cells per treatment were transferred to appropriately labelled 15ml 
sterilin tubes and pelleted by centrifugation at 1 000 rpm for 5 minutes at 24°C. Thereafter, the 
supernatant from each tube was carefully removed, so as to prevent any disruption of the pellet. 
The pellets of cells were then resuspended in 500f.l1 of 0.2% H3P04. The cell suspensions were 
then passed through a 25 gauge needle approximately twenty five times. This process provided 
efficient homogenisation, allowing for rupturing of the cells and subsequent release of 
intracellular constituents. An equal amount (500f.l1) of 2% H3P04 was thereafter added to each 
homogenate and the resulting solution was briefly vortexed. A 400 f.l I aliquot of the 
homogenate from each sample was then dispensed into appropriately labelled glass test tubes. 
A blank sample (negative control) containing homogenate from the control was also included 
in order to correct background absorbance. A 200f.l1 aliquot of 7% H3P04 was then dispensed 
into each test tube followed by the addition of 400f.lL TBAlBHT solution (BHT is added to the 
TBA solution to prevent oxidation in the reaction during heating) to each sample, and 400f.lL 
of 3mM HCI to the blank. All test tubes were briefly vortexed and the pH of each solution was 
subsequently adjusted to 1.5 using 1M HCI. The test tubes were thereafter placed in a water 
bath (lOO°C). After 15 minutes, the tubes were removed and allowed to cool to room 
temperature before pipetting 1.5ml of butanol into each tube. All test tubes were subsequently 
vortexed for approximately 1 minute each and the samples were allowed to settle. 
Approximately 500f.l1 of the butanol (which comprised the upper phase of the solutions present 
in the test tubes) was then transferred to appropriately labelled eppendorfs and centrifuged at 
13 200 rpm for 6 minutes at 24°C. A 100f.l1 aliquot of each sample was then pipetted into 
individual wells of a 96-well microtiter plate. This part of the assay was performed in triplicate. 
The absorbance of the butanol phase was measured at 532nm (maximum absorbance for 
TBARS) with a reference wavelength of 600nm using a Bio-Tek f.lQuant microplate 
spectrophotometer. 
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4.6.2.5 Data analysis and statistics 
Data acquired from the GSH assay are represented as relative light units (RLU) plus or minus 
the standard deviations and TBARS data are represented as mean absorbance (nm) values plus 
or minus the standard deviations. The net GSH-dependant luminescence or net TBARS-
dependant absorbance of each sample was calculated by subtracting the average 
luminescence/absorbance of the blank control from the average luminescence/absorbance of 
each sample. Samples were compared for differences using one-way ANOV A and the Tukey-
Kramer multiple comparisons test (GraphPad InStat Software, version 3.06). A probability 
value (p) of less than 0.05 (p<0.05) was considered as statistically significant (* indicates 
significant (p<0.05) differences between treated and control groups; # indicates significant 
(p<0.05) differences between treated groups). 
4.7 Results and Discussion 
Within a normal cell, there is always a balance between pro- and antioxidant pathways. 
However, upon stress stimuli, an imbalance of the redox milieu develops and leads to the 
accumulation of ROS (Sreedhar and Csermely, 2004). 
Reactive oxygen species such as O2-, H20 2 and ·OH, can be generated by a variety of 
mechanisms (Sreedhar and Csermely, 2004) and their capacity to readily react with cellular 
components and cause oxidative damage has been well documented. 
Within normal cells, a primary defence against oxidative damage is provided by antioxidants 
such as GSH (Meki et ai., 2004). 
To evaluate the effects of SF, L-can and AFBl on the cellular redox state, the GSH-GloTM 
Glutathione assay the TBARS assay were employed. 
The results of the GSH-GloTM Glutathione assay illustrates that all samples evoked an increase 
in cellular GSH content when compared to the control (Figure 4.3). Intracellular GSH content 
is a function of the balance between its use and synthesis. Although its utilisation is beneficial 
to the cell, GSH must be regenerated. One way of doing so is via the reduction of GSSG by 
glutathione reductase to regenerate GSH at the expense of NADPH, but the replacement of 
GSH is principally due to de novo synthesis following increased transcription of GCS 
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(Dickinson and Forman, 2002). Because GCS is feedback inhibited by GSH, depletion of GSH 
(by conjugation reactions via GST or by GSSG formation) can result in a short term increase in 
GSH synthesis. To some extent, a decrease in GSH will cause a transient increase in the 
activity of pre-existing GCS by decreasing the feedback inhibition by GSH, resulting in a short 
term increase in GSH synthesis (Dickinson and Forman, 2002). Thus, the observed increases in 
GSH content after administration of all samples (Figure 4.3) can be due to such a mechanism. 
In addition, a remarkably large number of compounds, including oxidants and GSH-
conjugating agents have been shown to increase GSH synthesis through increased transcription 
of GCS. One particularly well studied inducer of GSH biosynthesis is the lipid peroxidation 
end product 4-hydroxynonenal (4HNE) (Dickinson and Forman, 2002). Therefore, the 
increases in GSH levels (Figure 4.3) may also be ascribed to increased oxidative stress. 
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Figure 4.3 The effect of SF, L-can, AFBh SF-AFBt and L-can-AFBt treatments on 
intracellular levels ofGSH in HepG2 cells. ***p<O.OOl , ##p<O.Ol. 
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Furthermore, DNA damage induced by ROS results in the formation of DNA chain breaks and 
changes in chromatin structure, a consequence of which is p53 activation and stabilisation 
(Hickman et ai., 2002). The tumour suppressor protein p53 (TP53), can then activate the 
expression of several genes, one of which is a gene named TIGAR (TP53-induced glycolysis 
and apoptosis regulator) which has been shown to function by lowering the intracellular levels 
of fructose-2,6-bisphosphate (F-2,6-BP), a substrate that promotes glycolysis by activation of 
phosphofruktokinase-l. Enhanced TIGAR expression lowers F-2,6-BP levels, thereby slowing 
glycolysis and redirecting glucose to the pentose phosphate pathway (PPP). The PPP is a major 
source of NADPH which is utilised by glutathione reductase to regenerate GSH from GSSG 
(Bensaad and Vousden, 2007). Increased TIGAR activity is therefore a certain possibility 
following genomic insult and may represent a mechanism by which GSH levels are restored 
and subsequently maintained within cells. It is thus presumed that the increased GSH levels 
(Figure 4.3) are due, to a certain extent, to increased TIGAR activity which occurs ,as a result 
of ROS-induced DNA damage. 
In this study, the lowest level of lipid peroxidation occurred after the administration of SF. 
When compared to the control sample, the 1.28-fold (p<0.001) decrease in TBARS levels 
(Figure 4.4) was accompanied by a 2.22-fold (p<0.001) increase in cellular GSH levels (Figure 
4.3) when HepG2 cells were incubated with SF for 24 h. 
The observed protective effects of SF may be ascribed to its free radical scavenging properties 
as reported by Fernandes et ai. (2004), who, on the basis of luminol and lucigenin enhanced 
chemiluminescence, showed that an SF hot water extract possessed 02- as well as H20 2 
scavenging activities, and Tai et al. (2004), who demonstrated the ·OH scavenging activity of 
SF by utilising a 70% ethanolic extract of the plant. 
Although the exact mechanism by which SF mediates this protective effect remains elusive, it 
may be due to the role of flavonoids, one of the various bioactive compounds isolated from SF 
(van Wyk, 2008). Flavonoids are low molecular weight, secondary plant phenolics 
characterised by the flavan nucleus. Most of the beneficial health effects of flavonoids can be 
ascribed to their antioxidant and chelating abilities. The protective effects of flavonoids in 
biological systems are due to their capacity to transfer electrons to free radicals, chelate metal 
catalysts, activate antioxidant enzymes, reduce a-tocopherol radicals and inhibit oxidases 
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(Heim et aI. , 2002). Thus, the inhibitory effects on lipid peroxidation by SF can be attributed to 
the presence of various bioactive components such as flavonoids present in the plant extract. 



















Figure 4.4 The effect of SF, L-can, AFBt, SF-AFBt and L-can-AFBt treatments on 
intracellular levels ofMDA in HepG2 cells. ***p<o.o~n, ###p<O.OOl. 
A study by Ojewole (2004) showed that SF was able to induce significant (p<0.001) 
hypoglycaemia in STZ-induced diabetic rats. In addition, Chadwick et al. (2007) demonstrated 
a significant (p<0.001) increase in glucose uptake by muscle and adipose tissue of male Wistar 
rats receiving the plant extract. In this regard, it has been reported that pinitol, a constituent of 
SF, is capable of inducing an insulin-like effect by affecting cellular glucose uptake (Bates et 
al.,2000). 
It is therefore suggested that pinitol present in SF mediates an increase in cellular glucose 
uptake, the consequence of which is increased glycolysis and subsequently increased PPP flux . 
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As a result, more NADPH would be available for the regeneration of GSH. This may be a 
further mechanism by which GSH levels are increased by SF. 
It has been reported that L-can is present in relatively high concentrations within SF (van Wyk 
and Albrecht, 2008). Thus, the observed increase in GSH levels after exposure of HepG2 cells 
to SF can also be due to the role that L-can has in influencing the PPP (discussed below). 
The highest level of lipid peroxidation was observed following the administration of L-can 
(2mM), which evoked a 3.61-fold (p<0.001) increase in TBARS levels when compared to the 
control (Figure 4.4). 
To date, no experimental evidence exists to show the exact source of ROS which initiates lipid 
peroxidation in cells exposed to L-can; however the capacity of L-can to induce ROS and 
subsequent lipid peroxidation was demonstrated in a study by Riganti et ai. (2003) who 
investigated the oxidative effects of L-can in a mouse glial cell line, NIL Using a luminol-
amplified chemiluminescence experiment, Riganti et al. (2003) showed that L-can (lmM) 
significantly (p<0.05) increased ROS production in NIl cells. In addition, the authors 
observed a significant (p<0.05) increase in lipid peroxidation. It was concluded that L-can was 
able to induce oxidative stress in exposed cells which in tum favoured an increase of lipid 
peroxidation. 
Nitric oxide synthases function to mediate the biosynthesis of NO and L-citrulline from the 
amino acid L-arg (Luzzi and MarIetta, 2005). One critical function of NO is to act as a 
scavenger of reactive radical species thus preventing cellular damage. It is able to exert this 
protective action through reaction with alkoxyl and peroxyl radicals, thus inhibiting lipid 
peroxidation. Moreover, it suppresses superoxide-hydrogen peroxide mediated cytotoxic 
effects by acting as a scavenger of ROS (Li and Wogan, 2005). It facilitates this effect by 
specifically scavenging the O2-radical, leading to the synthesis of nitrate (Riganti et aI., 2003). 
Luzzi and MarIetta (2005) demonstrated that L-can is a selective inhibitor of NOS. It was 
established that L-can functioned as an alternate substrate for the NOS reaction since it was 
converted to L-homoserine by the enzyme. The consequence is decreased NO synthesis. 
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Hence, the significant (p<0.001) increase in lipid peroxidation by L-can (Figure 4.4) is 
possibly due to its ability to influence the role that NO has in cellular oxidant-buffering. 
However, this may not be the only mechanism by which L-can can induce oxidative effects. 
Riganti et al. (2003) reported that the increases in ROS and lipid peroxidation by L-can were 
independent of NOS inhibition, suggesting that L-can is able to influence an alternate pathway 
leading to ROS generation. 
The substitution of an L-arg residue in a protein with L-can may considerably affect important 
interactions that function to institute the tertiary and quaternary structure of the protein 
(Rosenthal et ai., 1989). The resulting erroneous integration of L-can into proteins instead of 
L-arg leads to an induction of structural changes that ultimately alter protein function and at the 
same time accelerates the formation of aberrant proteins (Rosenthal and Dahlman, 1991b). 
Protein folding and post-translational modification are mediated by the ER (Hsieh et ai., 2007). 
The accumulation of aberrantly folded proteins within the cell and in the ER specifically, may 
result in a proposed overload of the ER (Remy et ai., 1998). A consequence of such effects is 
ER stress which is processed via certain signalling pathways one of which is the ER overload 
response (EOR). The EOR mediates calcium (Ca2+) efflux from the lumen of the ER as well as 
the release of reactive oxygen from the mitochondrion (Hsieh et ai., 2007). The released Ca2+ 
can then activate ROS producing enzymes such as cyclooxygenase and/or lipooxygenase 
(Remy et ai., 1998). This is another possible mechanism by which L-can induces ROS 
formation. 
It is known that in L-can the methylene group close to the guanidine moiety is replaced by an 
O2 atom which has an electron withdrawing centre thus making L-can less basic than L-arg. In 
addition, the chemical substitution of L-can adds further lone electron pairs to the L-arg 
molecule (Riganti et ai., 2003). Therefore it is also possible that one of these features might 
also account for the ability of L-can to trigger the generation of ROS. 
Together with a significant increase in TBARS levels induced by L-can (Figure 4.4), was a 
2.35-fold (p<0.001) increase in cellular GSH levels when evaluated against the control (Figure 
4.3). This effect may be due to the increased transcription of GCS by lipid peroxidation end 
products such as 4HNE (Dickinson and Forman, 2002). 
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The activity of the GCS holoenzyme can be negatively regulated by S-nitrosylation (Dickinson 
and Forman, 2(02), the biochemical process which involves reversible coupling of NO to 
various target proteins (Iyer et aI., 2008). Due to its structural similarity to L-arg, it is 
suggested that L-can contributed to relieving the negative regulation of GCS by S-nitrosylation 
because its inhibition of NOS decreases the bioavailability of NO for S-nitrosylation. A 
consequence of this is increased GCS activity accompanied by increased GSH synthesis. This 
process is postulated to be a further contributor to the observed increase in GSH levels after L-
can administration (Figure 4.3). 
Furthermore, Riganti et al. (2003) demonstrated a significant (p<0.05) increase in the flux of 
the PPP when NIl cells were exposed to ImM L-can for 3 h. As a result, the increased levels 
of GSH by L-can (Figure 4.3) may be due to increased NADPH production via the PPP. 
Previous studies (Shen et al., 1994; Madhusudhanan et al. 2004; Meki et al., 2004; Lee et al., 
2005; Jodynis-Liebert et al. , 2006; Preetha et al. , 2006) demonstrated that oxidative damage 
might playa role in the cytotoxic and genotoxic effects of AFB 1• 
Shen et al. (1996) investigated the formation of ROS in rat hepatocytes treated with AFB 1• In 
this study, a fluorescent probe, 2' ,7' -dichlorofluorescin diacetate (DCFH-DA) was used for the 
measurement of intracellular ROS formation in cultured rat hepatocytes. The principle of this 
assay is that DCFH-DA diffuses through the cell membrane and is enzymatically hydrolysed 
by intracellular esterases to the non-fluorescent dichlorofluorescein (DCFH). In the presence of 
ROS, DCFH is rapidly oxidised to the highly fluorescent dichlorofluorescein (DCF). When 
hepatocytes were treated with I~M AFB 1, a significant (p<0.05) increase in fluorescence 
intensity was observed as early as 0.5 h. After 4 h incubation, the fluorescence intensity was 
about three times higher than that in the control group. These findings clearly demonstrated 
that AFBI enhanced intracellular ROS formation in cultured rat hepatocytes. 
In another study, Shen et al. (1995) showed significant increases of MDA as early as 12 h in 
rat hepatocytes exposed to AFBI (1~M). Malondialdehyde concentration reached a peak at 48 
h and remained at a significantly high level up to 72 h. In this study the effects of SOD and 
CAT on AFB I-induced MDA generation was also investigated. It was observed that MDA 
concentration in these two groups were significantly (p<0.05) lower than in the AFBI group. 
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There was also a significant (p<O.05) protective effect afforded by desferral (DFO) on AFB 1-
induced MDA generation. Desferral readily chelates Fe3+ to form a redox-inert Fe (ill) 
complex, which removes Fe3+ from the redox cycle, and prevents ·OH formation via the Fenton 
reaction. The liver is particularly vulnerable to free radical-induced damage involving Fe, 
because it is stored in large amounts as ferritin and haemosiderin (Towner et at., 2(03). 
Overall, it was demonstrated that AFB) was capable of inducing lipid peroxidation in cultured 
rat hepatocytes and the protective effects of SOD, CAT and DFO against lipid peroxidation 
indicated that 02-, H202 and ·OH are intermediates in oxidative damage induced by AFB) 
exposure. 
The present data is in agreement with other studies (Shen et al., 1995; Shen et al. , 1996) and 
showed that AFB) increases oxidative stress. Incubation of HepG2 cells with 111M AFB) for 24 
h had a significant (p<O.001) influence on TBARS levels (Figure 4.4), clearly evidenced by the 
2.87-fold increase in lipid peroxidation when compared to the control. These findings indicate 
that the oxidation of lipids is mediated by free radicals induced subsequent to AFB) exposure. 
It is well known that AFB) requires metabolic activation by CYP450 to form the highly reactive 
metabolite AFB1-exo-8,9-epoxide in order to exert its cytotoxic and carcinogenic effects. On 
the other hand, it is also well documented that CYP 450 is an important source of intracellular 
ROS generation. Towner et at. (2002) utilised electron paramagnetic resonance (EPR) spin-
trapping to search for free radicals produced in vivo by AFB I . It was demonstrated that 
preadministration of SKF525A, a CYP 450 inhibitor, prior to AFB 1 exposure resulted in a 
substantial oecrease in the level of AFB)-induced radicals. These findings suggested that the 
free radicals induced by AFB 1 occurred as a result of CYP 450 acti vi ty. 
Another possible origin of AFB)-induced free radicals could be the dialdehyde formed from 
the AFB 1-8,9-dihydrodiol, which may be further metabolised to free radical intermediates 
(Towner et ai., 2002). 
Thus the possible reason for AFB)-induced lipid peroxidation (Figure 4.4) is that AFB) was 
able to mediate the generation of oxygen-centred radicals that in particular attack cellular 
membranes rich in PUF As initiating a chain reaction leading to peroxidation of the fatty acids. 
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In contrast to the significant (p<O.OO 1) increase in TBARS levels after exposure of HepG2 cells 
to AFBI (Figure 4.4), a marginal 1.56-fold increase in cellular GSH levels was noted (Figure 
4.3). When compared to the control, the observed increase in GSH levels by AFBI was found 
to be insignificant (p>0.05). This finding is in agreement with studies conducted by Gyamfi 
and Aniya (1998) who reported an insignificant increase in hepatic GSH levels in Fischer 344 
rats after 48 h following a single dose (1mglkg, Lp) of AFB I. Similarly, in rats fed an AFBJ 
contaminated diet (3mglkg feed) for 15 days, no significant changes in hepatic GSH level were 
found (Abdel-Wahhab and Aly, 2(03). Nevertheless, the observed increase in GSH levels due 
to AFB I exposure may be ascribed to the increased transcription of GCS by end-products of 
lipid peroxidation (Dickinson and Forman, 2002). 
Mitochondria are the powerhouses of cells (Pieczenik and Neustadt, 2007). They operate by 
electron transport, the machinery of which is prone to leakage of a small percentage of 
electrons which become trapped by 02, forming 02'. Manganese-SOD normally scavenges the 
02- produced by the ETC; however impairment of the electron transport machinery may cause 
more electrons to leak and form more O2'. It has been suggested that 02' is generated by the 
ETC (mainly complex I and ill but also from complex II) when electron flow is interrupted by 
biochemical inhibitors. Therefore it is possible that mitochondria are the major source of 
intracellular free radicals, and that impairment of the ETC could increase mitochondrial ROS 
generation (Indo et al., 2(07). 
Winston and Bosmann (1971) showed that L-can inhibited both rat liver and brain 
mitochondrial systems at a concentration of O.lmglml, whereas Wilkie (1970) demonstrated 
the inhibitory effects of L-can on mitochondrial function in Saccharomyces cerevisiae, These 
particular effects were detectable as inhibition of growth, greatly reduced respiratory activity 
and decreases in the synthesis of the amounts of the mitochondrial enzymes cytochromes a 
(complex IV) and b (complex III). 
Doherty and Campbell (1973) and Pai et al. (1975) reported the major site of inhibition of 
electron transport in rat liver by AFBI to be between cytochromes b and C1 (complex ill). Other 
studies (Obidoa and Obonna, 1981; Obidoa, 1986; Sajan et ai., 1995) demonstrated the 
inhibitory effect of AFB I on succinate dehydrogenase, cytochrome oxidase and ATPase 
activity, which could also contribute to an alteration in ETC function. 
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Therefore L-can and AFB \ can independently impair the ETC. The consequence is increased 
ROS production and subsequent damage to various cellular components. 
When considering the combined effects of the aforementioned compounds, TBARS results 
revealed that L-can co-administration along with AFB\ evoked a 2-fold (p<O.OOI) increase in 
lipid peroxidation compared to the control (Figure 4.4). However, the same combination 
induced a l.81-fold (p<O.OOI) and a l.44-fold (p<O.OOI) decrease in TBARS levels when 
compared to lipid peroxidation induced after the individual administration of L-can and AFB\ 
respectively. 
The type of chemical interaction which describes the effect seen following the L-can-AFB1 
combination is antagonism, defined in terms of toxicology as 'exposure to a combination (L-
can-AFBI) of chemicals, in which each chemical generally induces a defined toxic effect when 
given alone, but in combination produces a reduced toxic effect'. 
The precise mechanisms by which these compounds act in concert to influence TBARS levels 
are not fully understood. It is clearly evident from the results that when combined, these 
compounds exhibit significant differences in bioactivity, which is assumed based on the 
differences in the observed effects when they are administered together compared to when each 
is given alone. The effects induced by such combination are probably due to the ability of each 
compound to influence the bioactivity of the other when administered in combination. 
Within mammalian cells the arginases mediate the divalent cation-dependent hydrolysis of L-
arg to the nonprotein amino acid L-ornithine (Ash, 2004). L-canavanine, being an analogue of 
L-arg, is also an inhibitor of the arginases. It is cleaved hydrolytically by arginase to yield L-
canaline and urea (Rosenthal, 1981). 
Modified tetrapyrroles are the most abundant pigments found in nature, their most famous 
representative being haem. Many enzymes such as the large group of CYP450 enzymes rely on 
haem as a prosthetic group. The biosynthesis of haem requires the coordinated activity of up to 
10 different enzymes one of which is aminolevulinic acid (ALA) synthase, a pyridoxal 
phosphate-dependent enzyme which mediates the condensation of glycine and succinyl-CoA 
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with the elimination of C02 to form ALA during the first step of haem biosynthesis 
(Heinemann et aI., 2008). 
Rosenthal (1981) demonstrated the ability of L-canaline to bind with pyridoxal phosphate 
subsequently forming a Schiffs base linkage. It is therefore possible that L-canaline possesses 
the capacity to inhibit haem synthesis by binding to and sequestering pyridoxal phosphate thus 
rendering the molecule inactive and unavailable as a coenzyme for ALA synthase. As a result, 
this would be detrimental to haem synthesis and subsequently to CYP 450 (haem-containing 
enzymes). 
The antagonistic effect of L-can on AFBI-induced ROS and lipid peroxidation may therefore 
be due to the role that L-canaline possibly has in mediating an inhibition of haem synthesis and 
a subsequent alteration in CYP3A4 function. The consequence may well be reduced 
bioactivation of AFB I accompanied by decreased AFB I-induced ROS. 
Other results in this study demonstrated that L-can-AFB1 co-administration induced a 2.38-fold 
(p<O.001) increase in GSH levels compared to the control (Figure 4.3). In contrast, a marginal 
l.01-fold (p>O.05) increase was noted when cellular GSH levels induced by L-can-AFBI were 
compared to that mediated by L-can. 
More importantly, in addition to L-can significantly reducing the levels of TBARS when 
combined with AFBI (Figure 4.4), it also significantly (p<O.01) increased GSH content (Figure 
4.3) which may further explain its ameliorative effect on AFB1-induced ROS and lipid 
peroxidation. 
The increase in GSH levels by L-can-AFB I may be due to the effects of each compound. 
Aflatoxin B1-induced ROS and lipid peroxidation may have influenced GCS transcription. L-
canavanine may have contributed to the increase in GSH levels in a similar way or by its effect 
on the PPP, and its ability to influence S-nitrosylation and subsequent activity of GCS. 
The results indicate an inhibition of AFBl-induced ROS by L-can, and the high levels of GSH 
observed after L-can-AFBI co-administration (Figure 4.3) suggests that AFB1-induced ROS 
may have been conjugated to GSH, thus accounting for the reduced levels of TBARS (Figure 
4.4). 
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Contrary to the L-can-AFBJ combination, which induced a lower level of lipid peroxidation 
than each compound given alone, SF-AFBJ induced a higher level of lipid peroxidation than 
each compound given alone (Figure 4.4). According to the results, SF co-administration along 
with AFBJ evoked a 3.20-fold (p<O.OOI) increase in the oxidative damage to lipids compared 
to the control (Figure 4.4). In addition, a 4.12-fold (p<O.OOI) and a 1.12-fold (p<O.OOI) 
increase in TBARS levels by SF-AFBJ was noted when compared to lipid peroxidation 
induced by the individual administration of SF and AFBJ respectively (Figure 4.4). 
The type of chemical interaction which describes the effect of the SF-AFBJ combination is 
potentiation, defined in terms of toxicology as 'exposure to a combination (SF-AFBJ) of 
chemicals, in which one chemical generally induces no toxic effect when given alone (SF), but 
in combination with the other chemical (AFB J), which generally induces a defined toxic effect 
when given alone, produces a toxic effect greater than that which is induced by the toxic 
chemical itself'. Thus SF potentiates the lipid peroxidation induced by AFB J. 
This effect may be attributed to the oxidative properties and effects of each compound. 
Aflatoxin BJ-induced oxidative stress may have influenced TBARS levels and similarly L-can, 
which is known to exist in relatively high concentrations within SF. 
Accompanied with the significant increase in TBARS levels following the co-administration of 
SF with AFBJ (Figure 4.4) was a 2. 13-fold (p<O.OOI) increase in cellular GSH content when 
evaluated against the control (Figure 4.3). In addition, SF-AFBJ induced a 1.04-fold (p>O.05) 
decrease and a 1.37 -fold (p>O.05) increase in GSH content when compared to GSH levels 
induced by the individual administration of SF and AFBJ respectively. 
The increase in GSH levels by this combination may be due to the effects of either compound. 
Aflatoxin BJ and the L-can in SF may have influenced GCS transcription. In addition, the 
ability of L-can to influence S-nitrosylation and GCS activity as well as its effects on the PPP 
may have contributed to increase GSH. The observed elevation in cellular GSH content may 
also be due to the presence and activity of flavonoids, which might have substituted and 
consequently spared GSH due to their potent antioxidant capacity, and pinitol in SF. 
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The means by which SF-AFBI acts in concert to influence cellular redox state are not fully 
understood. As previously mentioned, when in combination, compounds may exhibit 
differences in bioactivity, which may be due to the capacity of each compound to influence the 
bioactivity of the other. 
4.8 Conclusion 
In conclusion, the results provide in vitro evidence that a single dose of AFB I led to a 
significant increase in lipid peroxidation at the end of the experimental period. As reported in 
the literature, such an effect is possible due to the capacity of AFBI to induce various ROS. 
In addition, the data presented strongly suggests that SF and L-can are able to exert their 
effects via an alteration of the intracellular redox metabolism since their supplementation 
enhanced the antioxidant status of HepG2 cells. The increase of intracellular GSa content to 
above normal levels by SF and L-can indicates that they playa vital role in mitigating AFB 1-
induced oxidative stress. The stronger effect of L-can compared to SF as depicted by the GSH 
and TBARS results is probably due to it being applied in a higher concentration than that 
which is present in the plant extract, thus indicating a concentration dependent effect. 
Overall, the GSH and TBARS assays both served as efficient techniques in assessing the 
intracellular redox state following the exposure of HepG2 cells to the various compounds under 





Genomic DNA is under constant attack from both endogenous and exogenous sources of DNA 
damaging agents (Gasser and Raulet, 2(06). Chemicals that interact with DNA can cause direct 
damage by covalent modifications, such as adducts or strand breaks, or can perturb DNA and 
chromatin function by non-covalent binding. Both types of interactions lead to genetic changes 
such as stalled replication, cell cycle delays, mutations and even cytotoxicity (Li et ai. , 2(07). 
DNA damage is thus directly deleterious to cells and accumulated damage may cause genomic 
instability, which in organisms with renewable tissues may result in cancer (Gasser and Raulet, 
2(06). Nucleic acid stains can be useful tools for investigating the integrity of DNA by 
fluorescence microscopy. 
5.2 Fluorescence Microscopy 
A fluorescent compound absorbs light energy over a range of wavelengths that is characteristic 
for that compound. This absorption of light influences an electron in the compound to be raised 
to a higher energy level. The excited electron rapidly decays to its ground state, emitting the 
excess energy as a photon of light. This transition of energy is called fluorescence (BD 
Biosciences, 2000). 
Absorption spectrum is the term given to the range over which a fluorescent compound can be 
excited. As more energy is consumed during absorption than is emitted in fluorescence, 
emitted wavelengths will be longer than those absorbed. The range of emitted wavelengths for 
a particular compound is termed its emission spectrum (BD Biosciences, 2000). The difference 
between the exciting and emitting wavelengths, known as the Stokes shift, is the critical 
property that makes fluorescence so powerful (Lichtman and Conchello, 2005). 
Due to its intrinsic selectivity, fluorescence imaging has become the mainstay of microscopy in 
the service of biology. Many of the technical improvements in microscopes over the years have 
centred on increasing the contrast between what is interesting (signal) and what is not 
(background). Fluorescence microscopy is the prototypical example, as its primary aim is to 
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reveal only the objects of interest in an otherwise black background (Lichtman and Conchello, 
2(05). 
Although many organic substances have intrinsic fluorescence (autofluorescence), and a few 
are useful for labelling of components in biological systems, the typical approach to 
fluorescence microscopy is to take advantage of synthesised compounds. Over the past several 
decades, organic chemists have devised a variety of fluorescent probes that provide a means of 
labelling virtually any imaginable aspect of a biological system. Molecules that are used by 
virtue of their fluorescent properties are called fluorophores (Lichtman and Conchello, 2(05). 
Examples of fluorophores are ethidium bromide (EtBr) and Hoechst 33342. 
The light source in fluorescence microscopy is usually a xenon or high pressure mercury 
vapour lamp, which emits from the UV into the red wavelengths (Figure 5.1). A specific 
wavelength of light is used to excite the fluorophore present in the specimen. Such interactions 
initiate the release of longer wavelengths of light which can subsequently be imaged (White 
and Errington, 2(05). This imaging is accomplished in the fluorescent microscope by utilising 
a combination of filters that are specific for the excitation and emission characteristics of the 
fluorophore concerned. There are usually three main filters: an excitation filter, a dichroic 




Typical filter setup of a fluorescence microscope (Innes, 2008). 
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For example, the commonly used fluorophore EtBr is optimally excited at a wavelength of 
510nm and emits maximally at 595nm. A set of glass filters for viewing EtBr requires that all 
wavelengths of light from the lamp be blocked except the 510nm light. The excitation filter 
allows a maximum amount of 510nm light to pass through it, which is then directed to the 
specimen via the dichroic mirror (Figure 5.1). Any EtBr in the specimen is subsequently 
excited by the 510nm light and the resulting light that returns from the specimen passes back 
through the dichroic mirror and, the emission filter, which only allows light of 595nm to pass 
through to the detector, ensures that only the signal emitted from the fluorophore of interest 
reaches the detector. A sensitive digital camera is able to detect such signals efficiently 
(Wilson and Walker, 2005). 
S.2.1 Fluorescent nucleic acid stains utilised for the analysis of genomic integrity 
An example of a commonly utilised nucleic acid stain is the bisbenzimidazole, Hoechst 33342 
(Figure 5.2). It is a cell membrane permeable supravital DNA stain that fluoresces bright blue 
upon stoichiometrically binding to the AT-rich regions of the minor groove of DNA (Freshney, 
1992). Binding of Hoechst to DNA is ~tabilised by hydrogen bonding, van der Waals 
interactions and electrostatic interactions between the dye and DNA (Gamer, 2008). Its 
fluorescence intensity is an index of DNA content, chromatin structure and conformation, and 
may be utilised to discriminate between cells in different phases of the cell cycle (Hawle~ and 
Hawley, 2004). Hoechst 33342 excitation is in the UV range of 350-363nm, while emission is 
recovered above 460nm (Freshney, 1992). 
Figure S.2 Chemical structure of Hoechst 33342 (Garner, 2008). 
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In addition, the most widely utilised DNA stain is the highly fluorescent dye, EtBr (Figure5.3). 
It is a cyclic planar molecule about the size of one base pair, and is able to efficiently 
intercalate the stacked base pairs of DNA (Wilson and Walker, 2005). The partial positive 
charge on its exocyclic amines is important for mediating electrostatic attraction and hydrogen 
bonding interactions with DNA phosphate groups (Nafisi et ai., 2007). 
Figure 5.3 Chemical structure of ethidium bromide (Naflsi et al., 2007). 
It accumulates at the site of DNA and upon exposure to UV light it fluoresces orange-red. 
Ethidium bromide excitation occurs at 51Onm, while emission is recovered at 595nm (Wilson 
and Walker, 2005). It is commonly utilised to stain DNA molecules resolved by agarose gel 
electrophoresis, however it may be employed for use in alternate DNA analysis assays, one of 
which is the comet assay. 
5.3 The comet assay 
5.3.1 Principle and applications 
The comet assay, also called the single cell gel electrophoresis (SCGE) and microgel 
electrophoresis (MGE) assay was first introduced by Ostling and Johanson (1984) as a 
microelectrophoretic technique for the direct visualisation of DNA damage in individual cells 
(Fairbairn et al., 1995). Since then, the assay has been modified several times in order to 
improve its sensitivity for detecting DNA damage in isolated cells with the most widely 
utilised version being one described by Singh et ai. (1988). In this version of the assay, a single 
cell suspension of the cell culture under investigation is embedded in low-melting-point-
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agarose (LMPA) in a gel sandwich on a microscope slide, lysed by detergents at high salt 
concentrations and then electrophoresed for a short time under alkaline conditions. Under the 
influence of an electrical current, cells exhibiting DNA damage display increased migration of 
the DNA from the nucleus toward the anode, giving the appearance of a 'comet tail' (Rojas et 
aI., 1999). With increasing numbers of breaks, DNA 'strands' migrate freely into the tail of the 
comet, and at the extreme, the head and tail are well separated. Comet tail length increases with 
DNA damage and the distance of DNA migration from the body of the nuclear core is used to 
evaluate the extent of DNA damage (Fairbairn et aI. , 1995). 
The DNA damage detected by the assay can arise through various mechanisms, including 
DNA single- and double-strand breaks, DNA interstrand cross-linking, alkali labile sites and 
incompletely repaired excision sites (Rojas et al., 1999). Virtually any eukaryotic cell can be 
processed for analysis of DNA damage using this assay (Fairbairn et aI., 1995). 
A useful application of the comet assay is in the area of genetic toxicology and a number of 
investigators have used the assay to evaluate in vitro and/or in vivo genotoxicity of several 
chemicals (Rojas et aI., 1999). 
The aim of this chapter was to utilise the comet assay and Hoechst 33342 staining to determine 
the influence of SF, L-can and AFB 1, when administered individually and in combination, on 
genome integrity. 
5.4 Materials and Methods 
5.4.1 Materials 
Low-melting-point-agarose and NaCI were purchased from Saarchem (SA), whereas slides and 
coverslips were acquired from Shalom (SA). Triton X-IOO, NaOH, EDTA, Tris, Na2EDTA and 
paraformaldheyde (PFA) were all obtained from Merck (SA). Hoechst 33342 (IOmglml) was 
purchased from Invitrogen. All other reagents and consumables utilised were obtained from the 
sources mentioned previously. 
5.4.2 Methodology 
5.4.2.1 Treatment, isolation and harvesting of HepG2 cells for the comet assay 
HepG2 cells were treated and harvested as described in chapter 4, section 4.6.2.1. 
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5.4.2.2 The comet assay on cultured HepGz cells 
The procedure described for SCGE by Singh et al. (1988) was utilised with minor 
modifications. Initially, 1 % LMPA (0.5g dissolved in 50ml PBS) was prepared by heating the 
mixture in a microwave until a clear solution was obtained. When the agarose had cooled to 
approximately 37°C, an initial layer (4001l1) was pipetted toward the frosted end of a 
microscope slide (Lasec, 76 x 26mm) and covered with a coverslip (60 x 20mm). Slides were 
thereafter kept at 4°C for 10 minutes to allow for the agarose to solidify. 1 % LMPA was used 
as the first layer in order to promote a solid foundation of support for the subsequent layers. 
For the second and third layers, 0.5% LMPA (0.5g dissolved in 100ml PBS) was utilised. 
Briefly, after the removal of the coverslips from the first layer, a cell suspension (251l1 
containing approximately 20 000 cells) from the relevant treatment was mixed with 175111 of 
0.5% LMPA (37°C) and pipetted onto the microscope slides already comprising the initial 
solidified layer. Slides were then covered with coverslips and maintained at 4°C for 10 
minutes. The coverslips were thereafter removed and a third layer (2001l1) of 0.5% LMPA 
(37°C) was pipetted onto the previous two solidified layers. Coverslips were then placed on 
each of the slides and the final layer of LMPA was allowed to solidify at 4°C for 10 minutes. 
Coverslips were subsequently removed and all slides were immersed in freshly prepared cold 
lysing solution [500ml; 2.5M NaCl, 100mM EDTA, 1% Triton X-lOO, lOmM Tris (PH 10) and 
10% DMSO] for 1 h at 4°C and protected from light. 
After the 1 h incubation in lysing solution, all slides were removed, the excess lysing solution 
was drained off and the slides were placed side-by-side into the electrophoresis tank with the 
frosted ends closest to the cathode. The tank was thereafter filled with freshly prepared 
electrophoresis buffer (300mM NaOH, ImM Na2EDTA; pH 13) to a level approximately 
20mm above the slides. Prior to electrophoresis, the slides were equilibrated for 20 minutes in 
the alkaline electrophoretic solution, which contains low salt and no detergents. This period of 
incubation was to facilitate the unwinding of DNA. Following the 20 minute incubation, the 
tank was sealed and a current of 300mA (25V) was applied for 35 minutes (room temperature) 
using a Bio-Rad compact power supplier. After electrophoresis, all slides were removed, 
drained, placed on a tray and carefully washed with three changes of 5 minutes each of 
neutralisation buffer (O.4M Tris; pH 7.4) in order to remove detergents and alkali. Slides were 
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thereafter stained with SOil I EtBr (20llglrnl), covered with a coverslip and stored overnight at 
4°C to facilitate efficient intercalation of the dye between the base pairs of DNA. 
5.4.2.3 Treatment of HepG2 cells for Hoechst staining 
HepG2 cells were grown to approximately 80% confluency in a 2Scm
3 culture flask. Cells were 
rinsed with three changes of pre-warmed (37°C) PBS and thereafter harvested by trypsinisation 
and counted. A CCM-cell suspension (2rnl containing approximately 200 000 cells) was added 
onto a coverslip present in each well of a 6 well microtiter plate (l well was utilised for each 
treatment). The plate was then sealed with parafilm, swabbed with 70% ethanol and incubated 
(37°C) overnight to facilitate the efficient attachment of the cells onto the coverslips. After the 
overnight incubation, the spent culture medium from each well was removed and cells were 
rinsed with three changes of pre-warmed (37°C) PBS. An aliquot of 3ml of the appropriate 
sample (Table 5.1) was subsequently added into the relevant wells. The plate was then sealed 
with parafilm, sterilised using 70% ethanol and incubated (37°C) for 24 h. 
Table 5.1: Preparation of samples 
Sample Volume of sample (fll) 
Final volume Final dilution! 
with CCM (ml) concentration of sample 
Control - 12 -
SF 4000 12 1:6 
L-can 6000 (4mM) 12 2mM 
AFBI 37 (321IlM) 12 1J1M 
SF+AFBI 2000 + 37 (321IlM) 12 1:6 + 1J1M 
L-can+ AFBI 6000 (4rriM) + 37 (321IlM) 12 2mM+1J1M 
5.4.2.4 Preparation of 10% paraformaldehyde and Hoechst 33342 stock solutions 
A 10% PFA solution was prepared by initially dissolving 2g of PFA in 18rnl of PBS. This 
mixture was then vortexed and heated (60°C) in a water bath until a clear solution was 
obtained. The pH of this solution was adjusted to 7.4 and made up to 20rnls with PBS. 
An aliquot of Sill of a Hoechst 33342 stock solution (lOmglrnl) was topped to lOrnl with PBS 
in order to obtain a Hoechst 33342 working solution with a concentration of Sllglrnl. 
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5.4.2.5 Hoechst 33342 staining 
Cells were washed with three changes of pre-warmed PBS (37°C) subsequent to the overnight 
incubation and then fixed to the coverslips by adding 2ml of a 10% PF A solution into each 
well. After 5 minutes, the used fixative was decanted and each coverslip subsequently washed 
with PBS. A l00IlL aliquot of the Hoechst 33342 working solution was then pipetted onto each 
coverslip and the plate was covered and incubated at 37°C. After a 15 minute incubation 
period, PBS was utilised to wash the stained cells and remove any residual Hoechst working 
solution. A 2ml aliquot of PBS was then added to each well and the plate was sealed. 
5.4.2.6 Instrumentation and analysis of samples 
All images were analysed using an Olympus IXSI inverted microscope equipped with 510-
560nrn excitation and 590nrn emission filters (SCGE), and 350nrn excitation and 450nrn 
emission filters (Hoechst). The microscope was connected to a personal computer-based 
analysis system (Analysis LS Research Software) and a charge-coupled device (CCD) digital 
camera (CC-12) which was utilised to capture images. 
With regards to SCGE, the degree of DNA damage for each cell was quantified as cornet tail 
length (Ilm), the distance from the end of the head to the end of the tail. A total of 60 individual 
cells were randomly selected and screened (200x magnification) per treatment (30 cells from 
each of two replicate slides). 
5.4.2.7 Data analysis and statistics 
Data acquired from the cornet assay are represented as the mean cornet tail length (Ilm) plus or 
minus the standard deviations. Samples were compared for differences using one-way 
ANOV A and the Kruskal-Wallis test (GraphPad InStat Software, version 3.06). A probability 
value (P) of less than 0.05 (p<0.05) was considered as statistically significant (* indicates 
significant (p<0.05) differences between treated and control groups; # indicates significant 
(p<0.05) differences between treated groups). 
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5.5 Results and Discussion 
HepG2 cells have retained many of the functions of normal liver cells and express different 
inducible xenobiotic metabolising enzymes. These cells have been extensively used in 
metabolism studies and are recommended for the detection/screening of mutagens (Belloir et 
ai., 2(06). 
Xenobiotics can induce chromosomal damage by direct and indirect action. By the ftrst 
mechanism, covalent adducts are formed between the xenobiotic and/or possible metabolites 
thereof, and DNA; by the second mechanism, the xenobiotic and/or its metabolites may induce 
the formation of reactive secondary agents upon interaction with non-DNA targets. The 
secondary agents which can then facilitate DNA damage are mostly ROS, lipid-
hydroxperoxides and their degradation products (Amstad et aI., 1984). Besides oxidative 
damage directly inflicted on DNA by free radicals, there are other indirect mechanisms by 
which radicals can cause DNA damage. Lipid peroxides enter the nucleus where they react 
with Fe2+ to generate the alkoxyl radical which attacks DNA. Also, intracellular Ca2+ levels 
increase as a result of oxidative damage to cell membranes and Ca2+ then enters the nucleus 
where it can activate nucleases which cause DNA strand breaks (Meki et ai., 2(04). 
DNA damage results in the formation of DNA chain breaks that activate chromatin-bound 
protein kinases which function to phosphorylate p53 (Hickman et ai., 2(02) leading to its 
activation and accumulation (Komarova and Gudkov, 1998). Tumour suppressor protein p53 
may stimulate apoptosis when cells are confronted with severe, irreparable damage (Shmueli 
and Oren, 2(07). A characteristic alteration in nuclear morphology occurring as a consequence 
of apoptosis is chromatin condensation (Wang et aI., 2008). 
To evaluate the effects of SF, L-can and AFBI on genomic integrity, the comet assay and 
Hoechst 33342 staining were employed. These assays are rapid and sensitive techniques which 
can be utilised to analyse DNA integrity at the individual cell level. 
Based on results of the comet assay, the nuclear material of cells exposed to the control can be 
clearly visualised as a large, compact, intact core of DNA with very little visible DNA 
migration or damage (Figure 5.4a). The average comet tail length for the nuclei of these cells 
was statistically determined to be 8.6 ± 1.9!!m (Figure 5.5). This result was consistent with that 
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shown by Hoechst 33342 staining which revealed the nuclei of the control cells to appear small 
and dull with no observable chromatin condensation (Figure 5.6a). 
In contrast, the strongest effect was seen with AFBl (Figure 5.4d), where incubation of HepG2 
cells with 1JlM AFBI for 24 h induced a significant (p<0.001) influence on comet tail length 
(156.8 ± 18.7Jlm) (Figure 5.5), evidenced by the 18-fold increase in DNA migration when 
compared to the control (8.6 ± 1.9Jlm). 
Figure 5.4 Ethidium bromide staining of Hep~ cells (400x magnification). 
The data obtained is in agreement with other studies (Amstad et al., 1984; EI-Khatib et al., 
1998; O'Brien et aI., 2000; Raj et al., 2001; Ehrlicha et al., 2(02) which have established that 
AFBl damages DNA. A study by Uh1 et al. (2000) demonstrated the ability of AFBI to induce 
a dose-dependent (0, 0.008, 0.01, 0.03, 0.1, 0.3 and 1.0JlM) increase in DNA migration of 
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HepG2 cells after 24 h. The lowest concentration of AFBI that caused a significant positive 
result was 0.OO8!J.M. Additionally, Majer et al. (2004) investigated the induction of 
micronuclei in HepG2 cells exposed to AFBI (0.0,0.1 , 0.5, 1.0!J.M) for 24 h. It was shown that 
AFBI induced micronuclei in a dose-dependant manner with the strongest response that caused 
a significant effect being observed at concentrations greater than or equal to 0.5!J.M. 
It has been suggested by Amstad et ai. (1984) and Shen et ai. (1994) that oxidative stress 
mediated by AFB 1 may be one of the underlining mechanisms for AFB l-indu~ed DNA 
damage. Results from the TBARS assay (Chapter 4) showed that AFBI induced a significant 
(p<O.OOl) increase in lipid peroxidation. This finding facilitates the presumption that one of the 
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Figure 5.5 Induction of DNA migration by SF, L-can, AFBh SF -AFBI and L-can-
AFBI in HepG2 cells. ***p<O.OOl , ###p<O.OOl. 
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An early important defence mechanism that can be activated in response to DNA damage 
comprises transient inhibition of cell cycle progression by inducing antiproliferating genes. 
During growth arrest, DNA is coiled and protected by histone proteins. Transient growth arrest 
allows the cell to repair and/or to replace damaged DNA and to mount an adaptive response 
against further DNA damage (Weber et al., 2007). 
Histones are small basic proteins within which lysine and arginine residues are abundant. 
Within the nuclei of all eukaryotic cells, genomic DNA is highly folded, constrained, and 
compacted by both histone and non-histone proteins in a dynamic polymer called chromatin 
(Jenuwein and Allis, 2001). Chromatin structure plays an important role in most processes 
pertaining to DNA metabolism (Escargueil et al., 2(08) and a well-known function of 
chromatin is its involvement in DNA packaging. Another function related to chromatin 
structure includes its ability to regulate processes such as DNA repair by controlling the 
accessibility of the different macromolecular machineries to their cognate substrates 
(Escargueil et al., 2(08). 
Aflatoxin Bl has been reported to bind many nuclear proteins one of which is histones (Yu et 
al., 1988; Chih et al., 1993). Besides AFBI itself or the generated exo-isomer interacting with 
proteins and histones specifically, the dialdehyde generated from the AFB l-8,9-dihydrodiol is 
capable of condensing with primary amino acid groups, such as lysine forming a Schiff's base 
(Guengerich et al., 1998) and possibly contributing to alterations in histone structure and 
function. Thus, an additional mechanism by which AFBI influences DNA integrity is by its 
capacity to mediate alterations in histone structure, accompanied by subsequent perturbation of 
chromatin function. 
The significant DNA damage induced by AFBI (Figure SAd) is accompanied by nuclei that 
exhibit stronger fluorescence (Figure S.6d) compared to the control (Figure S.6a) as illustrated 
by Hoechst staining. In addition, the nuclei of the AFBI treated cells display a slight reduction 
in size and exhibit a circular shape when compared to the nuclei of the control cells. 
Subsequent to Hoechst staining, apoptotic cells exhibit brighter fluorescence, a consequence of 
chromatin condensation (Lee and Shukla, 200S) , which has previously been reported by 
Yoneyama et al. (1987) to occur in MDBK cells and primary foetal bovine kidney cells 
following exposure to AFBI for 24 h. In addition, studies conducted by O'Brien et al. (2000) 
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demonstrated extensive cell shrinkage and chromatin condensation when HepG2 cells were 
incubated with AFBt. The difference in Hoechst 33342 fluorescence intensity between normal 
and apoptotic cells may also be attributed to a more rapid membrane uptake of the dye by cells 
undergoing apoptosis (Omar and Hu, 2(03). 
Figure 5.6 Hoechst 33342 staining of Hep~ cells (400x magnification). 
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Thus, the stronger fluorescence that these cells exhibit, due to chromatin condensation, is an 
indication of apoptosis, a consequence of which is presumed to occur following the deleterious 
effects of the toxin. 
Other results demonstrated lower levels of activity after the individual administration of SF 
(Figure 5.4b) and L-can (Figure 5.4c), for which the average comet tail for the nuclei of these 
cells were 66.3 ± 2.7J.lm and 73.5 ± 2.7J.lm respectively (Figure 5.5). However, both samples 
did mediate a significant (p<O.OOI) increase in DNA migration when compared to the control 
(8.6 ± 1.9J.lm). These samples induced a similar intensity of DNA damage. 
Results from the TBARS assay (Chapter 4) revealed SF to induce significantly (p<O.OOI) 
lower levels of lipid peroxidation. As a result, it is unlikely for SF-induced DNA damage to be 
a consequence of oxidative stress. It is therefore presumed that SF mediates DNA damage via 
an indirect mechanism which possibly involves the inhibition of DNA repair processes. 
In contrast, it is suggested that one of the mechanisms by which L-can is able to mediate DNA 
damage is via its capacity to induce ROS and subsequent oxidative stress. This postulation is 
based on the high level (p<O.OOI) of lipid peroxidation induced by L-can as evidenced by data 
obtained from the TBARS assay (Chapter 4). 
Studies conducted by Schachtele et al. (1968) and Hare (1969) demonstrate a possible 
mechanism by which L-can is able to influence DNA integrity. After exposing Escherichia coli 
to L-can, Schachtele et al (1968) carried out electron microscopy studies which showed a 
profound change in nuclear organisation, characterised by extensive physical disruption of the 
nuclear region. The authors suggested that the lethal action of L-can was related to its 
integration into membrane bound proteins which resulted in the disruption of the E. coli 
genome. A similar study conducted by Hare (1969) illustrated the capacity of L-can to induce 
alterations in the nuclear architecture of mammalian cells. The observed alterations were 
characterised by the formation of irregular aggregates of nucleoplasmic contents frequently 
attached to the nuclear membrane. The author postulated that L-can was able to induce such an 
effect as a result of the formation of canavanyl protein-DNA aggregates. 
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Arginases facilitate the hydrolysis of L-arg to L-ornithine, which is the biosynthetic precursor 
of the polyamines (Ash, 2004). The polyamines (putrescine, spermidine and spermine) are 
organic cations of low molecular weight. As a consequence of their polybasic character, they 
adhere strongly to nucleic acids, stabilising DNA by neutralising the negative charges of the 
phosphate groups and decreasing the repulsion between the strands of DNA (Yerlikaya, 2(04). 
Spermidine and spermine influence DNA to condense, aggregate and bend or contort the 
normal a-helical structure (Criss, 2(03). Studies have also shown that spermidine and spermine 
are able to stabilise chromatin and that polyamine-depleted cells undergo changes in chromatin 
and DNA structure (Berger et ai., 2(07). In addition, many histone acetylases and deacetylases, 
which either add or remove acetyl groups from the lysine residues of all histones and 
subsequently influence histone function, are regulated by gene promoters and inhibitors, 
which, in tum, are controlled by polyamines (Criss, 2(03). The polyamines therefore perform 
crucial functions related to the integrity of the genome and any perturbation of polyamine 
homoeostasis may lead to alterations in polyamine pool sizes and as a result, may have critical 
consequences on DNA structure and integrity. Because it is an analogue of L-arg, L-can may 
therefore alter DNA integrity as a result of its inhibitory effect on the arginases and subsequent 
L-ornithine and polyamine synthesis. 
When compared to control cells (Figure 5.6a), characterisation of cellular morphology after 
incubation with L-can (Figure 5.6c) revealed cytoplasmic shrinkage and chromatin 
condensation, both of which are morphological hallmarks of apoptosis (Stander et al., 2(07). 
This finding demonstrates the apoptotic inducing properties of L-can and is in agreement with 
Cervera et al. (1983) who used pulse and chase autoradiography and showed that the nuclei of 
HeLa S3 cells became round and compact with an accumulation of perichromatin granules and 
fibrils after exposure to L-can. 
In addition, HepG2 cells stained with Hoechst 33342 after exposure to SF displayed nuclei that 
were brightly fluoresced (figure 5.6b) compared to the control (figure 5.6a). As observed in the 
other treatments, these cells also exhibit chromatin condensation. Apoptosis is apparent based 
on the observed chromatin condensation as well as findings by Chinkwo (2005) who 
demonstrated chromatin condensation in CHO cells by SF. 
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Comet assay analysis subsequent to co-administration of L-can with AFBI (82.1 ± 3.4llm) 
revealed significant (p<O.OOl) increases in DNA migration compared to the control (8.6 ± 
1.91lm) and L-can (73.5 ± 2.7Ilm) (Figure 5.5). However, when compared to the nuclei of 
AFB1-treated cells (156.8 ± l8.7Ilm), treatment with the same combination evoked a 
significant (p<O.OOl) decrease in DNA migration and comet tail length (Figure 5.4t). 
The ability of L-canaline to mediate alterations in CYP3A4 function was previously described 
(Chapter 4). The antagonistic effect of L-can on AFBI-induced DNA damage may be due to 
the role that L-canaline possibly has in mediating an inhibition of haem synthesis with a 
subsequent alteration in CYP3A4 function. The consequence is presumably reduced 
bioactivation of AFBI accompanied by decreased AFBI-induced ROS and DNA damage. 
In addition to the abovementioned, a further protective mechanism by which L-can possibly 
antagonises AFBI-induced DNA damage may result from enhanced conjugation of AFB 1-
induced ROS as well as the AFBI-epoxide with GSH. This is presumed based on results of the 
GSH assay (Chapter 4) which revealed the capacity of L-can to enhance the antioxidant status 
by mediating a significant (p<O.Ol) increase in intracellular GSH content and therefore playing 
a vital role in mitigating AFBI-induced oxidative stress and subsequent DNA damage. 
Riganti et ai. (2003) demonstrated a significant (p<O.05) increase in the flux of the PPP when 
Nll mouse glial cells were incubated with L-can. In addition to increased NADPH synthesis 
for the regeneration of GSH, the upregulation of the PPP can have other consequences of 
interest including an increase in other intermediate metabolites, such as ribose-5-phosphate, 
which could contribute to DNA synthesis and repair (Bensaad and Vousden, 2(07). It has been 
demonstrated that L-can is an inhibitor of NOS, the consequence of which is decreased NO 
synthesis (Luzzi and MarIetta, 2(05). Nuclear enzymes associated with the repair of alkylated 
DNA are inhibited by NO. In the presence of NO the zinc finger motifs of DNA repair 
enzymes lose their integrity, resulting in inhibition of DNA repair (Kim et ai., 200l). It is 
therefore suggested that the antagonistic effect of L-can on AFBI-induced DNA damage may 
also be attributed to its capacity to indirectly promote DNA repair due to its ability to influence 
the PPP and as a consequence of NOS inhibition. 
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Incubation with L-can-AFB\ (figure 5.6f) mediated cytoplasmic shrinkage with nuclei that 
were abnormally larger and rounder in shape when compared to the control cells (figure 5.6a). 
Once again, the intense chromatin condensation is an indication of apoptosis. 
Regarding SF co-administration along with AFB\, the results illustrated significant (p<O.OOl) 
increases (88.2 ± 8.2Jlm) in DNA migration compared to the control (8.6 ± 1.9Jlm) and SF 
(66.3 ± 2.7Jlm) (Figure 5.5). However, when compared to the nuclei of AFBJ-treated cells 
(156.8 ± 18.7Jlm), the same combination evoked a significant (p<O.OOl) antagonistic effect on 
DNA migration and comet tail length (Figure 5.4e). 
In order to exert its cytotoxic and carcinogenic effects, AFB J requires metabolic activation by 
CYP3A4. Utilising microsome-based in vitro fluorometry, Mills et al. (2005 b) reported 
significant decreases in CYP3A4 activity by both a water extract (68.5% inhibition) as well as 
an ethanolic extract (95.7% inhibition) of SF. Thus, the protection afforded by SF against 
AFBJ-induced DNA damage may be due to its inhibitory effect on CYP3A4 activity and 
subsequent AFBJ bioactivation. 
The decrease in DNA damage after SF-AFBJ exposure is also possibly due to the role of 
flavonoids present in SF. It is suggested that flavonoids present in SF may provide strong 
nucleophilic centres enabling them to react with electrophilic agents, thereby inactivating or 
scavenging them, but ultimately intercepting mutagens and consequently reducing DNA 
damage. 
Protection by SF against AFBJ-induced DNA damage may alternatively result from enhanced 
conjugation of AFB1-induced ROS as well as AFB1-epoxides with GSH for AFBJ 
detoxification. This is based on results of the GSH assay (Chapter 4) which demonstrated that 
SF enhanced the antioxidant status, by increasing intracellular GSH content, when 
administered in combination with AFB J. 
The protective effect that SF affords against AFBJ-induced genotoxicity may also be due to L-
can, present within the plant extract, to promote DNA repair due to its ability to influence the 
PPP and inhibit NOS. 
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Although Hoechst 33342 is a nucleic acid specific stain, the intense fluorescence imparted by 
this dye when it intercalates DNA also allows for visualisation of other cellular components 
such as the cell membrane. Based on this and when compared to the control sample (Figure 
5.6a), not only do the nuclei of cells treated with SF-AFBI (Figure 5.6e) display strong 
Hoechst staining but the cells themselves exhibit membrane blebbing (Figure 5.6e; arrows) as 
well as cytoplasmic shrinkage. All three morphological features described are key hallmarks of 
apoptosis (Omar and Hu, 2003; Stander et aI. , 2(07). 
5.6 Conclusion 
In this study, the strongest effect was seen with AFBI . Such an effect was anticipated since this 
mycotoxin is postulated to be one of the most potent human carcinogens. 
DNA damage including inefficient repair is expected to initiate the process of genotoxicity by 
AFBI. Modulation of these parameters by SF and L-can suggests that these compounds may 
afford protection against genotoxicity induced by AFB I. Protection by SF and L-can may be 
explained by both inhibition of CYP 450 enzymes and induction of phase II biotransformation 
enzymes. To obtain insight into this aspect, further investigation on the modulation of drug 
metabolising enzyme activities by SF and L-can in HepG2 cells is necessary. 
Overall, the comet assay was shown to be a useful technique for assessing the level of DNA 
damage induced by the samples under investigation in the current study. In addition, the 





Cells respond to the presence of toxic chemicals by numerous biochemical mechanisms. One 
of the key cellular responses to toxicant exposure, which could potentially be used as an early 
marker of toxicity, is the HSR (Golli et al., 2006). 
In mammalian cells, the 70kDa Hsp is the most abundant sub-group of the Hsp family and the 
most closely linked to cytoprotection following a variety of noxious events. The molecular 
mechanisms which induce Hsp70 expression following exposure of cells to xenobiotics, are not 
well understood, however it is generally admitted that the initial step is related to denaturation 
of cellular proteins (Golli et al., 2006). 
Denaturation is the conformational alteration of a biological macromolecule which entails a 
reversible or irreversible loss of its ability to perform a certain biological function (Meredith 
and Lepock, 1999). Heat shock / thermal stress (temperatures ranging between 40°C to 45°C) 
causes thermolabile proteins to destabilise and unfold thereby undergoing denaturation. Such 
unfolding facilitates the formation of molten globule intermediates (structures that exhibit a 
hydrophobic core and residual secondary features) that accumulate and form aggregates 
(Meredith and Lepock, 1999) which perturb normal cellular function and prompt cell death 
(Parcellier et al., 2003). 
In addition to thermal stress, oxidative stress has also been implicated in mediating protein 
denaturation (Meredith and Lepock, 1999). It has been demonstrated that ·OH and singlet 
oxygen produce covalently crosslinked protein aggregates with glyceraldehyde-3-phosphate 
dehydrogenase, alcohol dehydrogenase and myoglobin (Prinsze et al., 1990). In this regard, 
studies involving gamma-rays have revealed that the ·OH mediates the oxidation of side chains 
of amino acid residues (cysteine, methionine, histidine, lysine, arginine, proline) in proteins 
and subsequently inhibits enzyme/protein function (Meredith and Lepock, 1999). 
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Essentially, oxidative stress that results in non-native modification of proteins causes 
thermolabile proteins to destabilise and undergo thermal denaturation at physiological 
temperatures (37°C). These modified proteins unfold and form a similar structure as produced 
by thermal stress, a molten globule intermediate, which is prone to aggregate (Meredith and 
Lepock, 1999). 
Negative regulation of monomeric Hsf-l is relieved by the accumulation of stress generated 
denatured protein that is prone to form aggregates. Heat shock factor-l then undergoes 
trimerisation, gaining DNA binding activity with subsequent activation of Hsp transcription 
and synthesis (Meredith and Lepock, 1999). Increased intracellular levels of Hsp help the cell 
survive stresses (Verma et ai., 2007). 
In general, the protective mechanism of Hsp's is believed to involve their capacity as 
molecular chaperones, by binding to partially denatured proteins and assisting to refold these 
proteins into more stable native structures (Verma et ai., 2007). In addition, it has been 
suggested that the cytoprotective effect of Hsp' s might arise from their ability to assist in the 
transfer of newly synthesised proteins into mitochondria, helping to maintain mitochondrial 
integrity, or by preventing apoptosis by inhibiting caspase activity. On the other hand, Hsp's 
may exert their anti-apoptotic effect downstream of caspases (Robertson et al., 1999). 
Heat shock protein 70 was shown to acquire both enhanced peptide binding ability and peptide 
complex stability under oxidative conditions (Sreedhar and Csermely, 2004). Park et al. 2007 
reported that unregulated oxidative stress could induce differential expression of Hsp's, which 
in turn may play distinct roles in cellular defence. The redox state of the cell has also been 
reported to influence Hsp synthesis via a direct activation of Hsf-l (Sreedhar and Csermely, 
2004). According to the literature, the potential mechanisms involved in Hsp protection against 
ROS include maintenance of A TP levels as well as prevention of protein degradation, lipid 
peroxidation and increases in intracellular Ca2+ levels (Golli et ai., 2006). Another mechanism 
by which Hsp expression may afford cytoprotection against induced oxidative injury is thought 
to be due to their ability to decrease ROS by raising the intracellular concentration of GSH as 
well as preventing the malfolding of endogenous antioxidant enzymes (CAT, SOD and GPX) 
and enhancing their levels and activities (Hassen et ai. , 2007). 
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In addition to Hsp's, p53 is a central factor in cellular stress responses. It governs the adaptive 
and protective responses following several types of exo- and endogenous damage, such as 
DNA damage, hypoxia, oxidative stress, and spindle damage (Latonen and Laiho, 2(05). 
Upon activation, p53 is considered to determine the fate of the cell (Latonen and Laiho, 2(05). 
The biological end-points of p53 induction are growth arrest, which can be transient or 
permanent (senescence or differentiation), or apoptosis (Meek, 2004). 
Tumour suppressor protein p53 arrests the cell cycle in the G1 and G2 phases. In the DNA 
damage response, it participates in DNA repair and recombination by regulating transcription 
and by direct interaction with components of the repair and recombination machineries 
(Latonen and Laiho, 2(05). 
The ability of p53 to induce apoptosis may be its most important tumour-suppressive function. 
It induces several genes that contribute to both death receptor (Fas, DR5) and mitochondrial 
(Apaf-1, Bax, Noxa, p53AIPl and PUMA) apoptotic pathways (Latonen and Laiho, 2(05). 
6.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
6.2.1 Principle of the technique 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) is a method 
commonly used for analysing protein mixtures qualitatively and is based on the separation of 
proteins according to size. Samples to be resolved by SDS-PAGE are initially briefly boiled in 
a sample buffer containing ~-mercaptoethanol and SDS. The ~-mercaptoethanol reduces any 
disulphide bridges holding together the protein tertiary structure, whereas SDS, an anionic 
detergent, binds strongly to and denatures the protein. Each protein present within the sample 
is thereafter fully denatured and opens up into a rod-shaped structure with a series of 
negatively charged SDS molecules along the polypeptide chain. This treatment results in all 
proteins becoming linear and possessing a uniform charge (Wilson and Walker, 2(05). 
The sample buffer also contains an ionisable tracking dye, bromophenol blue, which allows for 
the electrophoretic run to be monitored, and sucrose or glycerol, which gives the sample 
solution density thus allowing for the sample to settle easily through the electrophoresis buffer 
to the bottom when pipetted into the loading well (Wilson and Walker, 2(05). The samples to 
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be separated are in fact not directly loaded into the main separating gel but rather into a 
stacking gel, the purpose of which is to concentrate the protein sample into a sharp band before 
it enters the main separating gel. 
After the samples are loaded and the electrophoresis buffer added, the current is switched on 
and the negatively charged protein-SDS complexes move toward the anode and because they 
have the same charge per unit length, they travel into the separating gel under the applied 
electrical field with the same mobility. However, as they pass through the separating gel, the 
proteins separate due to the molecular sieving properties of the gel (Wilson and Walker, 2005). 
The gel consists of a three dimensional network which is formed by the cross-linking of long 
polyacrylamide chains comprising polymerised acrylamide monomers. The pore size of the gel 
depends on the concentration of acrylamide, which determines the average polymer chain 
length, and bis, which determines the extent of cross-linking (Andrews, 1986). In essence, the 
smaller the protein, the more easily it will move through the pores of the gel, whereas large 
proteins are retarded by frictional resistance due to the sieving properties of the gel (Wilson 
and Walker, 2005). 
When the dye reaches the bottom of the gel, the current is switched off, and the gel is removed 
and stained using an appropriate staining solution. The gel is then destained in a solution that 
removes the unbound background stain from the gel, leaving stained proteins visible on a clear 
background. Using the stained gel, the molecular weights of specific proteins in the sample can 
be determined by comparing its mobility with those of a number of standard proteins of known 
molecular weight that are simultaneously run on the same gel (Wilson and Walker, 2005). The 
gel can alternatively be placed into transfer buffer and utilised for western blotting. 
6.3 Western Blotting 
6.3.1 Principle of the technique 
Western blotting, also known as protein blotting or immunoblotting, evolved from DNA 
(Southern) blotting and RNA (Northern) blotting (Kurien and Scofield, 2006). It is a technique 
that allows for equal amounts of protein extracted from cells or tissues, to be separated by 
SDS-PAGE, electrophoretically transferred from the gel to an adsorbent support membrane 
such as nitrocellulose and to subsequently be probed with antibodies. Primary polyclonal or 
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monoclonal antibodies react specifically with antigenic epitopes presented by target proteins 
attached to the membrane (Figure 6.1). A secondary antibody, conjugated with horseradish 
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Chemiluminescent detection in western blotting (Roda et aL, 2003). 
Chromogenic or radioisotope labelling methods may be used to visualise the bound 
components, however, the most sensitive nonradioactive method currently available for HRP-
conjugated secondary antibodies is enhanced chemiluminescence (Clynes, 1998). In the 
presence of H20 2 and the chemiluminescent (CL) substrate luminol, HRP oxidises the luminol 
which becomes excited and immediately decays via a light-emitting pathway. The intensity of 
the light signal generated by this reaction is increased 1 OOO-foid by the presence of a chemical 
enhancer thus allowing easy visualisation of the antigens present on the membrane. Less than 
1 pg of protein can be detected using this method and exposure time is typically less than 1 
minute (Kurien and Scofield, 2006). 
A number of important characteristics of protein antigens can be determined using the 
technique of western blotting, namely, the presence and quantity of the antigen, its relative 
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molecular weight and the efficiency with which it can be extracted from crude protein 
preparations (Clynes, 1998). 
The aim of this chapter was to utilise SDS-PAGE and western blotting to determine the 
influence of SF, L-can and AFBJ, when administered individually and in combination, on 
Hsp70, Hsp90 and p53 expression. 
6.4 Materials and methods 
6.4.1 Materials 
CytoBuster™ protein extraction reagent was purchased from Merck (SA). Bicinchoninic acid 
(BCA), copper (II) sulphate (CUS04), ~-mercaptoethanol and all antibodies were acquired from 
Sigma (SA). Acrylamide/bis, ammonium persulphate (APS), the molecular weight marker, the 
Silver Stain Plus kit, nitrocellulose membranes, non-fat dry milk, Tween20 and the Immune-
Star HRP substrate kit were all purchased from Bio-Rad. Glycerol, KH2P04, acetic acid and 
methanol were obtained from Saarchem (SA). Glycine, SDS, TEMED, K2EDTA and DIT 
were purchased from Merck (SA). All other reagents and consumables utilised were obtained 
from the sources mentioned previously. 
6.4.2 Methodology 
6.4.2.1 Treatment, isolation and harvesting of HepG2 cells 
HepG2 cells were treated and harvested as described in chapter 4, section 4.6.2.1. 
6.4.2.2 Protein isolation 
Approximately 3 x 106 cells per treatment were transferred to appropriately labelled 15ml 
sterilin tubes and pelleted by centrifugation. The supernatant from each tube was thereafter 
carefully removed, so as to prevent any disruption of the pellet. The pellet of cells was then 
resuspended in PBS to facilitate a wash step and this was followed by further centrifugation. 
Each of the aforementioned centrifugation steps was carried out at 1 000 rpm for 5 minutes at 
24°C. The washed pellet was then resuspended in 500J.lI of the CytoBuster™ protein extraction 
reagent (a formulation of detergents optimised for efficient extraction of soluble proteins from 
mammalian cells) followed by incubation on ice for 5 minutes. Thereafter, a final 
centrifugation step at 5 000 rpm for 10 minutes at 24°C was utilised and the resulting 
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supernatants (4501ll) which served as the crude protein extract were transferred to 
appropriately labelled hnl eppendorfs and kept on ice until utilised. 
6.4.2.3 Protein quantification and standardisation 
Protein concentrations were quantified spectrophotometric ally using the BCA assay by which 
total protein concentration was determined by a colour change of the sample solution from 
green to purple in proportion to protein concentration. The BCA assay relies on two reactions. 
First, the peptide bonds in protein reduce Cu2+ ions to Cu1+. The amount of Cu2+ reduced is 
proportional to the amount of protein present in the solution and second, two molecules of 
BCA chelate with each Cu1+ ion, forming a purple-coloured product that strongly absorbs light 
at a wavelength of 562nm. The concentration of protein in each sample was determined by 
comparison to a protein of known concentration, bovine serum albumin (BSA), which was 
serially diluted (0, 0.2, 0.4, 0.6, 0.8 and 1.0mg/ml) in order to construct a standard curve 
(Appendix 2). The assay was performed in duplicate using a 96-well microtitre plate. An 
aliquot of 251lL of each sample (supernatant) and the relevant standards (BSA) were added to 
appropriately labelled wells. The BCA working solution (2021l1, 4111 CUS04 and 198111 BCA) 
was thereafter dispensed into each of these wells and the microtitre plate was incubated (37°C) 
for 30 minutes. After incubation, the absorbance of the various samples were read at 562nm 
using a spectrophotometer. The absorbance' s of the standards (BSA) obtained were used to 
construct a standard curve, from which the protein concentration of each sample was 
determined. All samples were thereafter diluted using storage buffer [0.1M KH2P04 (PH 7.4), 
0.5mM K:2EOTA, 0.1mM OTT and 0.25M sucrose] and standardised to a final protein 
concentration of 1mg/ml (Appendix 2). 
6.4.2.4 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
The Mini-PROTEAN 3 SOS-PAGE apparatus (Bio-Rad) was assembled according to 
manufacturer's instructions. A 12% resolving gel [dH20, 105M Tris-HCI (PH 8.8), 10% (w/v) 
SOS, 30% Acrylamidelbis, 10% APS (fresh daily), TEMEO] was prepared and added in-
between the cleaned glass plates by using a pasteur pipette (this was done very carefully so as 
to prevent the formation of air bubbles). A layer of dH20 was added on top of the resolving gel 
so that a smooth interface was created for efficient addition of the stacking gel. Once the gel 
had set, the dH20 was removed by being absorbed to filter paper that was carefully placed in-
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between the two glass plates containing the gel. A 4% stacking gel [dH20, 0.5M Tris-HCI (PH 
6.8), 10% (w/v) SDS, 30% Acrylamide/bis, 10% APS, TEMED] was then added in-between 
the glass plates. A Bio-Rad plastic comb was placed into the stacking gel between the glass 
plates in order to create sample loading wells. Once the gels had set, the gel cassette sandwich 
was removed from the casting stands and clamped into the electrode assembly. 
Sample buffer [dH20, 0.5M Tris-HCI (PH 6.8), glycerol, 10% SDS, ~-mercaptoethanol, 1% 
bromophenol blue] was thereafter added (1:1) to the protein samples, which were then boiled 
for 5 minutes in order to activate the ~-mercaptoethanol and SDS to allow for reduction and 
unfolding of proteins. Wells were subsequently loaded with 20!J.g of total protein from the 
relevant sample. A molecular weight marker (Mwt) was loaded into a separate well in order to 
facilitate identification of the relative weights of the resolved proteins. 
The inner chamber assembly was then placed in the electrophoresis mini tank and a 2x 
electrode buffer (dH20, Tris, glycine, SDS; pH 8.3) subsequently added. The apparatus was 
sealed and the tank was then placed in a container approximately half-filled with ice. Samples 
were then allowed to resolve by electrophoresis (150V, using a Bio-Rad compact power 
supplier) until the tracker dye reached the bottom of the gel. After electrophoresis, gels were 
removed and either stained by silver staining (Figure 6.2) or the resolved proteins were 
electroblotted to nitrocellulose membranes. 
6.4.2.5 Silver staining 
All reagents utilised for silver staining were from the Bio-Rad Silver Stain Plus kit. Following 
electrophoresis, the gels were placed in the fixative enhancer solution [200ml methanol (50% 
v/v), 40ml acetic acid (10% v/v), 40ml fixative enhancer concentrate (10% v/v), 120ml dH20] 
and fixed for 20 minutes with gentle agitation. The fixative enhancer solution was thereafter 
decanted and the gels were rinsed with two changes of 10 minutes each of 400ml dH20. Gels 
were then placed into the staining solution (35ml dH20, 5ml silver complex solution, 5ml 
reduction moderator solution, 5ml image development reagent, 50ml development accelerator 
solution) and after the desired staining was achieved they were transferred to 5% acetic acid for 
15 minutes to stop the staining reaction. The acetic acid was thereafter decanted and gels were 
rinsed for 5 minutes in dH20. 
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6.4.2.6 Western blotting 
The electrophoresed gels were removed from the SDS-PAGE apparatus and placed in transfer 
buffer (25mM Tris, 192mM glycine, 20% v/v methanol; pH 8.3), for 10 minutes (to allow the 
gel and proteins to equilibrate). The blotting membrane, nitrocellulose, as well as the fibre pads 
and filter paper were appropriately cut according to the dimensions of the gel and prepared by 
submerging in dH20 and thereafter soaking in transfer buffer until they were ready to be used. 
The gel sandwich was assembled by first placing a fibre pad on the area of the gel holder 
cassette that would be placed near to the cathode. A piece of filter paper was then placed onto 
the first fibre pad. The equilibrated gel with the migrated protein samples was then placed on 
the filter paper, followed by the nitrocellulose membrane. The membrane was cut at a comer 
which corresponded to the upper area of the gel into which the molecular weight marker was 
loaded. This facilitates efficient identification at a later stage of the procedure. An additional 
piece of filter paper and a final fibre pad was then placed on the nitrocellulose membrane. Any 
trapped air bubbles which might reduce the efficiency of the transfer or distort band patterns 
were removed by rolling a glass rod over the final fibre pad. The gel holder cassette was then 
firmly closed, tightly clamped (to prevent skewing of the bands or band spreading during 
transfer) and placed into the transfer module and subsequently into the mini tank. The tank was 
then filled with transfer buffer (incorporation of methanol in the transfer buffer allows for the 
stabilisation of the gel during transfer as well as to increase the binding capacity of 
nitrocellulose for protein). A teflon coated magnetic stirrer was added into the tank to help 
maintain even buffer temperature and ion distribution during the transfer process. The 
apparatus was sealed and the tank was then placed in a container approximately half-filled with 
ice. Resolved proteins were then electroblotted to the nitrocellulose membranes at a constant 
current of 400mA for 1 h. 
After the transfer, the nitrocellulose membranes were removed and unoccupied sites were 
blocked overnight (4°C) with 5% (5g) non-fat dry milk in TTBS [lOOml; Tris-buffered saline 
(TBS) containing 0.5% Tween20] in order to reduce background noise and prevent nonspecific 
binding by antibodies. The spent non-fat dry milk was discarded after the overnight blocking 
and each membrane was then incubated (room temperature) for 1 h with the relevant primary 
antibody (anti-mouse Hsp70, 90 or p53). Primary antibodies were diluted 1: 1 500 in 1 % BSA 
in TTBS. After incubation, the primary antibody was removed and the membranes were 
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thoroughly washed with three changes of 10 minutes each of TIBS. The membranes were 
subsequently incubated (room temperature) with an HRP-conjugated anti-mouse IgG 
secondary antibody (diluted 1:2 000 in 1 % BSA in TIBS) for 1 h. The secondary antibody was 
thereafter removed and the membrane was subject to a further three 10-minute washes with 
TIBS. During each wash step and antibody-incubation periods, the blot was subject to mild 
agitation by placing the container within which it was present, on an orbital shaker. 
6.4.2.7 Instrumentation and analysis of samples 
The GelDoc XRS apparatus (Bio-Rad), an instrument equipped with a digital camera, enabled 
capturing of images of both the silver-stained gels (white epiluminescence) as well as the 
nitrocellulose membranes (chemiluminscence). The instrument was connected to a personal 
computer equipped with the Bio-Rad Quantity One 4.4.1 software which enabled further 
analysis of the gels and blots. 
Development of each membrane was facilitated by utilising chemiluminescence. Briefly, the 
two chemiluminscence reagents (luminollenhancer and peroxide buffer) comprising the Bio-
Rad Immune-Star HRP substrate kit were mixed in a 1: 1 ratio. Approximately 4ml of this 
mixture was subsequently poured onto the nitrocellulose membrane which was allowed to 
incubate (room temperature) in the dark for 3 minutes. Thereafter, the membrane was placed 
into the GelDoc XRS chamber and the images of the protein bands on the membrane became 
visible following development using Chemi Hi Sensitivity exposure. 
6.4.2.8 Data analysis and statistics 
Data was analysed using Image] 1.41 image processing and analysis software and are 
represented as relative band density plus or minus the standard deviations. Groups were 
compared for differences using one-way ANOVA and the Kruskal-Wallis test (GraphPad 
InStat Software, version 3.06). A probability value (P) of less than 0.05 (p<0.05) was 
considered as statistically significant (* indicates significant (p<0.05) differences between 
treated and control groups; # indicates significant (p<0.05) differences between treated groups). 
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6.5. Results and Discussion 
Studies have indicated that Hsp synthesis increases together with elevated levels of ROS 
(Becker et al., 1990; Schoeniger et al., 1994; Flanagan et al., 1998). In addition, several 
published data have reported that many sources of oxidative stress can lead to the upregulation 
of Hsp's (Ma et al., 1998; Kim et al., 2005; Yu et al., 2006; Weber et al., 2007; Gaultieri et al., 
2008). Reactive oxygen species are therefore regarded to playa key role in the expression of 
Hsp's. 
Figure 6.2 Silver staining of crude HepGz cellular proteins resolved by SDS-PAGE. 
Mycotoxins have been shown to induce Hsp70 expression (Hassen et al., 2005; Golli et al., 
2006; Zourgui et al., 2008). In this regard, Meki et al. (2004) reported a 2.5-fold elevation of 
Hsp70 expression in rat liver when male Sprague-Dawley rats were treated with AFBI 
(50J1g/kg body weight) via gastric intubatio .. In addition, a statistically significant (p<0.001) 
increase in lipid peroxidation was induced by AFB 1. The authors concluded that the increasing 
levels of Hsp expression may be ascribed to die oxidative effect of AFB 1. 
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This study is in agreement with Meld et al. (2004) as it is apparent from the present data that 
incubation of HepG2 cells with 1 IlM AFB 1 for 24 h induced a significant (p<O.OOl) increase in 
Hsp70 (Figure 6.3) as well as Hsp90 (Figure 6.4) expression as evidenced by the 1.30-fold and 



























Western blot analysis of Hsp70 protein levels in HepGz cells treated with 
SF, L-can, AFBt, SF-AFBI and L-can-AFB1• ***p<O.OOl, ###p<O.OOl. 
The increases in Hsp expression by AFBJ may be attributed to its oxidative effect, which has 
been demonstrated as one of the underlining mechanisms for AFBJ-induced cytotoxicity. 
Results from the TBARS assay (Chapter 4) showed that AFBI significantly (p<O.OOl) 
increased lipid peroxidation in HepG2 cells. It may therefore be reasonable to assume that ROS 
generated by AFBI may have oxidised amino acid side chains of proteins, yielding carbonyl 
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derivatives. In addition, MDA, a product of lipid peroxidation, has also been shown to form 
reactive carbonyl derivatives of proteins. Carbonyl groups can also be introduced into proteins 
by reactions with a1kenes (conjugated dienes) produced during lipid peroxidation 
(Madhusudhanan et al. , 2004). Protein carbony1ation is a sign of irreversible oxidative damage, 
often leading to a loss of protein function (Zourgui et al. , 2008). Therefore, as a consequence 
of AFB\-induced ROS and associated lipid peroxidation, the affected proteins may aggregate 
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Figure 6.4 Western blot analysis of Hsp90 protein levels in HepG2 cells treated with 
SF, L-can, AFBt, SF-AFBt and L-can-AFBt. ***p<0.001, # # #p<O.OO 1. 
In addition to its oxidative effect, AFB\ is known to react and interact with various liver 
proteins to form a stable adduct (Amaya-Farfan, 1999). It is suggested that the structure and 
110 
activity of proteins may be detrimentally altered following non-specific-irreversible covalent 
and specific-reversible non-covalent binding with the toxin (McLean and Dutton, 1995). 
Enzyme inactivation is a further consequence of toxin binding (Amaya-Farfan, 1999). In 
addition to AFBJ itself or the generated exo-isomer interacting with proteins, the dialdehyde 
generated from the AFB J-8,9-dihydrodiol is capable of condensing with primary amino acid 
groups, such as lysine, and other cellular constituents, forming a Schiffs base (Guengerich et 
aI., 1998) thus also contributing to alterations in protein/enzyme structure and function. It is 
therefore presumed that AFBJ possibly interacted with and mediated alterations in protein 
structure and function, thereby inducing the observed increases in Hsp70 (Figure 6.3) and 
Hsp90 (Figure 6.4) expression. 
The ability of AFB 1 to influence p53 expression in HepG2 cells was previously investigated by 
Reddy et al. (2006). On the basis of a pantropic p53 protein ELISA, a decrease in p53 levels 
was noted after exposure to AFBI (11J.lglml). 
Using western blotting, Van Vleet et al. (2006) reported a concentration-dependent (0.015-
15J.lM) decline in p53 expression when human bronchial epithelial cells, B-CMVIA2 and 
B3A4, were incubated with AFB 1• 
The present data is in agreement with Reddy et al. (2006) and Van Vleet et al. (2006) as it also 
illustrates a decrease (p>0.05) in p53 expression after exposure of HepG2 cells to AFBJ (IJ.lM) 
(Figure 6.5). 
The tumour suppressor gene p53 is the most commonly mutated gene (approximately 50%) in 
all human cancers. Using restriction fragment length polymorphism, Aguilar et al. (1993) 
reported that AFB J preferentially induced the transversion of GC to T A in the third position of 
codon 249 of the p53 gene in HepG2 cells. It is therefore suggested that the observed decrease 
in p53 expression by AFBJ (Figure 6.5) could be due to a mutation and thus the carcinogenic 
potential of AFBJ is owed to its ability, at least in part, to interfere with the molecular 
mechanism of cell cycle regulation. 
In addition to oxidative stress, there are other agents which may interfere with protein folding. 
These are usually stress protein inducers which include amino acid analogues. The latter agents 
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are structural analogues of natural amino acids. They become rapidly incorporated into newly 
synthesised proteins thereby inducing irreversible aberrant protein formation and accumulation 
which ultimately leads to the induction of stress proteins, such as Hsp70 (Remy et ai., 1998). 
Li and Laszlo (1984) studied the effect of amino acid analogues on the induction of Hsp's in 
the Chinese hamster fibroblasts cell line (HA-1).1t was determined that exposure of HA-1 cells 
to L-can in particular, mediated enhanced synthesis of three major mammalian Hsp's with 
molecular weights 70, 87 and 11OkDa. 
L~~_ II' • I~ • 
Figure 6.5 Western blot analysis of pS3 protein levels in HepG2 cells treated with SF, 
L-can, AFB., SF-AFBI and L-can-AFB1• ***p<O.OOl, ###p<O.OOl. 
The product of the Ion gene in Escherichia coli, a protease known as La, mediates the 
degradation of aberrant proteins. Goff and Goldberg (1985) investigated whether the presence 
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of abnormal proteins stimulated the expression of this gene. Cells were induced to synthesise 
aberrant polypepetides following treatment with L-can. Treated cells displayed a 3-fold 
increase in Ion gene expression. Importantly, the induction of Ion by abnormal proteins 
required the heat shock regulatory gene htpR. Thus, the presence of aberrant proteins after 
exposure to L-can may be a common signal required for the induction of heat shock proteins 
(Goff and Goldberg, 1985). 
In addition, Robertson et ai. (1999) investigated the effect of L-can on the induction of Hsp70 
expression in FL5.12 cells. These authors reported a 2-fold increase in Hsp70 expression after 
cells were incubated for 4 h with lOmM L-can. 
Based on the findings of the above-mentioned studies (Li and Laszlo, 1984; Goff and 
Goldberg, 1985; Robertson et ai., 1999), it is suggested that one mechanism by which L-can is 
able to influence Hsp expression involves its ability to induce aberrant protein formation and 
accumulation. A further mechanism involves its capacity to induce ROS and subsequent 
oxidative stress (Riganti et ai. , 2003). This postulation is based on the high level (p<O.OOI) of 
lipid peroxidation induced by L-can as evidenced by results of the TBARS assay (Chapter 4). 
Thus, when compared to the control, both mechanisms can be employed to explain the 
significant (p<O.OOI) 1.79-fold increase in Hsp90 expression by L-can (Figure 6.4). 
In contrast, L-can induced a significant (p<O.OOI) 1.11-fold decrease in Hsp70 expression 
when compared to the control (Figure 6.3). A possible mechanism can be envisioned to explain 
such a result. While L-can leads to the accumulation of analogue-substituted proteins that are 
believed to be responsible for the accumulation of Hsp70, it could be that newly synthesised 
Hsp70 itself is aberrant or dysfunctional (Robertson et ai., 1999). 
When compared to the control, a 2.59-fold (p<O.OOI) increase in p53 expression was noted 
after incubation of HepG2 cells with L-can (Figure 6.5). This finding correlates with Ding et ai. 
(1999) who also established the ability of L-can (0-2mM) to cause p53 protein induction in 
vitro. 
Tumour suppressor protein p53 plays an essential role in maintaining genomic integrity (Liu et 
ai. , 2008). Following DNA damage, p53 levels and activity are subsequently increased and 
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lead to transcriptional activation of its target genes (P21) responsible for cell cycle arrest 
(Latonen and Laiho, 2005), so as to extend the time available for DNA repair. Conversely, 
replication of damaged cells is avoided through activation of apoptosis (Ricordy et al., 2002). 
In this regard, it is suggested that one of the mechanisms by which L-can is able to mediate an 
increase in p53 expression is via its capacity to induce ROS and subsequent DNA damage. 
This postulation is based on the high level (p<0.001) of lipid peroxidation induced by L-can as 
evidenced by results from the TBARS assay (Chapter 4) as well as the significant (p<0.001) 
increase in DNA migration as revealed by the comet assay (Chapter 5). 
Other results in this study (Figure 6.3) demonstrated lower levels of Hsp expression following 
the administration of SF, which induced a significant (p<O.OOl) 1.25-fold decrease in Hsp70 
expression when evaluated against the control. 
The lower levels of Hsp70 expression can be attributed to the free radical scavenging and 
antioxidant properties of the plant which contribute to the maintenance of low levels of 
intracellular ROS. This is supported by results of the TBARS and GSH assays (Chapter 4) 
which illustrated that SF induced significantly (p<0.001) lower levels of lipid peroxidation and 
significantly (p<0.001) higher levels of GSH respectively, compared to the control. As a result, 
it is unlikely for SF-induced Hsp70 expression to be a consequence of oxidative stress. 
In contrast, SF induced a significant (p<0.001) 1.20-fold increase in Hsp90 expression 
compared to the control (Figure 6.4). This result may be due to the effects of L-can which is 
present in relatively high concentrations within SF (van Wyk and Albrecht, 2008). 
Exposure of HepG2 cells to SF caused a 1.53-fold (p<O.OOl) incline in p53 expression when 
compared to the control (Figure 6.5). Comet assay analysis revealed SF to mediate a significant 
(p<0.001) increase in DNA migration (Chapter 5). It is therefore presumed that increased p53 
expression by SF occurred as a result of the genotoxic effect of the plant extract on the HepG2 
cell line. 
When compared to the control, western blot analysis revealed that L-can-AFB 1 evoked 1.68-
fold (p<O.OOl) and 1.82-fold (p<O.OOl) increases in Hsp70 (Figure 6.3) and Hsp90 (Figure 6.4) 
expression respectively. The same combination mediated significant (p<O.OOl) increases in 
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Hsp70 expression (Figure 6.3) when compared to Hsp protein levels induced by the individual 
administration of L-can and AFBJ. In addition, L-can-AFB J induced l.Ol-fold (p>O.05) and 
l.20-fold (p<O.OOl) increases in Hsp90 expression (Figure 6.4) compared to that induced by L-
can and AFBJ respectively. 
The observed increases in Hsp expression may be due to the oxidative properties of the 
combination as evidenced by the significant increase (p<O.OOl) in TBARS levels (Chapter 4) 
after exposure of HepG2 cells to L-can-AFBJ. 
When assessed against the control, p53 was upregulated l.74-fold (p<O.OOl) by L-can-AFBJ 
(Figure 6.5). The same combination evoked a l.49-fold (p<O.OOl) decrease and a 2.19-fold 
(p<O.OOl) increase in p53 levels when compared to expression induced after individual 
administration ofL-can and AFBJ respectively. 
Results from the comet assay (Chapter 5) showed that L-can-AFB J caused a significant 
(p<O.OOl) antagonistic effect on DNA migration and comet tail length when compared to 
AFBJ-treated cells. In this regard, it is reasonable to assume that L-can mediated an 
upregulation of p53 thereby promoting cell cycle arrest to facilitate the repair of AFBJ-induced 
DNA damage. 
Regarding SF-AFBJ, immunoblotting illustrated the combination to induce l.75-fold (p<O.OOl) 
and l.36-fold (p<O.OOl) increases in Hsp70 (Figure 6.3) and Hsp90 (Figure 6.4) expression 
respectively, compared to the control. When combined, these compounds also mediated 
significant (p<O.OOl) increases in Hsp70 (Figure 6.3) expression compared to that induced 
after individual exposure to SF and AFB 1• Furthermore, SF-AFBI evoked a 1.14-fold 
(p<O.OOl) increase and a l.l1-fold (p<O.OOl) decrease in Hsp90 expression when assessed 
against expression induced after individual administration of SF and AFBJ respectively (Figure 
6.4). 
Based on the results of the TBARS assay (Chapter 4), which revealed SF-AFBJ to mediate a 
significant (p<O.OOl) increase in lipid peroxidation, it is suggested that the oxidative stress 
induced after co-administration of these compounds contributed to the observed increases in 
Hsp expression. 
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The p53 protein measurements showed that SF-AFB) caused a 2.25-fold (p<O.OOl) 
upregulation in the p53 gene product when evaluated against the control (Figure 6.5). Further 
analysis demonstrated that this combination induced significant (p<O.OOl) increases in p53 
levels when compared to p53 expression induced by individual exposure to SF and AFB). 
Similarly to L-can-AFB), SF-AFBJ mediated a significant (p<O.OOl) decrease in DNA damage 
when compared to AFB)-treated cells (Chapter 5). Therefore, the increased levels of p53 may 
be regarded as a protective mechanism, eliciting cell cycle arrest in order to facilitate the repair 
of AFBJ-induced DNA damage. 
It is apparent that when combined these compounds act simultaneously to increase Hsp70 
expression. However, the precise mechanisms by which the combination treatments influence 
cellular Hsp and p53 expression levels remain elusive. As previously mentioned (Chapter 4), 
when in combination, these compounds may exhibit differences in bioactivity, which can be 
attributed to the ability of each compound to influence the bioactivity of the other. 
6.6 Conclusion 
The findings of the current study approves the strong correlation between oxidative stress and 
Hsp induction thus supporting the oxidative character of AFBJ as assessed in this study by the 
increase of TBARS, Hsp70 and Hsp90 levels. In addition, the p53-mediated response to AFBJ 
treatment may indicate that these cells are at an increased risk of developing mutations. 
The capacity of SF and L-can to influence Hsp and p53 protein expression, when administered 
individually and in combination with AFBJ, is unclear and requires further investigation. 
Among the stressors that have been demonstrated to result in Hsp and p53 induction is a rather 
extensive list of biotic and abiotic compounds and toxicants which have led some to suggest 
that the induction of these molecules may be a universal response to cytotoxicity. Based on the 
results of this study, it can be concluded that Hsp and p53 induction is undoubtedly more 





The one certainty of life is death. This may be the reason for the tremendous interest in 
understanding the mechanisms of death. At the cellular level, it is clearly evident that death is 
not always a stochastic event (Burgering and Kops, 2(02). Cell death may be divided into two 
classes, apoptosis and necrosis (Edinger and Thompson, 2004). 
Apoptosis is a form of cell death during which an individual cell undergoes an internally 
controlled transition from an intact metabolically active state into a number of shrunken 
remnants retaining their membrane bound integrity (Slater et ai., 1995). For cell death to be 
identified as apoptosis, nuclear condensation and fragmentation, cleavage of chromosomal 
DNA into internucleosomal fragments and packaging of the deceased cell into apoptotic bodies 
without plasma membrane breakdown must be observed (Edinger and Thompson, 2(04). It is 
apparent that lysis of internal organelles does not occur during this process, and little external 
leakage of the contents of the dying cell can be detected. Consequently, apoptotic cells do not 
induce an inflammatory response. Instead, the shrunken apoptotic bodies are phagocytosed by 
macrophages and their contents recycled. Apoptosis is therefore able to provide an organism 
both with a safe and efficient way to continuously turnover cells in any tissue, and the capacity 
to remove specific cells during development (Slater et ai., 1995). The morphologic features of 
apoptosis occur after the activation of caspases by either death receptor ligation or the release 
of apoptotic mediators from the mitochondrion. In addition, cell death by apoptosis requires 
energy in the form of ATP (Edinger and Thompson, 2(04). 
In contrast to apoptosis, necrosis has been traditionally regarded to be a passive form of cell 
death. It is the consequence of a bioenergetic catastrophe resulting from A TP depletion to a 
level incompatible with cell survival and is thought to be initiated mainly by cellular 
'accidents' such as physical damage or toxic insults (Edinger and Thompson, 2(04). 
Biochemical hallmarks of apoptosis such as activation of specific caspases and 
oligonucleosomal DNA fragmentation are usually absent in necrotic cells. Morphologically, 
necrosis is considerably different from 'classical' apoptosis (Proskuryakov et ai., 2003). This 
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form of cell death is typified by osmotic swelling of the cell and organelles (commonly 
mitochondria) (Lockshin and Zakeri, 2(02). Swelling during necrosis is emphasised in the term 
"oncosis" (derived from "oncos" meaning swelling), a term for cell death in opposition to 
apoptosis (Proskuryakov et aI. , 2003). In addition, necrosis is also characterised 
morphologically by the breakdown of the plasma membrane and an induction of inflammation 
around the dying cell, attributable to the rapid efflux of cell constituents and proinflammatory 
molecules into the extracellular space (Edinger and Thompson, 2(04). 
The importance of properly balanced cell survival and cell death within an organism is 
undeniable (LeBlanc, 2003). A better understanding of the mechanisms that regulate cell death 
pathways is necessary in order to improve the current therapeutic strategies as well as to define 
new strategies in various diseases (Solary et aI. , 1996). 
7.2 Flow cytometry 
Flow cytometry is a technology that simultaneously measures and then analyses several 
physical characteristics of single particles as they flow in a fluid stream through a beam of light 
(BD Biosciences, 2000). The particles analysed by flow cytometry are often cells. More 
recently however, flow techniques have also been used to analyse bacteria, sperm, plankton 
and individual particles that are not cells at all, for example viruses (Hawley and Hawley, 
2(04). A flow cytometer comprises three functional systems namely fluidics, optics and 
electronics, and the properties measured include a particles relative size, relative granularity or 
internal complexity and relative fluorescence intensity (BD Biosciences, 20(0). 
7.2.1 Fluidics 
The most important essential feature of any flow cytometer is the fluidics system, the purpose 
of which is to transport particles in a fluid stream to a laser beam for interrogation (Freshney, 
1992). To obtain consistency of measurement, the stream transporting the particles should 
ideally be positioned in the centre of the laser beam and only one cell or particle should move 
through the laser beam at a given moment (BD Biosciences, 2000). This is accomplished by 
the design of the flow chamber in the fluidics system which causes the fluid to accelerate the 
particles in a manner that restricts them to the centre of the fluid stream, a process referred to 
as hydrodynamic focussing (Hawley and Hawley, 2004). 
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7.2.2 Optics 
The optical system consists of excitation optics and collection optics (BD Biosciences, 2000). 
The excitation optics comprises a laser and, spherical and cylindrical lenses that are used to 
shape and focus the laser beam (BD Biosciences, 2000). The use of a laser beam is 
undoubtedly the best illumination source because fIrstly, the light is very bright and secondly, 
the beam emitted by a laser is coherent. Light is thus polarised and the beam is essentially 
parallel. In flow cytometry, the argon ion laser is commonly utilised (Freshney, 1992). 
Once a cell or particle passes through the laser light, light scattering (forward or side) occurs 
(BD Biosciences, 2000). Light scattering depends on a number of optical processes including 
diffraction, reflection and refraction. Forward scattered light (FSC) is proportional to size or 
cell-surface area and is a measurement of diffracted light (Freshney, 1992) whereas side 
scattered light (SSC) is proportional to cell granularity or internal complexity and is a 
measurement of refracted or reflected light (BD Biosciences, 2000). 
In addition to scattered light, the cell may also impart fluorescent light (Hawley and Hawley, 
2004). There are many fluorescent dyes that are useful in flow cytometry due to their ability to 
bind various cytochemical components and their subsequent detection aids in the investigation 
and analysis of various cellular processes. A key property of a fluorescent dye which 
determines its potential use in flow cytometry is its excitation wavelength, which must match 
the 488nm light emitted by the laser beam (BD Biosciences, 2000). 
Once a cell passes through the laser beam, the emitted light signals are directed to appropriate 
photodetectors via dichroic mirrors (optical mirrors) and optical fIlters (bandpass and shortpass 
fIlters). These components comprise the collection optics (BD Biosciences, 2000). 
Fluorescence and SSC light signals are diverted to photomultiplier tubes (PMTs) whereas a 
photodiode collects the FSC signals (BD Biosciences, 2000). 
7.2.3 Electronics 
The detected light signals are converted into proportional electronic signals (voltage pulses) by 
the photodetectors (BD Biosciences, 2000) and each voltage pulse is then assigned a digital 
value by an Analog-to-Digital Converter (ADC) (Hawley and Hawley, 2004). 
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7.2.4 Data collection and display 
Flow cytometric data is stored according to a standard format, the flow cytometry standard. 
Once a data file had been saved, cell populations can be displayed in several different formats 
(BD Biosciences, 2000). A single parameter can be displayed using a monodimensional 
histogram, whereas bivariate data can be displayed on dot plots or contour maps. Three 
dimensional (3-D) data can also be viewed by utilising x, y and z axes of a 3-D plot (Freshney, 
1992). 
7.3 Flow cytometric detection of apoptosis/necrosis 
The importance of apoptosis in the regulation of cellular homeostasis has mandated the 
development of several proficient assays capable of measuring different aspects of the proce~s. 
Apoptosis assays based on flow cytometry have proven particularly useful because they are 
rapid, quantitative and provide an individual cell-based mode of analysis. Furthermore, the 
multiparametric nature of flow cytometry facilitates the detection of more than one cell death 
characteristic in a single assay (Hawley and Hawley, 2004). 
Within viable cells, PS is located on the cytoplasmic surface of the cell membrane. Following 
the induction of apoptosis, rapid alterations occur at the cell surface. One of these are plasma 
membrane alterations involving the translocation of PS from the inner part of the plasma 
membrane to the outer layer, by which it becomes exposed at the external surface of the cell 
(Zimmermann et al., 2001). 
In vitro detection of PS can be achieved through its interaction with Annexin-V, a protein 
which binds in a Ca2+-dependent manner to negatively charged phospholipid surfaces and 
shows high specificity for and binds with high affinity to PS (Figure 7.1). This protein can thus 
be utilised as a sensitive probe for PS exposure and is therefore suitable for the efficient 
detection of apoptotic cells in cell populations. In flow cytometric applications, Annexin-V is 
conjugated to fluorescein isothiocyanate (FlTC), a fluorochrome (Roche, 2005). As previously 
mentioned (Chapter 5), a key property of a fluorescent dye which determines its potential use 
in flow cytometry is its excitation wavelength. Fluorescein isothiocyanate is suitable for flow 
cytometric applications as it possesses an excitation wavelength of 488nm and emits light 
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Principle of Annexin-V-FITC and PI staining (Nicoll, 2004). 
Since necrotic cells also expose PS as a result of loss of membrane integrity, apoptotic cells 
have to be differentiated from necrotic cells during analysis. The simultaneous application of a 
DNA stain, propidium iodide (PI), allows the discrimination of necrotic cells from Annexin-V 
stained cells, as PI stains DNA of leaky necrotic cells only (Figure 7.1). Propidium iodide 
functions to intercalate the DNA helix with a resultant increase in fluorescence of about 20-
fold. It is suitable for usage in flow cytometry as it possesses an excitation wavelength of 
488nm and emits light signals possessing a wavelength of 617nm (Roche, 2005). Therefore, 
cells which are positive for only Annexin-V are regarded as apoptotic whereas cells positive 
for both Annexin-V and PI are regarded as necrotic (Figure 7.1). 
The aim ofthis chapter was to utilise the Annexin-V-Fluos staining kit via flow cytometry to 
determine whether SF, L-can and AFB 1, when administered individually and in combination, 
induces apoptosis and/or necrosis of HepG2 cells. 
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7.4 Materials and methods 
7.4.1 Materials 
The Annexin-V-Fluos kit was purchased from Roche Diagnostics. All other reagents and 
consumables utilised were obtained from the sources mentioned previously. 
7.4.2 Methodology 
7.4.2.1 Treatment, isolation and harvesting of HepG2 cells 
HepG2 cells were treated and harvested as described in chapter 4, section 4.6.2.1. 
7.4.2.2 Preparation of Annexin-V-Fluos labelling solution 
The Annexin-V -Fluos labelling solution was prepared by diluting 20!!1 each of the Annexin-V-
Fluos labelling reagent and the PI solution in Iml incubation buffer. 
7.4.2.3 Staining procedure of cultured HepG2 cells 
Approximately 1 x 106 cells per treatment were transferred to appropriately labelled 15ml 
sterilin tubes and pelleted by centrifugation. The supernatant from each tube was thereafter 
carefully removed, so as to prevent any disruption of the pellet. The pellet of cells was then 
resuspended in PBS to facilitate a wash step and this was followed by further centrifugation. 
Each of the aforementioned centrifugation steps was carried out at 1 000 rpm for 5 minutes at 
24°C. The washed pellet was then resuspended in lOO!!1 of the Annexin-V-Fluos labelling 
solution and incubated (room temperature) in the dark for 15 minutes. 
7.4.2.4 Instrumentation and analysis of samples 
A FACS cali bur benchtop flow cytometer (BD Biosciences) was utilised for analysis of all 
samples. Subsequent to the incubation period, a 500!!1 aliquot of incubation buffer was added 
to each sample of stained cells in suspension. The tubes containing the samples were then 
gently shaken and placed into the flow cytometer. Analysis of all samples was conducted 
utilising an excitation wavelength of 488nm with subsequent FLI (Annexin-V -FITC-PS) and 
FL3 (propidium iodide-DNA) signals being detected via 515nm and 600nm bandpass filters 
respectively. Electronic compensation of the instrument was performed prior to analysis in 
order to exclude overlapping of the two emission spectra. 
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7.4.2.5 Data analysis and statistics 
The instrument was connected to a personal computer and data was acquired and analysed 
using FlowJo 8.7.l software. Dot plots (Figure 7.2 - Figure 7.5) were used to display the two 
parameter data obtained. A quadrant marker was used to divide the two parameter plots into 
four quadrants to distinguish populations that are considered negative, single positive, or 
double positive. The lower-left quadrant (population 1 - viable cells) contains cells that are 
negative for both parameters (Annexin-V-FITC negative, PI negative), the lower-right 
quadrant (population 2 - apoptotic cells) contains cells that are positive for the x-axis parameter 
(Annexin-V-FITC positive) but negative for the y-axis parameter (PI negative), the upper-right 
quadrant (population 3 - necrotic cells) contains cells that are positive for both parameters 
(Annexin-V-FITC positive, PI positive) and the upper left quadrant (population 4) contains 
cells that are positive for the y-axis parameter (PI positive). 
7.S Results and Discussion 
Apoptosis is described as an active, programmed process of autonomous cellular dismantling 
that avoids eliciting inflammation, whereas necrosis has been characterised as cell death 
resulting from environmental perturbations with uncontrolled release of inflammatory cellular 
contents (Nasri et al., 2006). 
In the present study, Annexin-V-FITC binding and PI staining by flow cytometry were used as 
criteria for distinguishing viable, apoptotic and necrotic cells. Apoptotic cells were identified 
on the basis of their PS externalisation, whereas necrotic cells were identified by DNA 
intercalation of PI. The potential for induction of apoptosis and necrosis differed remarkably 
between the compounds under investigation. 
Fluorescence activated cell sorting analysis demonstrated that L-can was the most potent 
ingredient to cause apoptosis (33.6%) in HepG2 cells (Table 7.1). In addition, the double 
staining of red fluorescence with PI showed that the compound also induced a 1.87-fold 
increase in the amount (6.17%) of necrotic cells when compared to the control. 
L-canavanine has been shown to possess cytotoxic effects on many human cancer cell lines 
such as the colon cancer cell line HT-29 (Green and Ward, 1983), the uterine sarcoma cell 
lines MES-SA and Dx-5, the leukaemia cells lines K562 and K562-R7 (Worthen et ai. , 1998), 
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the lung adenocarcinoma cell line A549 (Ding et aI., 1999), the bladder cancer cell line HTB9, 
the cervical cancer cell line HeLa (Bence and Crooks, 2003) as well as the pancreatic cell lines 
MIA PaCa-2 (Swaffar et aI., 1994), PANC-1 , CFPAC-1, Capan-1 and BxPC-3 (Bence et ai., 
2003). In addition, L-can does not only mediate cytotoxicity when evaluated in vitro, but also 
possesses the capacity to mediate shrinkage of tumour growth in both mice (Green et aI., 1980) 
and rats (Thomas et aI., 1980). 
Table 7.1: The percentage of viable, apoptotic and necrotic cells determined using 
flow cytometry. 
Sample % Viable cells % Apoptotic cells % Necrotic cells 
Control 94.3 2.16 3.3 
SF 95.4 2.73 1.48 
L-can 59.8 33.6 6.17 
AFBJ 93.7 4.49 1.65 
SF-AFBJ 95.8 2.58 1.02 
L-can-AFBJ 97.8 0.79 1.1 
The induction of apoptosis is an efficient strategy for cancer therapy. Using human acute 
leukaemia Jurkat T cells, Jang et al. (2002) investigated whether apoptosis is associated with 
the anticancer activity of L-can. It was reported that cell viability was 35% after a 36 h 
treatment period with 2.5mM L-can. DNA fragmentation was also easily detectable at 2.5mM 
L-can. In addition, flow cytometric analysis revealed that the sub-G! phase, which represents 
apoptotic cells, increased in a dose-dependent manner (1.25, 2.5, 5.0mM). Western blotting 
conducted by these authors showed that the level of active caspase-3 also increased 
concentration-dependently. The authors concluded that L-can-induced apoptotic DNA 
fragmentation accompanied the activation of caspase-3. 
L-canavanine may influence apoptosis via a number of mechanisms. One of the proposed 
apoptotic-inducing mechanisms of L-can involves its influence on NO synthesis. Nitric oxide 
synthases synthesise NO from L-arg. It has been established that L-can is an analogue of L-arg 
and further demonstrated that L-can functions as an alternate substrate for the NOS reaction 
(Luzzi and MarIetta, 2005) thus preventing the synthesis of NO. 
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One of the key mechanisms by which NO regulates the function of various target proteins is 
through S-nitrosylation, a biochemical process which involves the reversible coupling of NO to 
a reactive cysteine thiol leading to the formation of molecules referred to as S-nitrosothiols 
(Iyer et aI., 2008). Formation of nitrosylated proteins is an important, post-translational 
modification of protein structure which modulates protein function (Kim et al., 2001). 
Nitric oxide is known to inhibit apoptosis through S-nitrosylation of various proteins that are 
involved in the apoptotic cascade. An example is the nitrosylation of pro-apoptotic caspases 
such as caspase-8, 9 and 3 at their active site cysteine which subsequently inhibits their 
enzymatic activity (Iyer et al., 2008). 
Fas ligand is able to induce the down-regulation of cFLIP via ubiquitin-mediated proteasomal 
degradation (lyer et aI., 2008). It has been demonstrated that cFLIP can be nitrosylated, 
thereby preventing its ubiquitination and subsequent degradation. Since cFLIP is a key 
regulator of death receptor signalling that inhibits the recruitment of procaspase 8 to the DISC, 
its nitrosylation is therefore an important mechanism via which NO inhibits apoptosis (Dash et 
aI., 2007). Similarly, nitrosylation of Bcl-2 prevents its ubiquitination and subsequent 
degradation. Bcl-2 and cFLIP are anti-apoptotic proteins. Therefore, prevention of their 
degradation by nitrosylation will promote their anti-apoptotic activity and thus the anti-
apoptotic properties of NO (Iyer et aI., 2008). 
Protein kinase C plays an important role in apoptosis. Phosphorylation of cFLIP by PKC has 
been shown to prevent its recruitment to the DISC and to thus sensitise cells to apoptosis. It has . 
been demonstrated that in normal cells, NO inhibits the activity of PKC via nitrosylation. This 
process leads to prevention of the phosphorylation of cFLIP by PKC thus allowing cFLIP to be 
recruited to the DISC, essentially blocking the activation of caspase-8 and preventing apoptosis 
(Dash et aI., 2007). 
Nitric oxide is present in high concentrations in blood, extracellular fluid and also at even 
higher concentrations within cells. Due to its lipophilic nature, it can rapidly cross cell 
membranes and enter intracellular compartments where it interacts with and activates its target 
protein, a haem-containing protein, guanylyl cyclase. Activation of guanylyl cyclase by NO, 
leads to the formation of cyclic GMP (cGMP) from the nucleotide GTP (Bruckdorfer, 2005). 
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Cyclic GMP-dependent mechanisms can be mimicked by an analogue of cGMP, 8-bromo-
cGMP. In PC12 cells, 8-Bromo-cGMP blocked caspase-3 activity and activation as well as 
cytochrome c release. Apoptosis was also affected in hepatocytes after exposure to 8-Bromo-
cGMP which mediated a reduction in TNFa-induced apoptosis and caspase-3 activity (Kim et 
aI., 2(01). 
Another mechanism of cGMP-dependent inhibition of apoptosis by NO involves ceramide. In 
human U937 monocytes, ceramide was shown to potentiate, whereas NO inhibited TNFa-
induced TRADD recruitment and caspase activity (Kim et aI., 2001). 
Tissue trans glutaminase (TGase) is a member of the TGase family catalysing protein cross-
linking by transamidation. There are several classes of enzymatically active TGases identified 
as having an important role in packing the cell at the late phase of apoptosis to prevent a 
massive inflammatory process (Sreedhar and Csermely, 2004). Another target of NO which 
serves as an apoptotic effector molecule is the TGases. S-nitrosylation of the tissue TGase 
active site by NO prevents apoptosis due to inhibition of the enzyme (Kim et aI., 2001). 
Experiments in lurkat cells have demonstrated that NO attenuates apoptosis by inhibiting 
Apaf-llcaspase-9 and subsequently promotes the formation of an inactive apoptosome 
complex (Li and Wogan, 2005). 
Since L-can is an inhibitor of NO synthesis, it would therefore prevent the anti-apoptotic 
properties of NO. This may be a possible mechanism by which L-can induces apoptosis. 
It is well established that L-can induces the synthesis and subsequent accumulation of 
misfolded proteins due to its structural similarity to L-arg. The accumulation of aberrantly 
folded proteins within the cell and in the ER specifically, may result in a proposed overload of 
the ER (Remy et aI., 1998), a consequence of which is ER stress, and leads to Ca2+ efflux from 
the lumen of the ER as well as the release of reactive oxygen from the mitochondrion (Hsieh et 
aI., 2(07). The released ROS may contribute to oxidative stress but the Ca2+ may contribute to 
cellular lethality in a variety of ways. For example, normal cytoskeletal organisation is 
perturbed when intracellular Ca2+ increases, apparently as a result of Ca2+ -mediated 
dissociation of actin microfilaments and an activation of phospholipases and proteases. In 
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addition, the released Ca2+ can also activate certain endonucleases, which results in DNA 
fragmentation and chromatin condensation (Amdur et ai., 1991), two morphological hallmarks 
of apoptosis (Edinger and Thompson, 2004; Stander et ai., 2(07). Lastly, the released Ca
2
+ can 
activate ROS producing enzymes such as cyclooxygenase and/or lipooxygenase (Remy et ai., 
1998) further contributing to oxidative stress and cellular damage. 
The ability of L-can to elicit a marked oxidative effect in HepG2 cells was revealed in the 
present study as indicated by the high level of lipid peroxidation induced by the compound 
(Chapter 4). Therefore, L-can-induced ROS may be a further mechanism which contributed to 
the observed cellular lethality, since excess oxidative stress kills cells either by apoptosis or 
necrosis (Kannan and Jain, 2000). 
It has been suggested that ROS, and related secondary oxidant species such as lipid 
hydroperoxides, might be triggers or mediators of apoptosis (Raffray and Cohen, 1997). 
Apoptosis may serve as a fail-safe device to prevent cells from proliferating uncontrollably in 
the face of persistent oxidative stress (Kannan and Jain, 2(00). 
Candidate mechanisms underlying ROS-stimulated apoptosis may differ but probably include 
either p53-mediated effects due to DNA strand breaks or cellular sensors detecting non-
specific changes, for example Ca2+ accumulation, A TP depletion, and thiol group disturbance 
(Raffray and Cohen, 1997). In addition, it has been suggested that the global shutdown of 
mitochondrial function under conditions of oxidative stress could contribute to apoptosis 
because of the ' dramatic depletion in cellular energy supply (Kannan and Jain, 20(0). In 
contrast, ROS-mediated lipid peroxidation end products such as 4HNE have been shown to 
induce necrotic cell death (Proskuryakov et ai. , 2(03). 
Thus, it seems that oxidative stress induces an apoptotic response when cells can maintain their 
reducing capacity against ROS, whereas necrosis is triggered when this reducing homeostasis 
is disturbed, for example by excess of ROS or damage of natural antioxidative systems 
(Proskuryakov et ai., 2(03). 
127 
The inhibitory effects of L-can on mitochondrial function as demonstrated by Wilkie (1970) 
and Winston and Bosmann (1971) may also contribute to mitochondrial ROS generation as 
well as depletion in cellular energy, both of which can prompt cell death. 
On the basis of western blotting, the highest level of p53 expression was observed after L-can 
administration (Chapter 6). Tumour suppressor protein p53 triggers a variety of cell cycle 
regulatory events to limit the proliferation of damaged cells. The ability of this 'gate keeper' 
gene to inhibit cell growth is due, at least in part, to its ability to bind to specific DNA 
sequences, and activate the transcription of target genes which encode proteins involved in cell 
cycle control (p21, Mdm2) and apoptosis (PIG3, Bax, DR5, PUMA, p53AIP1) (Zhang et aI., 
2008). The findings of this study therefore suggest that induction of p53 by L-can (Chapter 6) 
could act as a transcriptional activator for the high level of apoptosis induced by the 
compound. 
Western blotting also demonstrated that exposure to L-can impaired Hsp70 induction in HepG2 
cells (Chapter 6). This absence of an important protective mechanism could be relevant for the 
cumulative destructive effects of L-can thus leading to the observed levels of apoptosis and 
necrosis. 
Cellular lethality may also be mediated by L-canaline. It has been reported that stable oximes 
are formed following the rapid reaction of L-canaline with glyoxylate and other 2-oxo acids. 
The ability of L-canaline to form oximes indicates its capacity to scavenge essential 2-oxo-
containing metabolites such as pyruvate and oxaloacetate, thus depleting TCA cycle reserves 
and interfering with A TP production (Rosenthal, 1997). Significant energy depletion will 
inevitably lead to loss of cell function and cell death (Amdur et aI., 1991). 
Other results revealed that treatment with SF for 24 h resulted in a 1.26-fold increase of the cell 
popUlation that was positive for Annexin-V staining (Table 7.1). The data exhibited that SF 
induced the exposure of PS on the surface of approximately 2.73% of HepG2 cells. In contrast, 
a 2.23-fold decrease in the amount (1.48%) of necrotic cells was noted after exposure to SF. 
Different types of cancer chemopreventive agents, including natural products have been 
studied for efficacy both in vitro and in vivo (Chou et al., 2003). Sutherlandia has been shown 
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to possess cytotoxic effects on many human cancer cell lines such as the prostate cancer cell 
line DU-145 (Steenkamp and Gouws, 2(06), MCF-7 (Steenkamp and Gouws, 2006; Stander et 
al., 2(07), the leukaemia Jurkat cell line, the mammary adenocarcinoma cell line MDA-MB-
468, as well as the promyelocyte cell line HL60 (Tai et al., 2004). 
Recently, extracts prepared from a variety of plants were demonstrated to possess the ability in 
triggering the apoptotic pathway (Chou et al., 2(03). In this regard, Chinkwo (2005) 
investigated the apoptotic properties of a crude aqueous SF whole plant extract. Results 
showed that CHO cells exposed to SF exhibited several morphological features (PS 
externalisation, chromatin condensation, and DNA fragmentation) associated with apoptosis. 
In addition, other results from the same study revealed that 84% of Jurkat T cells were 
apoptotic following Annexin-V staining and analysis by flow cytometry. The author suggested 
that there were active constituents in the plant extract that induced the observed morphological 
changes and cell death. 
Incidentally, one of the bioactive compounds isolated from SF is flavonoids (van Wyk, 2(08). 
Flavonoids have been shown to possess apoptotic effects on some cancer cells such as colon 
cancer cells, cervical cancer cells, prostate cancer cells, lung cancer cells and oesophageal 
cancer cells (Zhang et al., 2(08). Therefore, apoptosis induced by SF may be attributed to the 
presence and activity of flavonoids present within the plant extract. 
The observed levels of apoptosis and necrosis induced by SF (Table 7.1) may also be ascribed 
to the cytotoxic potential of L-can present within the plant extract. 
Other results in this study revealed SF to induce significantly low levels of lipid peroxidation 
accompanied by a marked increase in cellular GSH levels (Chapter 4). As a result, it is unlikely 
for SF-induced apoptosis to be a consequence of oxidative stress. 
From apoptosis and necrosis profiles using flow cytometry, it was determined that AFB\ 
exerted a distinct apoptotic effect. When evaluated against the control (Figure 7.2), HepG2 
cells treated with AFB\ exhibited a 2.08-fold increase apoptosis (Figure 7.3). In contrast, a 2-
fold decrease in the amount (1.65%) of necrotic cells was observed after AFB\ exposure (Table 
7.1). 
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Figure 7.2 Dot-plots showing Annexin-V-FITC versus propidium iodide fluorescence 
of HepG2 cells (control). 
The ability of AFBI to mediate apoptosis in HepG2 cells was previously investigated by 0' 
Brien et al. (2000). These authors demonstrated that AFBI produced DNA fragmentation in a 
dose-dependant (l-80J!M) manner. Additional analysis by flow cytometry revealed a dose-
dependent increase in apoptotic cells by AFB 1• To further conftrm that cell death was mediated 
via apoptosis, these authors employed the TUNEL assay and observed a dose-dependent 
increase in TVNEL-positive cells. 
In addition, Reddy et al. (2006) reported the development of several morphological features 
associated with apoptosis when HepG2 cells were incubated with AFBI (l1J!glml). These were 
chromatin condensation, DNA fragmentation, nuclear breakdown, membrane blebbing and cell 
fragmentation with the formation of apoptotic bodies. 
The results of the present study correspond to the ftndings of 0' Brien et al. (2000) and Reddy 
et al. (2006) by demonstrating that AFB 1 induces apoptosis of HepG2 cells. 
Caspase-3 plays a major role in the execution of apoptotic cell death (Meki et al., 2004). In this 
regard, a number of studies, both in vivo (Meki et al., 2001; EI-Gibaly et al., 2003; Meki et al., 
2004; Abbes et al. , 2008) and in vitro (Guerra et al., 2005; Van Vleet et al., 2006) have 
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demonstrated increases in caspase-3 activity by AFBI and suggested that caspase-3 activation 
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Dot-plots showing Annexin-V -FITC versus propidium iodide fluorescence 
of HepG2 cells (AFB1). 
In addition, caspase-3 substrate cleavage has been observed under oxidative stress. 
Incidentally, one of the manifestations of AFBI-induced toxicity is oxidative stress, and it is 
accepted that oxidative stress is an apoptotic inducer (Meki et ai., 2004). 
Therefore, on the basis of previous studies (Shen et ai. , 1994; Shen et ai., 1995, Shen et ai., 
1996; Madhusudhanan et ai. 2004; Meki et ai., 2004; Lee et ai., 2005; Jodynis-Liebert et ai., 
2006; Preetha et ai. , 2006) which have outlined the capacity of AFBJ to mediate oxidative 
stress as well as the results of the TBARS assay from the present study (Chapter 4), it is 
suggested that AFBJ-induced ROS may be a potential mechanism which contributed to the 
observed levels of apoptosis and necrosis (Figure 7.3). Furthermore, the capacity of AFBJ to 
influence mitochondrial function, specifically the ETC (Doherty and Campbell, 1973; Pai et 
ai., 1975; Obidoa and Obonna, 1981; Obidoa, 1986) is also suggested to contribute to 
mitochondrial ROS generation as well as A TP depletion, the consequence of which may be 
cellular lethality via apoptosis or necrosis. 
Studies have shown that AFBI possesses DNA damaging potential due to its ability to mediate 
a marked genotoxic effect (Amstad et ai., 1984; EI-Khatib et ai., 1998; O'Brien et ai., 2000; 
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Raj et al., 2001; Ehrlicha et al. , 2(02). It has been demonstrated that AFBl is metabolised to an 
epoxide which produces DNA adducts causing DNA strand breaks and point mutations (Meki 
et al., 2004). Accordingly, the results of the comet assay (Chapter 5) revealed AFB} to mediate 
a marked increase in DNA migration when compared to the control. One of the responses of 
normal cells to severe DNA damage is the induction of cell death by apoptosis (Raj et al. , 
2(01). Therefore, the significant DNA damage induced by AFB} may also serve as a trigger for 
the 2.08-fold increase in apoptosis (Figure 7.3). 
After 24 h of incubation in the presence of SF-AFB}, approximately 2.58% of cells were 
positively stained with Annexin-V (Table 7.1). When evaluated against the control (Figure 
7.2), it was revealed that this combination (Figure 7.4) evoked a marginal 1. 19-fold increase in 
the number of apoptotic cells. In contrast, a minimal 1.06-fold decrease was noted when 
apoptosis levels induced by SF-AFB} were compared to that mediated following individual 
administration of SF. However, when compared to AFB}-exposed cells, treatment with the 
same combination mediated a marked (1.74-fold) antagonistic effect on apoptosis levels. In 
addition, PI staining revealed only 1.02% of HepG2 cells to exhibit necrosis when incubated 
with SF-AFB} . 
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Figure 7.4 Dot-plots showing Annexin-V-FITC versus propidium iodide fluorescence 
of HepG2 cells (SF -AFBl)' 
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It has been well documented that AFBI requires metabolic activation by CYP3A4 to form the 
highly reactive AFB 1-exo-8,9-epoxide in order to exert its cytotoxic effects. As previously 
mentioned (Chapter 5), Mills et al. (2005b) reported significant decreases in CYP3A4 activity 
by SF. Thus, the protective effect of SF towards AFBJ-induced apoptosis can be ascribed to its 
inhibition of CYP3A4 activity and subsequent AFBI bioactivation. 
The observed protective effects of SF may also be due to its antioxidant and free radical 
scavenging properties as reported by Fernandes et ai. (2004) and Tai et al. (2004). In addition, 
the high levels of GSH observed following the co-administration of SF-AFBI (Chapter 4) 
suggests enhanced anti-oxidant status of the cells, a condition which would effectively 
ameliorate AFBJ-induced ROS as well as facilitate enhanced conjugation of AFBJ-epoxides 
with GSH for AFBJ detoxification. 
Heat shock proteins are important regulators of lethal programs. The most studied of them is 
Hsp70, which can inhibit apoptosis caused by various stimuli. In addition, the overexpression 
of Hsp's has been shown to protect cells from necrosis as well (Proskuryakov et ai., 2003). 
Based on the results of western blotting (Chapter 6), the protective effect of SF against AFB J-
induced apoptosis and necrosis can also be attributed to the significant (p<0.001) increases in 
Hsp70 and Hsp90 expression induced by SF-AFBJ. 
Another protective mechanism which can be envisioned is related to the upregulation of p53. It 
is presumed that the increased levels of p53 induced by SF-AFBJ (Chapter 6) is able to mediate 
cell cycle arrest in order to facilitate efficient repair of AFBJ-induced DNA damage thus 
protecting cells against apoptosis and necrosis. 
A minimal amount of cells were detected in an apoptotic (0.79%) or necrotic (1.1 %) state by 
FACS analysis of HepG2 cells treated with L-can-AFBJ for 24 h (Table 7.1). Further analysis 
revealed that this combination (Figure 7.5) mediated evident decreases in the levels of 
apoptosis (2.73-fold) and necrosis (3-fold) when compared to the control (Figure 7.2). When 
compared to AFBJ-exposed cells, further antagonism by L-can-AFB J on apoptosis (5.68-fold) 
and necrosis (1.5-fold) was noted. In addition, when evaluated against L-can treated cells, L-
can-AFB J evoked an astounding 32.81 % decrease in apoptosis levels accompanied by a 5.6-
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Figure 7.5 Dot-plots showing Annexin-V-FITC versus propidium iodide fluorescence 
of HepG2 cells (L-can-AFB1). 
Van Ness et al. (1998) found that lysine residues are important for conferring high AFB 1-
epoxide conjugation activity. In addition, studies have shown that the AFBI dialdehyde 
condenses with the epsilon amino group of lysine to form a Schiffs base (Sabbioni et al., 
1987; Amaya-Farfan, 1999; Guengerich et al., 2(02). It is proposed that these are the 
mechanisms by which AFB 1 forms adducts with proteins such as albumin (Sabbioni et al., 
1987; Chih et al., 1993; Amaya-Farfan, 1999; Guengerich et al. , 2(02) and histones (Yu et al., 
1988; Chih et al., 1993), both of which are rich in lysine. 
It is also known that albumin contains a high concentration of L-arg in its peptide chain (Aoki 
and Takeuchi, 1997; Bosshart and Heinzelmann, 2002) and that L-arg is abundant in histones 
as well (Jenuwein and Allis, 2001). Therefore, in addition to binding to the side-chain amino 
group of lysine, it is proposed that AFBI and/or its metabolites are also able to condense with 
L-arg possibly via the strongly basic nitrogen atoms in its guanidine moiety (Tornqvist et al., 
2(02). This postulation is substantiated by many studies which have documented that AFB 1 
inhibits NO synthesis by possibly binding to L-arg (Moon, 1998; Moon and Pyo, 1999; Moon 
et al., 1999a; Moon et al., 1999b; Moon et al., 1999c). 
Because L-can is an analogue of L-arg, it is possible for AFBI and/or its metabolites to also 
bind to L-can, most probably via its oxyguanidino group. It is therefore suggested that when 
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combined, AFBI becomes sequestered by L-can thereby forming an adduct and reducing the 
cytotoxicity of each compound resulting in the observed lower levels of apoptosis and necrosis 
(Figure 7.5). 
The decreases in the levels of apoptosis and necrosis may also be due to the protective effect 
afforded by the overexpression of Hsp's induced by L-can-AFB 1 co-administration (Chapter 
6). In addition, results of the GSH assay (Chapter 4) reveal the highest level of GSH to be 
present after exposure of cells to L-can-AFB 1• Thus, the enhanced anti-oxidant status of the 
cells may have provided efficient protection against ROS-mediated cellular lethality. This is 
further evidenced by the significant decreases in lipid peroxidation following administration of 
L-can-AFBl, when compared to that induced by individual administration of each compound 
(Chapter 4). It is also possible that the highly electrophilic AFBl-epoxides may have been 
diverted to detoxification rather than interaction with cellular biomolecules owing to the 
increased GSH levels. 
The low levels of apoptosis and necrosis by this combination (L-can-AFB 1) can additionally be 
attributed to the increased p53 levels (Chapter 6), which play an important role in arresting the 
cell cycle and mediating DNA repair thus preventing cell death. 
The ability of these compounds to act in combination and influence cell viability is not fully 
understood. However, it is presumed that the effects induced by such combination may be due 
to the capacity of each compound to influence the bioactivity of the other when combined. 
7.6 Conclusion 
Apoptosis is among the number of pathways that can be exploited for cancer prevention and 
treatment (Zhang et a!., 2008). In this regard, the results of the present study not only 
corroborate the findings of many published studies but it also confirms the potential of L-can 
as an anti-cancer agent due its potent apoptotic-inducing properties. 
Other findings of this study provide scientific evidence demonstrating the ability of SF and L-
ean to attenuate the apoptosis-inducing activity of AFB 1• 
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The stronger effect of L-can compared to the SF extract is probably because it was applied in a 
higher concentration than that which is present in the extract, indicating a concentration 
dependent effect. 
Overall, flow cytometry was shown to be a valuable procedure as it offered the opportunity to 
evaluate a number of parameters. It can be efficiently utilised to analyse mechanisms of toxic 
insult by measuring aspects of the cell cycle, disruption of the mitochondrial membrane 
potential or induction of apoptosis or necrosis. The ease of the application and the high 




Aflatoxin B}, a food contaminant, has been implicated as a causative agent in human hepatic 
and extrahepatic carcinogenesis (Awney et ai., 2002). 
It is suggested that oxidative damage caused by AFB} may be one of the underlying 
mechanisms of AFB}-induced cell injury and DNA damage, which eventually leads to 
carcinogenesis. In this study, it was shown that AFB} exposure caused a significant increase in 
the level of TBARS, an index of cellular lipid peroxidation, thereby confirming that ROS is 
involved in AFB}-induced cellular injury of HepG2 cells. To date, little or no experimental 
evidence exists showing the exact source of ROS which initiates lipid peroxidation in AFB}-
exposed HepG2 cells. Therefore, further research is required for the direct detection of ROS 
formed inside hepatocytes following AFB} exposure. It was also noted that supplementation 
with L-can significantly reduced AFB}-induced lipid peroxidation which can be attributed to 
the enhanced antioxidant status of cells as evidenced by the increase of intracellular GSH 
content. 
The hepatotoxicity induced in HepG2 cells by AFBI was further confirmed by results of the 
comet assay which revealed the strongest effect to be observed after exposure to the toxin and 
it is notable in this context that AFB} has been ranked as one of the most potent human 
carcinogens (UbI et ai., 2000). More importantly, the results also indicate the efficacy of SF 
and L-can to significantly reduce AFB}-induced DNA damage. 
Flow cytometry was found to be a suitable tool for cell viability determination and showed that 
AFB 1 exerted a distinct apoptotic effect. In contrast, Annexin-V-PI staining demonstrated that 
SF and L-can ameliorated AFB I-induced increases in apoptosis and necrosis. 
A wide variety of compounds have been shown to provide protection against AFB}-induced 
hepatotoxicity. Many of these compounds are able to modulate AFB}-induced hepatotoxicity 
by mediating alterations in biotransformation pathways (Klein et ai., 2002). In this regard, a 
possible mechanism of protective action exerted by SF in AFB}-treated HepG2 cells is related 
to a study conducted by Mills et ai. (2005b), who demonstrated the ability of SF to decrease 
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CYP3A4 activity. Incidentally, CYP3A4 is the key enzyme involved in the bioactivation of 
AFB\ to the highly reactive AFB\-exo-8,9-epoxide. Therefore, a proposed mechanism by 
which SF reduces AFB\-induced toxicity is via a decrease in the activity of CYP3A4, leading to 
a decrease in AFB\-exo-8,9-epoxide formation and consequently reduced toxicity. 
According to its chemical composition and biological properties, further mechanisms of 
cytoprotection afforded by SF possibly include: a) a blockade of initial DNA damage, related 
to the presence of flavonoids (van Wyk, 2008) and their ability to act as a scavengers of free 
radicals (Fernandes et ai., 2004; Tai et ai., 2004) as well as b) an inactivation/detoxification of 
carcinogenic AFB\ metabolites, which is related to its antimutagenic activity (Reid et ai., 2006; 
Ntuli et ai., 2007). 
The most important detoxification mechanism of the AFB\-exo-8,9-epoxide is via GST 
mediated conjugation with GSH (Lee et ai., 2005). In this regard, protection against AFB\-
induced cytotoxicity may result from enhanced conjugation of AFB\ metabolites with GSH to 
facilitate AFB\ detoxification. This is presumed based on the elevated levels of intracellular 
reduced GSH after co-administration of SF and L-can with AFB \. 
Cytoprotection by SF and L-can against AFB\-induced toxicity is further substantiated by the 
significant increases in the expression of Hsp70, a protein, which when overproduced enhances 
cell survival (Gabai et ai., 1997). 
In conclusion, the results documented in the present study support the potential of an aqueous 
extract of SF as an effective cytoprotective agent. The bioactivity of SF is possibly related to 
the combined effects of the many phytochemicals found within the extract, thereby resulting in 
a relatively complex mechanism of action. In this regard, further investigation is warranted for 
the isolation and characterisation of individual compounds to elucidate their structure and 
functional capacity, which may be helpful in understanding the regulatory system of the 
bioactivity of AFB\ by such natural compounds. Overall, the above-mentioned properties of 
SF, together with its low toxicity, suggest that this plant may hold future promise as a 
protective feed additive, which can be utilised as part of an overall management strategy to 
improve human health. 
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Table A1: Components present in EMEM. 









Other components . 
Glucose 1000.00 
















Choline chloride 1.00 








Table A2: Absorbance's and concentrations of standards. 















































y = 1.2698x + 0.0345 
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Figure AI: BSA protein concentration versus average absorbance. 
Figure Al (values obtained from Table A2) was constructed as a standard curve. The equation 
defining the curve (y = 1.2698x + 0.9835) was used to determine the protein concentration of 
each sample (Table A3). 
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Table A3: Absorbance's and concentrations of samples. 
Sample ABS (1) ABS (2) AvgABS Sample (mg/ml) 
Control 2.216 2.370 2.293 1.8 
SF 1.895 1.955 1.925 1.5 
L-can 2.125 1.949 2.037 1.6 
AFBi 2.034 2.144 2.089 1.6 
SF-AFBi 1.683 1.817 1.750 1.4 
L-can-AFBi 2.266 2.064 2.165 1.7 
Table A4: Standardisation of proteins to Img/ml (200,11) using storage buffer. 
Sample Sample (mg/ml) Sample (111) SB (111) 
Control 1.8 112 88 
SF 1.5 134 66 
L-can 1.6 127 73 
AFBi 1.6 124 76 
SF-AFBi 1.4 148 52 
L-can-AFBi 1.7 119 81 
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Papers 
A scientific paper titled "The effects of L-canavanine and aflatoxin Bl in HepG2 cells" is 
currently in progress and will shortly be submitted to Toxicology in Vitro. 
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